PDB_ID,Title,Protein_description,NChain,Chain_ID,Num_Res,Complex,Discarted_Ligands,Ligand,Ligand_names,Ligand_types,Ligand_functions,Covalent_Bond,Bond,FASTA_ID,Mutation,Mutation_Location,Identity,Gaps
8dmd,Room temperature X-ray structure of SARS-CoV-2 main protease in complex with compound ZZ4461624291,3C-like proteinase,1,A,306,Yes,,SVL,1-[(3R)-4-[(3-chlorophenyl)methyl]-3-(2-methylpropyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tek,SARS-CoV-2 3CLPro in complex with N-(4-(1H-pyrazol-4-yl)phenyl)-N-(3-chlorobenzyl)-2-(pyridin-3-yl)acetamide,3C-like proteinase,1,A,306,Yes,,I2D,N-[(3-chlorophenyl)methyl]-N-[4-(1H-pyrazol-4-yl)phenyl]-2-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rfu,Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor,3C-like proteinase,1,A,306,Yes,,4YG,"(1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-[N-(methanesulfonyl)-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6xa4,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW241,3C-like proteinase,1,A,308,Yes,GOL,PRD_002391,inhibitor UAW241,Oligopeptide,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
5rfb,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1271660837,3C-like proteinase,1,A,306,Yes,DMS,K3S,"N-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]ethanamine",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7sfb,SARS-CoV-2 Main Protease (Mpro) in Complex with ML101,3C-like proteinase,1,A,306,Yes,"PGE
PEG",90U,"benzyl (1R,2S,5S)-2-({(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7t48,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 9c,3C-like proteinase,1,A,309,Yes,CL,"FHS
FEY","(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[7-(phenylacetyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid
(1R,2S)-2-{[N-({[(2r,4R)-7-acetyl-7-azaspiro[3.5]non-5-en-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8sxo,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H164I Mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,H164I,99.67,0
8f2c,SARS-CoV-2 Main Protease (Mpro) in Complex with ML3006a,3C-like proteinase nsp5,1,A,306,Yes,CL,X9Z,"(1R,2S,5S)-N-[(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-(2-oxopyrrolidin-1-yl)butan-2-yl]-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8u4y,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) L50F Mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,L50F,99.67,0
8d4n,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) E166Q Mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,E166Q,99.67,0
7nts,Crystal structure of the SARS-CoV-2 Main Protease with oxidized C145,Replicase polyprotein 1ab,1,A,306,No,"DMS
GOL
FMT",,,,,,,6LU7_1|Chain,0,,100.00,0
5rh3,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1264525706 (Mpro-x2649),3C-like proteinase,1,A,306,Yes,DMS,UHA,(2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ddi,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) E166N Mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,E166N,99.67,0
5ree,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2217052426,3C-like proteinase,1,A,306,Yes,DMS,T1M,"(2R,3R)-1-benzyl-2-methylpiperidin-3-ol",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8tqt,MPI52 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,K2X,"(3-chlorophenyl)methyl [(2S)-3-cyclohexyl-1-({(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}amino)-1-oxopropan-2-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7jpy,Crystal structure of the SARS-CoV-2 main protease in its apo-form,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gs2,Crystal structure of SARS-CoV-2 main protease in complex with cpd-25,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",5F8,3-(pyridin-3-yl)benzoic acid,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvy,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI25,3C-like proteinase,1,A,306,Yes,,7YQ,O-tert-butyl-N-{[(3-chlorophenyl)methoxy]carbonyl}-L-threonyl-3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7gf4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-17 (Mpro-x11560),3C-like proteinase,1,A,306,Yes,DMS,O1X,(2S)-2-(difluoromethoxy)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grm,Crystal structure of SARS-CoV-2 main protease in complex with cpd-9,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",ZHA,"~{N}-(5-oxidanylidene-7,8-dihydro-6~{H}-naphthalen-2-yl)ethanamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ay7,Structure of SARS-CoV-2 Main Protease bound to Isofloxythepin,3C-like proteinase,1,A,306,Yes,"DMS
IMD
PEG",S8T,"9-fluoranyl-3-propan-2-yl-5,6-dihydrobenzo[b][1]benzothiepine",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lzx,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 1c,3C-like proteinase,2,"A,B",309,Yes,PG4,"YMG
YMD","(1S,2S)-2-((S)-2-((((4,4-dimethylcyclohexyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-((((4,4-dimethylcyclohexyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7sh9,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI86,3C-like proteinase nsp5,1,A,306,Yes,,9HA,"benzyl [(2S,3R)-1-({(2S)-1-[2-acetyl-2-(3-amino-3-oxopropyl)hydrazinyl]-3-cyclohexyl-1-oxopropan-2-yl}amino)-3-tert-butoxy-1-oxobutan-2-yl]carbamate (non-preferred name)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gi8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-45817b9b-1 (Mpro-P0060),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QDF,"(4R)-6-chloro-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0e5afe9d-3 (Mpro-x12699),3C-like proteinase,1,A,306,Yes,DMS,PJ6,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gn2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-e69ed63d-1 (Mpro-P2273),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RS6,"(4S)-6-chloro-N-(7-fluoroisoquinolin-4-yl)-1-oxo-2-{2-oxo-2-[(propan-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8j36,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",298,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,M49I,97.06,8
7b2u,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 1,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,SQ5,"(5S)-5-(cyclohexylmethyl)-3-(5-fluoropyridin-3-yl)imidazolidine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dw6,SARS-CoV-2 Mpro mutant (H41A) in complex with nsp15|16 peptidyl substrate,"3C-like proteinase
nsp15/16 peptidyl substrate",2,"A,B","306, 20",No,,,,,,,,6LU7_1|Chain,"1
4","H41A
T190S, A191S, T257P, I259V","99.67
5.23","0
286"
7en9,Crystal structure of SARS-CoV-2 3CLpro in complex with the non-covalent inhibitor WU-02,3C-like proteinase,1,A,306,Yes,,J7O,"5-bromanyl-~{N}-methyl-3-nitro-2-[(4~{R},5~{S})-2-(7-oxidanylisoquinolin-4-yl)carbonyl-4-phenyl-2,7-diazaspiro[4.4]nonan-7-yl]benzamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8fy7,SARS-CoV-2 main protease in complex with covalent inhibitor,3C-like proteinase nsp5,2,"A,B",306,Yes,,YFK,4-methoxy-N-[(2S)-4-methyl-1-oxo-1-({(2S)-1-[(3S)-2-oxopyrrolidin-3-yl]but-3-en-2-yl}amino)pentan-2-yl]-1H-indole-2-carboxamide,non-polymer,,Yes,"CYS, 145-(YFK, .)",6LU7_1|Chain,0,,100.00,0
7gk4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-bb7ffe78-1 (Mpro-P0777),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QTC,2-(3-chloro-5-ethylphenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rg2,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with NCL-00025058,3C-like proteinase,1,A,306,Yes,DMS,T9M,N~2~-acetyl-N-prop-2-en-1-yl-D-allothreoninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5re6,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z54571979,3C-like proteinase,1,A,306,Yes,DMS,O0S,N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7uub,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI12,3C-like proteinase nsp5,1,A,306,Yes,DMS,7VB,N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methylidene-L-norvalinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8tpg,"Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease",Non-structural protein 7,1,A,305,Yes,,JKL,(3R)-N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-3-hydroxybutanamide,non-polymer,,No,,6LU7_1|Chain,0,,99.67,1
7gdt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAK-UNK-0d6072ac-20 (Mpro-x11223),3C-like proteinase,1,A,306,Yes,DMS,N00,(2R)-2-(6-chloro-1-methyl-9H-carbazol-2-yl)propanoic acid,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gb4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAR-DIA-23aa0b97-6 (Mpro-x10178),3C-like proteinase,1,A,306,Yes,DMS,KO9,N-(5-cyanopyridin-3-yl)-2-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfe,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z509756472,3C-like proteinase,1,A,306,Yes,DMS,JGG,N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7m8p,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 23,3C-like proteinase,2,"A,B",306,Yes,,YSJ,"5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6zru,Crystal structure of SARS CoV2 main protease in complex with inhibitor Boceprevir,Main Protease,1,A,306,Yes,DMS,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7k0f,1.65 A resolution structure of SARS-CoV-2 3CL protease in complex with a deuterated GC376 alpha-ketoamide analog (compound 5),3C-like proteinase,2,"A,B",309,Yes,PG4,VR4,"N-{(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-N~2~-[(benzyloxy)carbonyl]-L-leucinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
8r0v,"SARS-CoV-2 Mpro (Omicron, P132H) in complex with alpha-ketoamide 13b-K at pH 6.5",3C-like proteinase nsp5,4,"A,B,C,D",306,Yes,,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
7wo1,Discovery of SARS-CoV-2 3CLpro peptidomimetic inhibitors through H41-specific protein-ligand interactions,3C-like proteinase,1,A,306,Yes,,3XI,N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxidanylidene-1-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]pentan-2-yl]amino]-1-oxidanylidene-butan-2-yl]cyclohexanecarboxamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gb6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JOR-UNI-2fc98d0b-12 (Mpro-x10236),3C-like proteinase,1,A,306,Yes,DMS,KP0,N-(3-chlorophenyl)-N-(2-cyclohexylethyl)-N'-(pyridin-3-yl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdi,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-49816e9b-1 (Mpro-x11011),3C-like proteinase,1,A,306,Yes,DMS,M5I,N-(3-chlorophenyl)-2-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6m0k,The crystal structure of COVID-19 main protease in complex with an inhibitor 11b,3C-like proteinase,1,A,304,Yes,DMS,FJC,~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
8dkl,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,L89F,99.67,0
7gdc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-0a73fcb8-7 (Mpro-x10942),3C-like proteinase,1,A,306,Yes,DMS,M93,"(4R)-6-chloro-N-[4-(hydroxymethyl)pyridin-3-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lkr,1.65 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 2a,3C-like proteinase,2,"A,B",309,Yes,PG4,"Y4D
Y5S
Y8Y
Y91","(1R,2S)-2-((S)-2-(((((1R,3s,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1R,3s,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-(((((1R,3r,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1R,3r,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer
non-polymer
non-polymer","


","Yes
Yes
Yes
Yes","CYS145 A
CYS145 A
CYS145 B
CYS145 B",6LU7_1|Chain,0,,98.39,5
7sf3,SARS-CoV-2 Main Protease (Mpro) in Complex with ML1006m,3C-like proteinase,1,A,306,Yes,CL,90H,"(1R,2S,5S)-N-{(2S,3R)-3-hydroxy-4-(methylamino)-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7pfl,The SARS-CoV2 major protease (Mpro) apo structure to 1.8 A resolution,Replicase polyprotein 1ab,1,A,306,No,NA,,,,,,,6LU7_1|Chain,0,,100.00,0
8hhu,Crystal structure of the SARS-CoV-2 main protease in complex with SY110,3C-like proteinase nsp5,1,A,306,Yes,,LVX,"(1~{R})-3,3-bis(fluoranyl)-~{N}-[(2~{R})-3-methoxy-1-oxidanylidene-1-[[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(1,3-thiazol-2-ylmethylamino)butan-2-yl]amino]propan-2-yl]cyclohexane-1-carboxamide",peptide-like,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
7xb3,Crystal structure of SARS-Cov-2 main protease D48N mutant,Replicase polyprotein 1a,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,D48N,99.67,0
7gnm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-WEI-dcc3321b-2 (Mpro-P2761),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL
NA",S1L,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-{2-[3-(morpholin-4-yl)anilino]-2-oxoethyl}-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rme,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-52,3C-like proteinase,1,A,306,Yes,,5Z3,"6-{4-[4-chloro-3-(trifluoromethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7pzq,Oxidized form of SARS-CoV-2 Main Protease determined by XFEL radiation,3C-like proteinase nsp5,2,"A,B",306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
7gjt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-ba1ac7b9-11 (Mpro-P0642),3C-like proteinase,2,"A,B",306,Yes,DMS,QQU,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-{2-oxo-2-[(2R)-2-(1H-pyrazol-4-yl)piperidin-1-yl]ethyl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dz6,Crystal Structure of SARS-CoV-2 Main protease mutant Q189K in complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,Q189K,99.67,0
8k6c,Crystal structure of SARS-CoV-2 3CLpro M49K/S301P mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,2,"M49K, S301P",99.35,0
7vfa,the complex of SARS-CoV2 3CL and NB1A2,"NB1A2
3C-like proteinase",2,"A,B","152, 306",No,SO4,,,,,,,6LU7_1|Chain,"77
0","R4M, M6Y, A7L, F8L, T26A, L27A, N28A, L67A, V68A, G71A, N72Q, R76Q, V77E, I78S, F112G, L115A, N142R, G143L, G146A, S147V, V148S, F159S, C160V, H163W, H164F, M165R, E166Q, L167A, T175K, D176E, L177R, A193L, T196I, D197N, L205G, A206Y, W207T, L208T, A211D, V212S, I213V, N214K, A234I, M235S, Y237D, Y239S, P241N, L242T, T243L, Q244Y, D245L, H246Q, V247M, D248N, I249S, G251K, T257E, G258D, D263Y, M264Y, L268A, K269T, E270Y, T280F, I281A, L282S, G283L, P293N, D295P, V296Y, V297W, R298G, C300G, S301T, G302Q, F305H, Q306H
","19.81
100.00","178
0"
7gdo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c0c213c9-14 (Mpro-x11164),3C-like proteinase,1,A,306,Yes,DMS,MVR,N-[(1-methyl-1H-pyrazol-3-yl)methyl]-2-(pyridin-3-yl)-N-[4-(pyridin-2-yl)phenyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grk,Crystal structure of SARS-CoV-2 main protease in complex with cpd-7,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
NA",Y1H,"(6-fluoro-2H,4H-1,3-benzodioxin-8-yl)methanol",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ph4,Co-Crystal structure of the SARS-CoV2 main protease Nsp5 with an Uracil-carrying X77-like inhibitor,3C-like proteinase nsp5,2,"A,B",306,Yes,"MLI
NA
DMS",YQN,"~{N}-(4-~{tert}-butylphenyl)-~{N}-[(1~{S})-2-(cyclohexylamino)-2-oxidanylidene-1-pyridin-3-yl-ethyl]-2,6-bis(oxidanylidene)-5~{H}-pyrimidine-5-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rl0,PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-2 (Mpro-x3110),3C-like proteinase,1,A,306,Yes,DMS,VEG,ethyl N-[(2R)-2-[(4-tert-butylphenyl)(propanoyl)amino]-2-(pyridin-3-yl)acetyl]-beta-alaninate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gkb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-96f51285-5 (Mpro-P0831),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QVG,"(4R)-6-chloro-7-fluoro-N-(6-fluoroisoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-12c4873b-5 (Mpro-P2206),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RLR,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(3R)-2-oxopyrrolidin-3-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7xrs,Crystal structure of SARS-Cov-2 main protease in complex with inhibitor YH-53,Replicase polyprotein 1a,2,"A,B",299,Yes,,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"CYS, 143-(HUR, .)",6LU7_1|Chain,0,,97.71,7
7bgp,Crystal structure of MG-132 covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 in absence of DTT.,3C-like proteinase,2,"A,B",306,Yes,"EDO
CL
NA",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gf6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f42f3716-6 (Mpro-x11564),3C-like proteinase,1,A,306,Yes,DMS,O3I,"2-[(1M)-5-chloro-2',3'-difluoro-4'-methyl[1,1'-biphenyl]-3-yl]-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gl5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-10fcb19e-1 (Mpro-P1661),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R5O,"(4S)-6-chloro-N-{6-[(methanesulfonyl)amino]isoquinolin-4-yl}-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jq5,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI8,3C-like proteinase,1,A,306,Yes,,NOL,N-[(BENZYLOXY)CARBONYL]-O-(TERT-BUTYL)-L-THREONYL-3-CYCLOHEXYL-N-[(1S)-2-HYDROXY-1-{[(3S)-2-OXOPYRROLIDIN-3-YL]METHYL}ETHYL]-L-ALANINAMIDE,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5r7z,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1220452176,3C-like proteinase,1,A,306,Yes,DMS,HWH,~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dzc,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor 17,3C-like proteinase nsp5,1,A,306,Yes,GOL,U76,"(3,5-difluorophenyl)methyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-6-oxopiperidin-3-yl}carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-b3e365b9-1 (Mpro-x11612),3C-like proteinase,1,A,306,Yes,DMS,NSR,"(4R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvm,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI11,3C-like proteinase,1,A,306,Yes,,7V2,N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7gcp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NAU-LAT-64f4b287-5 (Mpro-x10710),3C-like proteinase,1,A,306,Yes,DMS,LM0,"(3S)-N',2-diacetyl-1,2,3,4-tetrahydroisoquinoline-3-carbohydrazide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7nby,Crystal structure of SU3327 (halicin) covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,Main Protease,2,"A,B",306,Yes,"NO3
CL
SO4
NA",U88,"5-nitro-1,3-thiazole",non-polymer,,Yes,CYS44 A,6LU7_1|Chain,0,,100.00,0
5ref,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z24758179,3C-like proteinase,1,A,306,Yes,DMS,6SU,methyl 3-(methylsulfonylamino)benzoate,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ges,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bb423b95-7 (Mpro-x11501),3C-like proteinase,1,A,306,Yes,DMS,NUR,2-(3-chlorophenyl)-N-(isoquinolin-4-yl)-N-methylacetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5reh,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z111507846,3C-like proteinase,1,A,306,Yes,DMS,AWP,1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ehl,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) S144M Mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,S144M,99.67,0
7ggh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-c9c1e0d8-3 (Mpro-x12587),3C-like proteinase,1,A,306,Yes,DMS,OWC,(3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8p54,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 150 micromolar MG-132.,3C-like proteinase nsp5,2,"A,B",306,Yes,"CL
NA
DMS
EDO",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ddc,Crystal structure of SARS-CoV-2 main protease in complex with Tafenoquine,3C-like proteinase,1,A,307,Yes,,H3F,Tafenoquine,non-polymer,,No,,6LU7_1|Chain,0,,99.67,1
7gii,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-8416115c-13 (Mpro-P0091),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QGC,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1-[(4H-1,2,4-triazol-3-yl)methyl]-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rh9,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4438424255 (Mpro-x2776),3C-like proteinase,1,A,306,Yes,DMS,UJ4,N-{4-[(1S)-1-methoxyethyl]phenyl}-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lzy,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 3c,3C-like proteinase,1,A,309,Yes,,"YMJ
YMM","(1R,2S)-1-hydroxy-2-((S)-4-methyl-2-(((((1s,4S)-4-propylcyclohexyl)oxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-1-hydroxy-2-((S)-4-methyl-2-(((((1s,4S)-4-propylcyclohexyl)oxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8yls,Structure of SARS-CoV-2 Mpro in complex with its degrader,3C-like proteinase nsp5,1,A,306,Yes,,A1LYZ,(4-methoxyphenyl)methyl ~{N}-[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8e61,Crystal structure of SARS-CoV-2 3CL protease in complex with a m-chlorophenyl dimethyl sulfane inhibitor,3C-like proteinase,2,"A,B",309,Yes,CL,"VLU
VM0","(1R,2S)-2-{[N-({2-[(3-chlorophenyl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-{[N-({2-[(3-chlorophenyl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7dk1,Crystal structure of Zinc bound SARS-CoV-2 main protease,3C-like proteinase,2,"A,B",306,No,"ZN
DMS
GLY
CL
BTB",,,,,,,6LU7_1|Chain,0,,100.00,0
7vvp,Crystal structure of SARS-Cov-2 main protease in complex with PF07304814,3C-like proteinase,2,"A,B",296,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,"CYS, 143-(80I, .)",6LU7_1|Chain,0,,96.73,10
8udq,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 1,3C-like proteinase nsp5,1,A,306,Yes,NA,WC0,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-{[2-(dimethylamino)ethyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gre,Crystal structure of SARS-CoV-2 main protease in complex with cpd-1,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",XWH,4-[3-(trifluoromethyl)-1H-pyrazol-5-yl]pyridine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gm2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-2e8b2191-12 (Mpro-P2074),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RG3,"(4S)-6-chloro-N-[7-(methanesulfonyl)isoquinolin-4-yl]-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-13 (Mpro-x10565),3C-like proteinase,1,A,306,Yes,DMS,LBC,2-(3-iodophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gnb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-ee636701-1 (Mpro-P2468),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RW0,"(3R,4S)-6-chloro-N-[7-(methanesulfonyl)isoquinolin-4-yl]-3-methyl-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8z46,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,3C-like proteinase nsp5,1,A,306,Yes,,A1D70,"(2~{S})-~{N}-(3-azanyl-3-oxidanylidene-propyl)-4-[4-[[(1~{S})-1-(2-chlorophenyl)-3-oxidanyl-propyl]amino]-6-(methylamino)-1,3,5-triazin-2-yl]-1-ethanoyl-piperazine-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8y4h,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with Bofutrelvir,3C-like proteinase nsp5,2,"A,B",301,Yes,,FHR,~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,K90R,98.04,5
7uj9,Room-temperature X-ray structure of monomeric SARS-CoV-2 main protease catalytic domain (MPro1-199),3C-like proteinase nsp5,2,"A,B",207,No,,,,,,,,6LU7_1|Chain,5,"P241H, L242H, T243H, Q244H, D245H",66.01,99
8u9h,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI64,3C-like proteinase nsp5,1,A,306,Yes,,VZB,"(1R,2S,5R)-3-[(cyclohexyloxy)acetyl]-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ueg,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 27,3C-like proteinase nsp5,1,A,306,Yes,,WEO,"2-cyano-D-phenylalanyl-2,4-dichloro-N-{(2S)-1-(4-fluorophenyl)-4-oxo-4-[(pent-4-yn-1-yl)amino]butan-2-yl}-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8jva,Cryo-EM structure of the N-terminal domain of Omicron BA.1 in complex with nanobody N235 and S2L20 Fab,"nanobody N235
S2L20 light chain
S2L20 heavy chain
Spike protein S2'",4,"A,B,C,D","126, 236, 473, 300",No,NAG,,,,,,,6LU7_1|Chain,"60
115
155
144","R4Q, K5V, M6Q, A7L, F8Q, P9E, C16G, M17L, C22P, W31R, Y37S, P39A, R40S, H41G, V42L, C44I, T45S, S46R, E47Y, P52S, N53W, Q74K, L75E, K88E, D92A, Y101I, K102P, F103A, V104A, I106P, N119A, G120D, P122V, S123K, F140R, L141D, G149A, F150K, C156T, E178Q, G179M, F181S, Y182L, G183K, T196E, D248C, I249N, L253E, Q273H, M276Y, L282Q, V296Q, R298T, Q299V, C300S, G302H, V303H, T304H, F305H, Q306H
T25D, G29L, D33L, D34W, V36P, Y37G, C38S, P39T, R40G, H41D, C44M, E47P, D48S, M49S, N51S, P52A, N53S, Y54V, E55G, H64V, N65T, F66I, L67T, V68C, V73S, L75I, V77F, I78Y, G79L, H80N, S81W, M82Y, N84Q, C85K, V86P, L87G, K90I, V91S, T93A, A94S, P96M, K97E, F103G, Q110S, T111R, P122G, M130T, R131D, P132F, N133T, F140S, V148Q, G149P, F150E, N151D, D153T, D155Y, F159Q, C160Q, M165D, E166N, G174F, T198F, T199K, I200R, N214P, G215S, W218E, F219Q, N221K, R222S, F223G, T225C, T226L, D229N, N238P, Y239R, P241A, L242K, T243V, D245W, H246K, I249A, G251Q, P252S, L253G, S254N, A255S, G258E, I259Q, A260D, V261S, L262K, M264S, C265T, A266Y, K269S, E270S, L271T, G283S, S284K, L286D, L287Y, D289H, E290K, F291V, T292Y, P293A, F294C, D295E, V297T, R298H, C300S, G302P, Q306S
S1L, G2W, F3V, R4L, K5L, M6L, A7W, F8V, K12L, C16G, M17G, T21Q, C22P, W31R, Y37S, R40A, H41A, V42S, I43G, C44F, E47Y, D48G, L50Q, N51A, N53G, Y54L, D56V, L57A, L58F, K61Y, S62D, N63G, H64G, L67K, V68Y, Q69Y, G71D, N72S, Q74K, L75G, V77T, M82R, Q83D, C85N, V86T, K88Y, V91E, P96L, T98D, P99S, K100R, K102G, F103S, V104Y, R105Y, I106D, Q107Y, P108W, F112V, L115S, C117S, Y118T, N119K, Y126F, Q127P, C128L, M130P, R131S, P132S, N133K, F134S, I136S, K137G, S139T, F140A, L141A, N142L, S147L, I152K, D155V, C156T, M162W, H163N, H164S, M165G, E166A, P168T, T169S, G174V, T175L, D176Q, L177S, E178S, N180L, F181Y, Y182S, G183L, P184S, F185S, D187V, R188T, Q189V, T190P, A191S, Q192S, A193S, A194L, D197Q, T199Y, T201N, L205C, A206P, W207P, L208C, Y209P, A211E, V212L, I213L, N214G, D216P, R217S, W218V, T224K, T225D, N228E, L232E, M235T, E240S, P241V, Q244V, D245L, V247Q, I249W, P252A, S254P, Q256K, M264N, C265Q, A266V, L271W, L272E, Q273S, M276N, G278Y, R279K, I281V, A285F, L286F, E288Y, D289S, E290K, F291L, F294V, V296K, V297S
S1M, G2F, F3V, R4F, K5L, M6V, A7L, F8L, K12L, E14S, G15S, C16Q, M17C, Q19N, V20L, T26Q, W31S, L32F, D33T, D34R, V35G, C38Y, R40D, H41K, I43F, C44R, T45S, M49V, P52H, N53S, Y54T, E55Q, I59P, R60F, K61F, H64T, N65W, L67H, Q69I, A70S, V73G, Q74T, L75K, M82F, Q83D, C85P, K88N, L89D, K90G, D92Y, T93F, K97S, T98I, P99E, Y101S, K102N, F103I, V104I, P108F, Q110T, A116D, C117S, Y118K, N119T, G120Q, P122L, S123L, G124I, Q127N, C128N, P132T, F134V, T135V, G138D, S139P, G143K, C145W, G146M, S147E, V148S, G149E, I152R, D153V, D155N, S158T, C160E, M162V, H163S, H164Q, M165P, E166F, T175M, Y182L, G183R, P184E, Q189G, T190Y, A191F, Q192K, A193I, A194Y, G195S, T196K, D197H, T199P, T201I, N203E, V204D, Y209E, A210P, A211L, L220I, N221T, T224Q, V233L, M235L, K236H, Y237R, N238S, H246P, V247G, P252S, L253S, A255G, Q256W, I259A, S267Y, L268Y, K269V, E270G, L271Y, G278P, I281F, L287K, E288Y, D289N, F291G, P293I, F294T, V296A, Q299D, V303E, F305T, Q306L","19.23
25.22
23.81
26.23","192
140
229
126"
7ghx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0e5afe9d-1 (Mpro-P0030),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",P7R,"(4R)-6-chloro-N-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-7-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gh4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-00c1612e-1 (Mpro-x12777),3C-like proteinase,1,A,306,Yes,DMS,Q1U,2-(3-chlorophenyl)-N-(6-methoxyisoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8yrh,Complex of SARS-CoV-2 main protease and Rosmarinic acid,3C-like proteinase nsp5,2,"A,B",298,Yes,,ROA,"(2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid",non-polymer,,No,,6LU7_1|Chain,1,N142A,97.06,8
7lfp,SARS-CoV-2 Main protease immature form - F2X Entry Library G05 fragment,3C-like proteinase,2,"A,B",309,Yes,"DMS
PEG",XY4,N-phenyl-N'-propan-2-ylurea,non-polymer,,No,,6LU7_1|Chain,0,,99.03,3
6xmk,1.70 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 7j,3C-like proteinase,2,"A,B",309,Yes,PG4,QYS,"(1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
8tpd,"Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease",3C-like proteinase nsp5,1,A,306,Yes,,JJO,N-[(1R)-2-(benzylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-[3-(2-chloroacetamido)phenyl]furan-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uup,SARS-CoV-2 Main Protease S144A (Mpro S144A) in Complex with Nirmatrelvir (PF-07321332),3C-like proteinase nsp5,1,A,306,Yes,CL,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S144A,99.67,0
7c8r,Complex Structure of SARS-CoV-2 3CL Protease with TG-0203770,3C-like proteinase,1,A,306,Yes,,TG3,"ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7aqi,Structure of SARS-CoV-2 Main Protease bound to Ifenprodil,3C-like proteinase,1,A,306,Yes,"DMS
IMD",QEL,"4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gje,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e69ad64a-2 (Mpro-P0213),3C-like proteinase,2,"A,B",306,Yes,DMS,QML,"(3S)-5-chloro-N-(isoquinolin-4-yl)-N-propanoyl-2,3-dihydro-1-benzofuran-3-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8dig,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,2,"A,B",306,Yes,,U26,"(3P)-1-[(4-fluorophenyl)methyl]-3-(isoquinolin-4-yl)imidazolidine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dd9,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) S144L Mutant in Complex with Inhibitor GC376,3C-like proteinase nsp5,1,A,306,Yes,,B1S,"(1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,S144L,99.67,0
8e6a,Crystal structure of SARS-CoV-2 3CL protease in complex with a p-chlorophenylethanol based inhibitor,3C-like proteinase,2,"A,B",309,Yes,CL,"WIX
WJ0","(1S,2S)-2-[(N-{[(2R)-2-(3-chlorophenyl)-2-hydroxypropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-[(N-{[(2S)-2-(3-chlorophenyl)-2-hydroxypropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gc6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-THE-c331be7a-6 (Mpro-x10513),3C-like proteinase,1,A,306,Yes,DMS,L8O,"1-[(4R)-4-(3-methylphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gry,Crystal structure of SARS-CoV-2 main protease in complex with cpd-21,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
NA",XZO,"1-(3,5-dichlorophenyl)pyrrolidine-2,5-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8h7k,SARS-CoV-2 Mpro Double Mutant (H41A and T21I) in complex with nsp4/5 peptidyl substrate,3C-like proteinase nsp5,1,A,306,Yes,,TSAVLQSGFR,nsp4/5 peptidyl substrate,polypeptide(L),,No,,6LU7_1|Chain,2,"T21I, H41A",99.35,0
7wo2,SARS-CoV-2 3CLPro Peptidomimetic Inhibitor TPM5,3C-like proteinase,1,A,306,Yes,,40I,N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxidanylidene-1-[[(2S)-1-oxidanylidene-3-[(3S}-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]pentan-2-yl]amino]-1-oxidanylidene-butan-2-yl]furan-2-carboxamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ghl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with GAB-REV-70cc3ca5-18 (Mpro-x3366),3C-like proteinase,1,A,306,Yes,DMS,Q8O,2-(1H-benzimidazol-6-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gh0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-ce760d3f-4 (Mpro-x12723),3C-like proteinase,1,A,306,Yes,DMS,PWR,"(4R)-6-chloro-N-(2-oxo-2lambda~5~-isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bnx,Crystal Structure of L50F SARS-CoV-2 Main Protease,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,L50F,99.67,0
9bo3,Crystal Structure of E166V SARS-CoV-2 Main Protease in Complex with Compound Mpro61,3C-like proteinase nsp5,1,A,306,Yes,,XEK,"(5P)-5-[(1P,3M,3'P)-3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl]-1-methylpyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,1,E166V,99.67,0
7b77,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 8,3C-like proteinase nsp5,1,A,306,Yes,DMS,T0W,2-(benzotriazol-1-yl)-~{N}-ethyl-~{N}-(furan-3-ylmethyl)ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8h3g,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) E166V Mutant in Complex with Inhibitor Enstrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,GOL,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,1,E166V,99.67,0
8udp,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 14,3C-like proteinase nsp5,1,A,306,Yes,,WBO,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-{[4-(dimethylamino)butyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8u25,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) L50F/E166A/L167F Triple Mutant,3C-like proteinase,4,"A,B,C,D",306,No,,,,,,,,6LU7_1|Chain,3,"L50F, E166A, L167F",99.02,0
7gn5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-968bafd9-1 (Mpro-P2295),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RT9,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(1-methoxycyclopropyl)methanesulfonyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8tpb,"Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease",Non-structural protein 7,2,"A,B",305,Yes,,JVX,N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(4-tert-butylphenyl)-2-chloroacetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7t42,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 2c,3C-like proteinase,2,"A,B",309,Yes,PG4,"FIK
FIW","(1S,2S)-2-[(N-{[(2-acetyl-2-azaspiro[3.3]heptan-6-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-1-hydroxy-2-{[N-({[2-(2-methylpropanoyl)-2-azaspiro[3.3]heptan-6-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gm9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-1bed62cf-3 (Mpro-P2113),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RIJ,"2-[(1'P,3'S)-6-chloro-1'-(isoquinolin-4-yl)-2',5'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vjx,Crystal Structure of SARS-CoV-2 Mpro at 2.20 A resolution-12,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7nf5,Crystal structure of MG-132 covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 in spacegroup C2.,3C-like proteinase,1,A,306,Yes,"EDO
IPA
CL
NA",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7vk6,Crystal Structure of SARS-CoV-2 Mpro at 2.25 A resolution-13,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
6xbi,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW248,3C-like proteinase,2,"A,B",308,Yes,"GOL
NA
DMS",PRD_002394,inhibitor UAW248,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
7gd4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c59291d4-2 (Mpro-x10871),3C-like proteinase,1,A,306,Yes,DMS,R30,N-{4-[(1H-benzotriazol-1-ylacetyl)(thiophen-3-ylmethyl)amino]phenyl}propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ge2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-6af13d92-1 (Mpro-x11313),3C-like proteinase,1,A,306,Yes,DMS,N4L,"N-[2-(2-methoxyphenoxy)ethyl]-5-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8v7w,"Room-temperature X-ray structure of SARS-CoV-2 main protease catalytic domain C145A precursor, residues nsp4(-6)-1-199-6H",Replicase polyprotein 1ab,2,"A,B",215,No,,,,,,,,6LU7_1|Chain,6,"C145A, P241H, L242H, T243H, Q244H, D245H",64.01,107
5rem,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0103016,3C-like proteinase,1,A,306,Yes,DMS,T2J,1 1-(4-(2-nitrophenyl)piperazin-1-yl)ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lmd,SARS-CoV-2 3CLPro in complex with 2-(benzotriazol-1-yl)-N-[4-(1H-pyrazol-4-yl)phenyl]-N-(3-thienylmethyl)acetamide,3C-like proteinase,1,A,306,Yes,,Y6A,2-(benzotriazol-1-yl)-~{N}-[4-(1~{H}-pyrazol-4-yl)phenyl]-~{N}-(thiophen-3-ylmethyl)ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8die,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,2,"A,B",306,Yes,,U1J,5-bromo-3-[(4-methyl-3-nitrophenyl)methoxy]pyridine-2-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8eke,Cryo-EM structure of SARS CoV-2 Mpro WT protease,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,C145A,99.67,0
7rw1,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI28,3C-like proteinase,2,"A,B",306,Yes,,800,N-(1H-indole-2-carbonyl)-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7gnd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIK-UNK-78dbf1b8-1 (Mpro-P2601),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RVR,"(4S)-6-chloro-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8v8e,Room-temperature X-ray structure of SARS-CoV-2 main protease catalytic domain (residues 1-199-6H) in complex with ensitrelvir (ESV),3C-like proteinase nsp5,2,"A,B",207,Yes,,"GTDTTLEHH
7YY","peptide
6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione","polypeptide(L)
non-polymer","
","No
No","
",6LU7_1|Chain,5,"P241H, L242H, T243H, Q244H, D245H",66.01,99
7vjy,Crystal Structure of Sars-Cov-2 Mpro at 1.90 A resolution-1,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8okb,SARS-CoV2 NSP5 in complex with a peptidomimetic ligand,3C-like proteinase nsp5,1,A,306,Yes,,VQR,methyl (4~{S})-4-[[(2~{S})-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]pentanoate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8dt9,Crystal Structure of SARS CoV-2 Mpro mutant L141R with Pfizer Intravenous Inhibitor PF-00835231,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,L141R,99.67,0
7gmh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-37 (Mpro-P2183),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RJX,4-[2-(3-chlorophenyl)acetamido]isoquinoline-6-carboxylic acid,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-611d11e7-4 (Mpro-P0978),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QYI,"(4S)-6-chloro-N-(6-fluoroisoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lbn,X-ray crystal structure of the SARS-CoV-2 main protease with Calpain I Inhibitor,3C-like proteinase,1,A,306,Yes,SO4,PRD_002460,Calpain I Inhibitor,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gh8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAR-DIA-23aa0b97-13 (Mpro-x2964),3C-like proteinase,1,A,306,Yes,DMS,Q3U,N-(5-aminopyridin-3-yl)-N'-(3-chlorophenyl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgh,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1619978933 (Mpro-x0395),3C-like proteinase,1,A,306,Yes,DMS,U0M,"5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8vsg,SARS-CoV-2 main protease with covalent inhibitor,3C-like proteinase nsp5,2,"A,B",306,Yes,"BTB
DMS
EDO",A1AD0,"(1R,2S,5S)-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-(1-phenylcyclopropane-1-carbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9bo8,Crystal Structure of T21I SARS-CoV-2 Main Protease in Complex with GC376,3C-like proteinase,1,A,306,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,T21I,99.67,0
8uef,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 32,3C-like proteinase nsp5,1,A,306,Yes,,WEK,"2-cyano-D-phenylalanyl-2,4-dichloro-N-{(2S)-1-(4-fluorophenyl)-4-[(4-methoxybutyl)amino]-4-oxobutan-2-yl}-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grr,Crystal structure of SARS-CoV-2 main protease in complex with cpd-14,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
SO4
MG",Y0O,5-(3-cyclohexylprop-1-yn-1-yl)pyridine-3-carboxylic acid,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-966f8da6-2 (Mpro-x12717),3C-like proteinase,1,A,306,Yes,DMS,PUU,"(4R)-1-acetyl-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ftl,Crystal structure of the SARS-CoV-2 (COVID-19) main protease (Mpro) in complex with inhibitor Jun89-3-C1,3C-like proteinase nsp5,2,"A,B",306,Yes,,5ZF,"N-([1,1'-biphenyl]-4-yl)-2-chloro-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8sk4,Co-structure of SARS-CoV-2 (COVID-19 with covalent pyrazoline based inhibitors),3C-like proteinase nsp5,1,A,306,Yes,IMD,I3R,"2-chloro-1-[(5R)-3-phenyl-5-(quinoxalin-5-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7glv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-a54ce14d-2 (Mpro-P2031),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R76,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5r82,PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z219104216,3C-like proteinase,1,A,306,Yes,DMS,RZS,6-(ethylamino)pyridine-3-carbonitrile,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rhd,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with SF013 (Mpro-x2193),3C-like proteinase,1,A,306,Yes,DMS,US7,1-[4-(methylsulfonyl)phenyl]piperazine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7git,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fce787c2-5 (Mpro-P0129),3C-like proteinase,2,"A,B",306,Yes,DMS,QIT,"(2S)-2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)-2-(methylamino)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bfb445d4-2 (Mpro-x11789),3C-like proteinase,1,A,306,Yes,DMS,OE6,N-(1H-benzotriazol-1-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7t45,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 7c,3C-like proteinase,2,"A,B",309,Yes,PG4,EW9,"(1S,2S)-2-{[N-({[7-(tert-butoxycarbonyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
8r19,"SARS-CoV-2 Mpro (Omicron, P132H) free enzyme",3C-like proteinase nsp5,1,A,306,No,,,,,,,,7TOB_1|Chain,0,,100.00,0
5rl2,PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-26 (Mpro-x3115),3C-like proteinase,1,A,306,Yes,DMS,VEM,N-(4-tert-butylphenyl)-N-[(1R)-2-[(2-methoxyethyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-9 (Mpro-x10327),3C-like proteinase,1,A,306,Yes,DMS,KUU,(2R)-2-(3-chlorophenyl)-3-methyl-N-(4-methylpyridin-3-yl)butanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dpv,SARS-CoV-2 3CL protease (3CLpro) in complex with 7-O-methyl-dihydromyricetin,3C-like proteinase,4,"A,B,C,D",306,Yes,,HF0,"(2S,3S)-3,5-dihydroxy-7-methoxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8hvu,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with PF07304814,3C-like proteinase nsp5,2,"A,B",299,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,"CYS, 143-(80I, .)",6LU7_1|Chain,1,G15S,97.39,7
8gfk,"Room temperature X-ray structure of truncated SARS-CoV-2 main protease C145A mutant, residues 1-304",3C-like proteinase nsp5,1,A,304,No,,,,,,,,6LU7_1|Chain,1,C145A,99.02,2
7dgf,The co-crystal structure of SARS-CoV-2 main protease with peptidomimetic inhibitor (S)-2-cinnamamido-N-((S)-1-oxo-3-((S)-2-oxopiperidin-3-yl)propan-2-yl)hexanamide,3C-like proteinase,1,A,306,Yes,,H60,(2~{S})-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]hexanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ig4,Crystal structure of SARS-Cov-2 main protease in complex with GC376,Non-structural protein 11,2,"A,B",301,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.37,5
5rgy,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1535580916 (Mpro-x2581),3C-like proteinase,1,A,306,Yes,DMS,UGS,N-(4-methoxypyridin-2-yl)-2-(naphthalen-2-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8jpq,SARS-CoV-2 Mpro in complex with D-5-96,3C-like proteinase nsp5,1,A,302,Yes,,(ACE)AI(V3E),ACE-ALA-ILE-V3E,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,98.69,4
7ggs,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0e5afe9d-1 (Mpro-x12696),3C-like proteinase,1,A,306,Yes,DMS,P7R,"(4R)-6-chloro-N-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-7-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfw,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102243,3C-like proteinase,1,A,306,Yes,DMS,T8M,1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfx,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102254,3C-like proteinase,1,A,306,Yes,DMS,T8P,1-[4-(4-methoxyphenyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lkt,1.50 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 2k,3C-like proteinase,2,"A,B",309,Yes,"FLC
PG4","Y7M
Y4V","(1S,2S)-2-((S)-2-(((adamantan-1-ylmethoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-(((adamantan-1-ylmethoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gly,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-23 (Mpro-P2057),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RDX,"(4S)-6-chloro-2-[(2-hydroxyethyl)(methyl)sulfamoyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rh2,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1129289650 (Mpro-x2646),3C-like proteinase,1,A,306,Yes,DMS,UH7,2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vk7,Crystal Structure of SARS-CoV-2 Mpro at 2.4 A resolution-11,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7ge9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-12 (Mpro-x11368),3C-like proteinase,1,A,306,Yes,DMS,NB6,2-(3-bromophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mau,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor dFFR-yne,3C-like proteinase,2,"A,B",306,Yes,SO4,"YVP
DIO","N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-carbamimidamido-2-oxohexan-3-yl]-L-phenylalaninamide
1,4-DIETHYLENE DIOXIDE","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
8p5a,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 5 millimolar X77 enantiomer R.,3C-like proteinase nsp5,2,"A,B",306,Yes,"EDO
CL
DMS
NA",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8eoy,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI37,3C-like proteinase,2,"A,B",306,Yes,,WOH,benzyl {(2S)-1-[2-(3-amino-3-oxopropyl)-2-(chloroacetyl)hydrazinyl]-4-methyl-1-oxopentan-2-yl}carbamate (non-preferred name),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gig,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-12 (Mpro-P0074),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QFU,2-(3-cyanophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7fay,Crystal structure of SARS-CoV-2 main protease in complex with (R)-1a,3C-like proteinase,1,A,306,Yes,,2XI,(2~{R})-~{N}-[(1~{R})-2-(~{tert}-butylamino)-2-oxidanylidene-1-pyridin-3-yl-ethyl]-~{N}-(4-~{tert}-butylphenyl)-2-oxidanyl-propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7kx5,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with noncovalent inhibitor Jun8-76-3A,3C-like proteinase,1,A,306,Yes,GOL,X7V,"N-([1,1'-biphenyl]-4-yl)-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]furan-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gbo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-20 (Mpro-x10392),3C-like proteinase,1,A,306,Yes,DMS,KY0,1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)cyclopropane-1-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8e4r,Room-temperature X-ray structure of SARS-CoV-2 main protease H41A miniprecursor mutant in complex with GC373,Replicase polyprotein 1ab,2,"A,B",314,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,H41A,97.13,8
8uh5,Crystal structure of SARS-CoV-2 main protease in complex with an inhibitor TKB-272,3C-like proteinase nsp5,1,A,306,Yes,PEG,WOK,"(1R,2S,5S)-N-{(1S,2S)-1-(5-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8fig,Room-temperature X-ray structure of SARS-CoV-2 main protease double mutant E290A/R298A in complex with GC373,3C-like proteinase nsp5,1,A,306,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,2,"E290A, R298A",99.35,0
7gdh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NEU-c8f11034-6 (Mpro-x11001),3C-like proteinase,1,A,306,Yes,DMS,M5X,"(3S)-3-hydroxy-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gj1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UNK-82501c2c-1 (Mpro-P0153),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QJR,"2-(3,4-dichlorophenyl)-N-(2,7-naphthyridin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ROB-IMP-e811baff-1 (Mpro-x11798),3C-like proteinase,1,A,306,Yes,DMS,OGF,2-(1H-benzotriazol-1-yl)-N-[4-(methylcarbamamido)phenyl]-N-[(thiophen-3-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ute,Structure of SARS-Cov2 3CLPro in complex with Compound 27,3C-like proteinase nsp5,1,A,306,Yes,EDO,XKQ,"methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S)-6,6-difluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7jp1,Structure of wild-type substrate free SARS-CoV-2 Mpro.,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gay,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-031a96cc-8 (Mpro-x10022),3C-like proteinase,1,A,306,Yes,DMS,KJO,N-phenyl-2-(pyridin-3-yl)prop-2-enamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9at0,Crystal structure of SARS-CoV-2 3CL protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (S-enantiomer),3C-like proteinase nsp5,2,"A,B",308,Yes,MLT,"A1AGX
A1AGW","(1S,2S)-2-{[N-({[(2S)-1-(cyclohexylmethyl)-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-{[N-({[(2S)-1-(cyclohexylmethyl)-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
9asv,Crystal structure of SARS-CoV-2 3CL protease in complex with a benzyl 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,"A1AGE
A1AGF","(1R,2S)-2-{[N-({[(2S)-1-benzyl-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-{[N-({[(2S)-1-benzyl-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
8dl9,Room temperature X-ray structure of SARS-CoV-2 main protease in complex with compound Z199538122,3C-like proteinase,1,A,306,Yes,,T4V,1-{4-[(naphthalen-1-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gxi,The crystal structure of SARS-CoV-2 main protease in complex with 14c,3C-like proteinase nsp5,1,A,306,Yes,,0BO,"N-[(2S)-3-cyclohexyl-1-[[(2S,3R)-4-(cyclopropylamino)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]butan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-benzofuran-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gfr,"Room temperature X-ray structure of truncated SARS-CoV-2 main protease C145A mutant, residues 1-304, in complex with NBH2",3C-like proteinase nsp5,1,A,304,Yes,,ZGO,"(1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-({1-[(2-methylpropane-2-sulfonyl)methyl]cyclohexyl}carbamoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,1,C145A,99.02,2
5rea,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z31432226,3C-like proteinase,1,A,306,Yes,DMS,JGP,"(azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tq3,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 5c,3C-like proteinase,2,"A,B",309,Yes,,IS5,"N~2~-({[(1R,2R)-2-(3-fluorophenyl)cyclopropyl]methoxy}carbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
8y7t,Crystal structure of SARS-CoV-2 main protease in complex with C2,3C-like proteinase nsp5,1,A,306,Yes,,A1LX1,"6-(iminomethyl)-4-(2-pyridin-2-ylethyl)-2-[4-(trifluoromethyl)phenyl]-1,2,4-triazine-3,5-dione",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
7gnp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-WEI-dcc3321b-5 (Mpro-P2889),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL
NA",S4X,"(4S)-6-chloro-2-(2-{[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]amino}-2-oxoethyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dpr,Crystal structure of SARS-CoV-2 main protease in complex with inhibitor TKB-248,3C-like proteinase nsp5,1,A,303,Yes,"DMS
ZN",T43,"2,2,2-trifluoro-N-{(2S)-1-[(1R,2S,5S)-2-({(2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamothioyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.37,5
7gl4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-1981ceba-3 (Mpro-P1638),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R5H,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-(3-methoxyazetidine-1-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7bij,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 13,3C-like proteinase nsp5,1,A,306,Yes,DMS,TU8,"(3~{S})-3'-(5-fluoranylpyridin-3-yl)spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfv,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102306,3C-like proteinase,1,A,306,Yes,DMS,T8J,1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8jop,Crystal structure of the SARS-CoV-2 main protease in complex with 11a,3C-like proteinase nsp5,1,A,306,Yes,,UWO,"methyl (6~{R})-5-ethanoyl-7-oxidanylidene-6-[4-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-6~{H}-benzo[b][1,4]benzodiazepine-2-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rgm,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102142 (Mpro-x0708),3C-like proteinase,1,A,306,Yes,DMS,U1D,"N'-acetyl-4,5,6,7-tetrahydro-1-benzothiophene-2-carbohydrazide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8jco,The crystal structure of SARS-CoV-2 main protease in complex with Compound 65,3C-like proteinase nsp5,1,A,306,Yes,DMS,B7Y,methyl (2S)-2-[[3-(4-chloranylbutanoyl)phenyl]carbonylamino]-3-methyl-butanoate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gey,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-66895286-3 (Mpro-x11540),3C-like proteinase,1,A,306,Yes,DMS,NYR,N-(3-chlorophenyl)-2-(3-methyl-1H-pyrazol-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gc3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-cedd89ab-4 (Mpro-x10488),3C-like proteinase,1,A,306,Yes,DMS,L7V,"1-[(2S)-2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]-2-(pyridin-3-yl)ethan-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-3 (Mpro-P1007),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QYR,"(4S)-6-chloro-2-(cyclopropanesulfonyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tc4,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 15/16,3C-like proteinase,2,"A,B",306,Yes,GOL,FYPKLQSSQ,Nonstructural protein 15/16,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
8tph,"Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease",Non-structural protein 7,1,A,305,Yes,,JKL,(3R)-N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-3-hydroxybutanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7gf0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bb423b95-1 (Mpro-x11542),3C-like proteinase,1,A,306,Yes,DMS,O0C,"2-(3-chlorophenyl)-N-(2,7-naphthyridin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gjb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5d65ec79-2 (Mpro-P0188),3C-like proteinase,2,"A,B",306,Yes,DMS,QLO,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-[2-(methylamino)-2-oxoethyl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7amj,Structure of SARS-CoV-2 Main Protease bound to PD 168568.,3C-like proteinase,1,A,306,Yes,"CL
DMS",RMZ,"(3~{S})-3-[2-[4-(3,4-dimethylphenyl)piperazin-1-yl]ethyl]-2,3-dihydroisoindol-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mb5,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp5/6 (P6-P1),3C-like proteinase,2,"A,B",306,Yes,,SGVTFQ,SER-GLY-VAL-THR-PHE-GLN,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gll,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-4fff0a85-1 (Mpro-P1988),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RAQ,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(oxan-4-yl)methanesulfonyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bo9,Crystal Structure of T190I SARS-CoV-2 Main Protease in Complex with GC376,3C-like proteinase nsp5,2,"A,B",306,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,T190I,99.67,0
7gfi,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with WIL-MOD-03b86a88-6 (Mpro-x11743),3C-like proteinase,1,A,306,Yes,DMS,OCI,2-(3-chloro-5-sulfamamidophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gim,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-UNI-3735e77e-2 (Mpro-P0111),3C-like proteinase,2,"A,B",306,Yes,DMS,QHI,"(4R)-6,8-dichloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-044491d2-1 (Mpro-x11764),3C-like proteinase,1,A,306,Yes,DMS,ODX,"2-(3-chloro-5-{[(1S,2S)-2-hydroxycyclopentyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dfe,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) S144L Mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,S144L,99.67,0
7gew,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bb423b95-2 (Mpro-x11530),3C-like proteinase,1,A,306,Yes,DMS,NWI,"2-(3-chlorophenyl)-N-(1,6-naphthyridin-8-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8wsh,"Crystal structure of SARS-Cov-2 main protease, pH=4.0",Replicase polyprotein 1ab,2,"A,B",298,No,,,,,,,,6LU7_1|Chain,0,,97.39,8
7n44,"Crystal structure of the SARS-CoV-2 (2019-NCoV) main protease in complex with 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione (compound 13)",3C-like proteinase,1,A,306,Yes,,06I,"5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vk8,Crystal structure of SARS-CoV-2 Mpro at 2.4 A Resolution,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gmc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-17 (Mpro-P2147),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RIY,"(4S)-6-chloro-2-(ethylsulfamoyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7wqk,wild-type SARS-CoV-2 main protease in complex with MG-132,3C-like proteinase,1,A,307,Yes,MG,ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
8hvv,Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with PF07304814,3C-like proteinase nsp5,2,"A,B",299,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,"CYS, 143-(80I, .)",6LU7_1|Chain,1,S46F,97.39,7
7wof,SARS-CoV-2 3CLpro,3C-like proteinase,1,A,306,Yes,,5IZ,"(2S,3S)-3-methyl-N-[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-2-[[(E)-3-phenylprop-2-enoyl]amino]pentanamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7nev,Structure of the hemiacetal complex between the SARS-CoV-2 Main Protease and Leupeptin,3C-like proteinase,1,A,306,Yes,"DMS
IMD
CL",PRD_000216,LEUPEPTIN,Oligopeptide,Enzyme inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfu,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102121,3C-like proteinase,1,A,306,Yes,DMS,T8D,1-{4-[(5-chlorothiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-a13804f0-3 (Mpro-P0607),3C-like proteinase,2,"A,B",306,Yes,DMS,QIZ,"(4R)-6-chloro-7-fluoro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8inu,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) G15S Mutant in Complex with Inhibitor nirmatrelvir,3C-like proteinase,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,G15S,99.67,0
8uho,Crystal structure of SARS CoV-2 3CL protease in complex with GSK4365096A,3C-like proteinase nsp5,2,"A,B",306,Yes,,WTE,"N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-[(2S,3Z)-1-[(2S)-oxolan-2-yl]-3-(2-oxooxolan-3-ylidene)propan-2-yl]-L-leucinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7jsu,Crystal structure of SARS-CoV-2 3CL protease in complex with GC376,3C-like proteinase,1,A,306,Yes,PO4,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7m04,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 21c,3C-like proteinase,2,"A,B",309,Yes,PG4,"YLV
YM1","(1R,2S)-1-hydroxy-2-((S)-4-methyl-2-((((perfluorophenyl)methoxy)carbonyl)amino)pentanamido)-3-((R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl)propane-1-sulfonic acid
(1S,2S)-1-hydroxy-2-((S)-4-methyl-2-((((perfluorophenyl)methoxy)carbonyl)amino)pentanamido)-3-((R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gj7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UCB-50c39ae8-7 (Mpro-P0179),3C-like proteinase,2,"A,B",306,Yes,DMS,Q0I,"(4R)-6-chloro-N-(isoquinolin-4-yl)-N-propanoyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ggk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-64a710fa-1 (Mpro-x12661),3C-like proteinase,1,A,306,Yes,DMS,OYX,N-(2-cyclohexylethyl)-2-(isoquinolin-4-yl)-N-[(thiophen-2-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-199e2e7c-1 (Mpro-x12000),3C-like proteinase,1,A,306,Yes,DMS,OKW,"2-(3-chlorophenyl)-N-(6,7-dihydro-5H-cyclopenta[c]pyridin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7u29,Structure of SARS-CoV-2 Mpro mutant (K90R) in complex with Nirmatrelvir (PF-07321332),3C-like proteinase nsp5,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,K90R,99.67,0
7gkw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e6dd326d-6 (Mpro-P1200),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R0Q,"methyl ({(4R)-6-chloro-4-[(isoquinolin-4-yl)carbamoyl]-3,4-dihydro-2H-1-benzopyran-4-yl}methyl)carbamate",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6y84,"SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19)",3C-like proteinase nsp5,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
7gro,Crystal structure of SARS-CoV-2 main protease in complex with cpd-11,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",Y3N,N-[4-cyano-2-(trifluoromethyl)phenyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gja,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-de59a476-4 (Mpro-P0187),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QLC,"(2R)-2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)-2-(2-methoxyethoxy)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgr,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z328695024 (Mpro-x1101),3C-like proteinase,1,A,306,Yes,DMS,K1G,"N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8u9w,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI105,3C-like proteinase nsp5,1,A,306,Yes,,W1U,N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-N~2~-[(2R)-2-phenylazetidine-1-carbonyl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gax,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with GAB-REV-70cc3ca5-4 (Mpro-x10019),3C-like proteinase,1,A,306,Yes,DMS,KJI,N-(4-methylpyridin-3-yl)-N~2~-(quinolin-4-yl)glycinamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xqt,Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Narlaprevir,3C-like proteinase,2,"A,B",306,Yes,,NNA,"(1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfh,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102277,3C-like proteinase,1,A,306,Yes,DMS,T6Y,1-{4-[(5-chlorothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8e26,Crystal Structure of SARS-CoV-2 Main Protease N142S mutant in complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,N142S,99.67,0
7uue,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI85,3C-like proteinase nsp5,1,A,306,Yes,,I65,"benzyl [(2S,3R)-1-({(2S)-1-[2-(3-amino-3-oxopropyl)-2-propanoylhydrazinyl]-3-cyclohexyl-1-oxopropan-2-yl}amino)-3-tert-butoxy-1-oxobutan-2-yl]carbamate (non-preferred name)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8hvx,Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with PF07304814,3C-like proteinase nsp5,2,"A,B",299,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,"CYS, 143-(80I, .)",6LU7_1|Chain,1,Y54C,97.39,7
7lkv,1.55 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3c,3C-like proteinase,2,"A,B",309,Yes,EDO,"Y4J
Y64","(1R,2S)-2-((S)-2-(((((1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gis,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-30 (Mpro-P0126),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QIQ,2-(5-chloropyridin-3-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-8df914d1-2 (Mpro-P2007),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",NM0,"2-(3-chlorophenyl)-N-[(4R)-imidazo[1,2-a]pyridin-3-yl]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hqf,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with inhibitor YH-53,Non-structural protein 7,2,"A,B",299,Yes,,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"MET, 47-(HUR, .); CYS, 143-(HUR, .)",6LU7_1|Chain,1,G15S,97.39,7
7rvn,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI12,3C-like proteinase,1,A,306,Yes,DMS,7VB,N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methylidene-L-norvalinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8r16,Structure of compound 12 bound to SARS-CoV-2 main protease,3C-like proteinase,2,"A,B",306,Yes,"CL
BR
EDO
NA",XJ9,"1-[6,7-bis(chloranyl)-3,4-dihydro-1H-isoquinolin-2-yl]-2-(5-methylpyridin-3-yl)ethanone",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gns,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-50a80394-1 (Mpro-P3050),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S6K,"1-{[(3'S,4'R)-6-chloro-1'-(isoquinolin-4-yl)-4'-methyl-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidine]-2(3H)-sulfonyl]methyl}cyclopropane-1-carbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dvw,SARS-CoV-2 Mpro mutant (H41A) in complex with nsp5|6 peptidyl substrate,"3C-like proteinase
nsp5/6 peptidyl substrate",2,"A,B","306, 20",No,DMS,,,,,,,6LU7_1|Chain,"1
2","H41A
A191F, L282K","99.67
5.88","0
286"
8aeb,SARS-CoV-2 Main Protease complexed with N-(pyridin-3-ylmethyl)thioformamide,3C-like proteinase nsp5,1,A,306,Yes,"DMS
NA",35J,N-(pyridin-3-ylmethyl)thioformamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ali,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 at 1.65A resolution (spacegroup P2(1)).,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7ggq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-92e193ae-1 (Mpro-x12692),3C-like proteinase,1,A,306,Yes,DMS,OQL,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rec,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1587220559,3C-like proteinase,1,A,306,Yes,DMS,T1J,2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-20 (Mpro-P2204),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RL8,4-[2-(3-chlorophenyl)acetamido]-N-methylisoquinoline-6-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8v8g,Room-temperature X-ray structure of SARS-CoV-2 main protease catalytic domain (residues 1-196) in complex with ensitrelvir (ESV),3C-like proteinase nsp5,2,"A,B",197,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,Yes,"CYS, 146-(7YY, .)",6LU7_1|Chain,0,,63.84,111
7ggb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-044491d2-7 (Mpro-x12300),3C-like proteinase,1,A,306,Yes,DMS,OT6,2-{3-chloro-5-[(2-cyano-2-methylpropyl)amino]phenyl}-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rmz,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-63,3C-like proteinase,1,A,306,Yes,,5ZJ,"6-{4-[3-chloro-4-(trifluoromethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vk5,Crystal Structure of SARS-CoV-2 Mpro at 2.10 A resolution-8,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8eyj,Crystal Structure of uncleaved SARS-CoV-2 Main Protease C145S mutant in complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",307,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,SER145 A,6LU7_1|Chain,1,C145S,99.35,1
8inw,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) K90R Mutant in Complex with Inhibitor nirmatrelvir,3C-like proteinase,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,K90R,99.67,0
7d1o,Crystal structure of SARS-Cov-2 main protease with narlaprevir,3C-like proteinase,1,A,306,Yes,,NNA,"(1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8wzq,Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with CCF0058981,3C-like proteinase nsp5,2,"A,B",303,Yes,,XIU,2-(benzotriazol-1-yl)-~{N}-[(3-chlorophenyl)methyl]-~{N}-[4-(1~{H}-imidazol-5-yl)phenyl]ethanamide,non-polymer,,No,,6LU7_1|Chain,3,"V186F, R222A, F223R",98.04,3
8fiw,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor Jun10221,3C-like proteinase nsp5,2,"A,B",306,Yes,,"Y0E
Y1E","N-([1,1'-biphenyl]-4-yl)-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]prop-2-enamide
N-([1,1'-biphenyl]-4-yl)-N-[(1S)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]prop-2-enamide","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 B",6LU7_1|Chain,0,,100.00,0
7dgi,The co-crystal structure of SARS-CoV-2 main protease with peptidomimetic inhibitor N-((S)-3-methyl-1-(((S)-4-methyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopiperidin-3-yl)propan-2-yl)amino)pentan-2-yl)amino)-1-oxobutan-2-yl)-4-nitrobenzamide,3C-like proteinase,2,"A,B",306,Yes,,H6L,~{N}-[(2~{S})-3-methyl-1-[[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]pentan-2-yl]amino]-1-oxidanylidene-butan-2-yl]-4-nitro-benzamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8sg6,SARS-CoV-2 Main Protease (Mpro) H163A Mutant Reduced with 20mM TCEP,3C-like proteinase nsp5,2,"A,B",306,No,GOL,,,,,,,6LU7_1|Chain,1,H163A,99.67,0
7gf3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-5 (Mpro-x11557),3C-like proteinase,1,A,306,Yes,DMS,O1I,(2S)-2-(3-chlorophenyl)-3-hydroxy-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-0e996074-1 (Mpro-x11159),3C-like proteinase,1,A,306,Yes,DMS,MU3,"(4R)-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gld,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-15 (Mpro-P1879),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R8I,"(4S)-6-chloro-2-{2-[(cyanomethyl)amino]-2-oxoethyl}-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8xwr,Crystal structure of SARS-CoV-2 3CLpro-T21I/L50F double mutant with its peptidyl substrate,3C-like proteinase nsp5,1,A,306,Yes,,CSGVTFQ,cleaved N-terminal product of nsp5/6 substrate peptide,polypeptide(L),,No,,6LU7_1|Chain,3,"T21I, L50F, C145A",99.02,0
8ueb,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 30,3C-like proteinase nsp5,1,A,306,Yes,"CL
EDO",WE8,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-1-(4-fluorophenyl)-4-oxo-4-{[3-(pyridin-4-yl)propyl]amino}butan-2-yl]-D-phenylalaninamide",non-polymer,,Yes,"CSO, 145-(WE8, .)",6LU7_1|Chain,0,,100.00,0
7nxh,Structure of SARS-CoV2 NSP5 (3C-like proteinase) determined in-house,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7ggt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-c852c98b-10 (Mpro-x12698),3C-like proteinase,1,A,306,Yes,DMS,P9O,"(4R)-6-chloro-N-(5,6,7,8-tetrahydro-2,6-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf3,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1741970824,3C-like proteinase,1,A,306,Yes,DMS,T5V,pyrimidin-5-amine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7aku,Structure of SARS-CoV-2 Main Protease bound to Calpeptin.,3C-like proteinase,1,A,306,Yes,CL,(P6S)L(EJM),Calpeptin,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-2db6411e-2 (Mpro-x11852),3C-like proteinase,1,A,306,Yes,DMS,OJO,1-{4-[(3-chloro-5-hydroxyphenyl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lmf,SARS-CoV-2 3CLPro in complex with 2-(benzotriazol-1-yl)-N-[4-(1H-imidazol-4-yl)phenyl]-N-(3-thienylmethyl)acetamide,3C-like proteinase,2,"A,B",306,Yes,,Y6G,2-(benzotriazol-1-yl)-~{N}-[4-(1~{H}-imidazol-4-yl)phenyl]-~{N}-(thiophen-3-ylmethyl)ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8iga,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with GC376,3C-like proteinase nsp5,2,"A,B",299,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,K90R,97.39,7
8tbe,Co-crystal structure of SARS-CoV-2 Mpro with Pomotrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,,ZQB,Pomotrelvir bound form,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gj0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-70ae9412-2 (Mpro-P0151),3C-like proteinase,2,"A,B",306,Yes,DMS,QJL,"(4R)-6-chloro-4-{[(N,N-dimethylglycyl)amino]methyl}-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7nt3,Crystal structure of SARS CoV2 main protease in complex with FSCU015,3C-like proteinase,2,"A,B",306,Yes,DMS,UQZ,"~{N}-[(1~{S})-2-(1,3-benzodioxol-5-ylmethylamino)-1-(3-hydroxyphenyl)-2-oxidanylidene-ethyl]-~{N}-propyl-prop-2-enamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grl,Crystal structure of SARS-CoV-2 main protease in complex with cpd-8,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
NA",Y1C,"4-(4,5-dibromo-2H-1,2,3-triazol-2-yl)butan-2-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hur,Crystal structure of SARS-Cov-2 main protease in complex with S217622,3C-like proteinase nsp5,2,"A,B",298,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,Yes,"MET, 163-(7YY, .)",6LU7_1|Chain,0,,97.39,8
7k40,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor Boceprevir at 1.35 A Resolution,3C-like proteinase,1,A,306,Yes,DMS,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ghb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with GAB-REV-70cc3ca5-8 (Mpro-x3080),3C-like proteinase,1,A,306,Yes,DMS,Q4R,N~2~-methyl-N-(4-methylpyridin-3-yl)-N~2~-(quinoline-8-sulfonyl)glycinamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gnh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-853c0ffa-9 (Mpro-P2649),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RYB,"1-{[(3'S)-6-chloro-1'-{6-[2-(dimethylamino)ethoxy]isoquinolin-4-yl}-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidine]-2(3H)-sulfonyl]methyl}cyclopropane-1-carbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rh7,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4439011584 (Mpro-x2705),3C-like proteinase,1,A,306,Yes,DMS,UJ1,N-(5-tert-butyl-1H-pyrazol-3-yl)-N-[(1R)-2-[(2-ethyl-6-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uju,Room-temperature X-ray structure of monomeric SARS-CoV-2 main protease catalytic domain (MPro1-196) in complex with nirmatrelvir,3C-like proteinase nsp5,2,"A,B",197,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,63.84,111
7jvz,"SARS CoV-2 MAIN PROTEASE 3CLpro, ROOM TEMPERATURE, DAMAGE FREE XFEL MONOCLINIC STRUCTURE",3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8dd6,SARS-CoV-2 Main Protease (Mpro) H163A Mutant in Complex with GC376,ORF1a polyprotein,1,A,306,Yes,DMS,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,H163A,99.67,0
7b2j,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 5,3C-like proteinase nsp5,1,A,306,Yes,"PEG
DMS",SQ2,"2-(1H-1,2,3-benzotriazol-1-yl)-1-(4-methylpiperidin-1-yl)ethan-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7uu6,Crystal structure of the SARS-CoV-2 main protease in its apo-form,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8j3a,Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,Y54C,97.39,7
7axo,Structure of SARS-CoV-2 Main Protease bound to AR-42.,3C-like proteinase,1,A,306,Yes,DMS,QCP,AR-42,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-e0fe77e5-13 (Mpro-P0950),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QY6,"(3R)-6'-chloro-1-(isoquinolin-4-yl)-2',3'-dihydro-1'H-spiro[piperidine-3,4'-quinolin]-2-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hqi,Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with inhibitor YH-53,3C-like proteinase nsp5,2,"A,B",299,Yes,,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"CYS, 144-(HUR, .)",7TOB_1|Chain,0,,97.71,7
5rg3,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with NCL-00025412,3C-like proteinase,1,A,306,Yes,DMS,T9P,N~2~-acetyl-N~1~-prop-2-en-1-yl-L-aspartamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6xfn,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW243,3C-like proteinase,1,A,308,Yes,GOL,(UZ7)L(V1V)(APY),UAW243,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
7lzv,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 19b,3C-like proteinase,2,"A,B",309,Yes,PG4,"YLM
YLS","(1R,2S)-2-((S)-2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8drv,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp8-nsp9 (C8) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp8-nsp9 (C8) cut site,4,"A,B,C,D",306,No,1PE,,,,,,,6LU7_1|Chain,4,"C145A, G302A, T304K, F305L",98.69,0
5rez,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with POB0129,3C-like proteinase,1,A,306,Yes,DMS,T54,"(1R,2S)-2-(thiophen-3-yl)cyclopentane-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gie,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-17 (Mpro-P0068),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QF9,2-(3-chloro-5-cyanophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gba,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ANT-OPE-d972fbad-1 (Mpro-x10296),3C-like proteinase,1,A,306,Yes,DMS,KS0,1-{4-[(4-fluorophenyl)methyl]piperazin-1-yl}propan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rl1,PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-27 (Mpro-x3113),3C-like proteinase,1,A,306,Yes,DMS,VEJ,N-(4-tert-butylphenyl)-N-[(1R)-2-[(3-methoxypropyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8aj1,SARS-CoV-2 Mpro in Complex with RK-107,3C-like proteinase nsp5,1,A,304,Yes,,A1IMU,"(2R,3S)-3-[[(2S)-3-cyclopropyl-2-[2-oxidanylidene-3-(phenylcarbamoylamino)pyridin-1-yl]propanoyl]amino]-N-methyl-2-oxidanyl-4-[(3S)-2-oxidanylidenepyrrolidin-3-yl]butanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
8e68,Crystal structure of SARS-CoV-2 3CL protease in complex with a p-fluorodimethyl oxybenzene inhibitor,3C-like proteinase,2,"A,B",309,Yes,PG4,"WGO
WGU","N~2~-{[2-(4-fluorophenoxy)-2-methylpropoxy]carbonyl}-N-{(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}-L-leucinamide
(1S,2S)-2-[(N-{[2-(4-fluorophenoxy)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7jq2,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI5,3C-like proteinase,1,A,306,Yes,,VHM,N-[(benzyloxy)carbonyl]-L-valyl-3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8wsj,"Crystal structure of SARS-Cov-2 main protease, pH=6.5","3C-like proteinase nsp5
3C-like proteinase nsp5",2,"A,B","295, 299",No,,,,,,,,6LU7_1|Chain,"0
2","
F140L, L141F","96.41
97.06","11
7"
8r1q,"SARS-CoV-2 Mpro (Omicron, P132H+T169S) in complex with alpha-ketoamide 13b-K",3C-like proteinase nsp5,2,"A,B",306,Yes,,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,1,T169S,99.67,0
7gh7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-714-22 (Mpro-x2912),3C-like proteinase,1,A,306,Yes,DMS,Q36,(2R)-2-(3-cyanophenyl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7t4b,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 14c,3C-like proteinase,2,"A,B",309,Yes,PG4,"FWI
FZI","(1R,2S)-2-{[N-({[1-(tert-butoxycarbonyl)azetidin-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl]propane-1-sulfonic acid
(1S,2S)-2-{[N-({[1-(tert-butoxycarbonyl)azetidin-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8huv,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with S217622,3C-like proteinase nsp5,2,"A,B",299,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,1,G15S,97.39,7
5rgl,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102962 (Mpro-x0705),3C-like proteinase,1,A,306,Yes,DMS,U0Y,1-[4-(4-methylbenzene-1-carbonyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mhj,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) at 298 K and High Humidity,3C-like proteinase,1,A,306,No,ZN,,,,,,,6LU7_1|Chain,0,,100.00,0
8dza,Crystal Structure of SARS-CoV-2 Main protease A193T mutant in complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,A193T,99.67,0
7aha,Structure of SARS-CoV-2 Main Protease bound to Maleate.,3C-like proteinase,1,A,306,No,"CL
DMS
SIN",,,,,,,6LU7_1|Chain,0,,100.00,0
7gid,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-1 (Mpro-P0066),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QF5,N-(isoquinolin-4-yl)-2-phenylacetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tiy,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor NK01-48,3C-like proteinase nsp5,1,A,306,Yes,"PO4
EDO",Y48,"(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-[(N-{[(2,4,5-trifluorophenyl)methoxy]carbonyl}-L-leucyl)amino]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8y4g,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with Bofutrelvir,3C-like proteinase nsp5,2,"A,B",296,Yes,,FHR,~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,4,"G15S, S46N, E47T, N142A",95.42,10
7bqy,THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR N3 at 1.7 angstrom,3C-like proteinase,1,A,306,Yes,,PRD_002214,"N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE",Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7rvo,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI13,3C-like proteinase,2,"A,B",306,Yes,,7VI,N-[(benzyloxy)carbonyl]-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
8dz9,Crystal Structure of SARS-CoV-2 Main protease G143S mutant in complex with Nirmatrelvir,3C-like proteinase nsp5,4,"A,B,C,D",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 B,6LU7_1|Chain,1,G143S,99.67,0
8k6b,Crystal structure of SARS-CoV-2 3CLpro M49K/M165V mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,2,"M49K, M165V",99.35,0
7gi4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-2eddb1ff-7 (Mpro-P0045),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QCC,2-(3-chloro-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gg8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-cd485364-2 (Mpro-x12202),3C-like proteinase,1,A,306,Yes,DMS,ORR,"1-(5-amino-3,4-dihydro-1,7-naphthyridin-1(2H)-yl)-2-(3-chlorophenyl)ethan-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ds1,Structure of SARS-CoV-2 Mpro in complex with nsp12-nsp13 (C12) cut site sequence,3C-like proteinase nsp5,12,"A,B,C,D,E,F,G,H,I,J,K,L",306,No,"NA
PEG",,,,,,,6LU7_1|Chain,5,"S301P, G302H, V303T, T304V, F305L",98.37,0
7zv8,Crystal structure of SARS Cov-2 main protease in complex with an inhibitor 58,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,"GF(HSV)
OCA","inhibitor 58
OCTANOIC ACID (CAPRYLIC ACID)","polypeptide(L)
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7gd3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c59291d4-3 (Mpro-x10870),3C-like proteinase,1,A,306,Yes,DMS,Y6J,~{N}-[4-[2-(benzotriazol-1-yl)ethanoyl-(thiophen-3-ylmethyl)amino]phenyl]cyclopropanecarboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dii,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,1,A,306,Yes,,U2I,"(2S)-N-(isoquinolin-4-yl)-2-methyl-2,3-dihydro-1,4-benzoxazepine-4(5H)-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rh1,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2010253653 (Mpro-x2643),3C-like proteinase,1,A,306,Yes,DMS,UGV,2-(5-chlorothiophen-2-yl)-N-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-477dc5b7-4 (Mpro-P2197),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RKC,"(3'R)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,3'-pyrrolidin]-2'-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8h57,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) A193P Mutant in Complex with Inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,A193P,99.67,0
7mb1,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM143,3C-like proteinase,2,"A,B",306,Yes,,YVJ,4-fluoro-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7geb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-93268d01-8 (Mpro-x11417),3C-like proteinase,1,A,306,Yes,DMS,NDI,2-(4-acetylpiperazin-1-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mhk,Crystal Structure of Apo/Unliganded SARS-CoV-2 Main Protease (Mpro) at 310 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7gfy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NOR-c954e7ad-4 (Mpro-x12010),3C-like proteinase,1,A,306,Yes,DMS,OLX,"[(3R)-5-ethyl-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-1-yl]acetic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9bo5,Crystal Structure of T190I SARS-CoV-2 Main Protease in Complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,T190I,99.67,0
7z0p,SARS-COV2 Main Protease in complex with inhibitor MG-131,3C-like proteinase nsp5,1,A,304,Yes,NA,I8H,"(1~{R},2~{S},5~{S})-3-[(2~{S})-2-(~{tert}-butylcarbamoylamino)-3,3-dimethyl-butanoyl]-6,6-dimethyl-~{N}-[(2~{S},3~{R})-4-(methylamino)-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
7c6u,Crystal structure of SARS-CoV-2 complexed with GC376,3C-like proteinase,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7m2p,Structure of the SARS-CoV-2 3CL protease in complex with inhibitor 18,3C-like proteinase,1,A,306,Yes,,PRD_002469,Inhibitor 18 in bound form,Peptide-like,Enzyme inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with KAD-UNI-80f122c8-2 (Mpro-P0743),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QR9,"(4S)-4-{2-[(1R,4R)-5-acetyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-oxoethyl}-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8yko,Crystal structure of SARS-Cov-2 main protease P132H mutant in complex withX77,3C-like proteinase nsp5,2,"A,B",298,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,7TOB_1|Chain,0,,97.39,8
7dgg,The co-crystal structure of SARS-CoV-2 main protease with (S)-2-cinnamamido-N-((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)hexanamide,3C-like proteinase,2,"A,B",306,Yes,,H63,(2~{S})-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]hexanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5reg,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1545313172,3C-like proteinase,1,A,306,Yes,DMS,LWA,(2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gin,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-869ac754-1 (Mpro-P0114),3C-like proteinase,2,"A,B",306,Yes,DMS,QHU,"(4R)-6,7-dichloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7pfm,A SARS-CoV2 major protease non-covalent ligand structure determined to 2.0 A resolution,Replicase polyprotein 1ab,2,"A,B",306,Yes,,7IL,N-[(1R)-2-(tert-butylamino)-2-oxidanylidene-1-pyridin-3-yl-ethyl]-N-(4-tert-butylphenyl)-1H-imidazole-5-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gru,Crystal structure of SARS-CoV-2 main protease in complex with cpd-17,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
NA",Y0H,3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-amine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgt,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4439011607 (Mpro-x2540),3C-like proteinase,1,A,306,Yes,DMS,UHS,"N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)propanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8tyk,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) T21I Mutant,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,1,T21I,99.67,0
7tb2,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 12/13,3C-like proteinase,1,A,306,Yes,,PHTVLQAV,Nonstructural protein 12/13,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
8t7y,Structure of SARS CoV-2 main protease in complex with Chymostatin.,3C-like proteinase nsp5,2,"A,B",306,Yes,,PRD_002331,Chymostatin A (bound form),Oligopeptide,Enzyme inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-3c72d439-1 (Mpro-x11810),3C-like proteinase,1,A,306,Yes,DMS,OIE,2-(4-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hoz,Crystal Structure of SARS-CoV-2 Omicron Main Protease (Mpro) in Complex with Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
7gms,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-be9e6f63-3 (Mpro-P2215),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RNI,"(4S)-6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-{7-[(methanesulfonyl)amino]isoquinolin-4-yl}-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grx,Crystal structure of SARS-CoV-2 main protease in complex with cpd-20,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",XZT,"1-(2,4-difluorophenyl)pyrrolidine-2,5-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dzb,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor 11,3C-like proteinase nsp5,1,A,306,Yes,GOL,U6Y,"benzyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-5-oxopyrrolidin-3-yl}carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-8 (Mpro-x10423),3C-like proteinase,1,A,306,Yes,DMS,L6R,(2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)pentanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-18 (Mpro-P1980),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R95,"(4S)-6-chloro-2-[(cyanomethyl)(methyl)sulfamoyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ftc,Crystal structure of main protease of SARS-CoV-2 complexed with inhibitor,3C-like proteinase nsp5,1,A,306,Yes,,Y8O,"(1R,2S,5S)-3-[N-(difluoroacetyl)-3-methyl-L-valyl]-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopiperidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6wnp,X-ray Structure of SARS-CoV-2 main protease bound to Boceprevir at 1.45 A,3C-like proteinase,1,A,306,Yes,,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gaz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DUN-NEW-f8ce3686-14 (Mpro-x10049),3C-like proteinase,1,A,306,Yes,DMS,KL6,"1-{2-[(methanesulfonyl)amino]ethyl}-1,2,3,4-tetrahydroquinoline-7-sulfonamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xkh,THE 1.28A CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH OXIDIZED C145 (sulfinic acid cysteine),3C-like proteinase,1,A,306,No,"EDO
FMT
ACT",,,,,,,6LU7_1|Chain,0,,100.00,0
8r26,"SARS-CoV-2 Mpro (Omicron,P132H) in complex with alpha-ketoamide 13b-K at pH 8.5",3C-like proteinase nsp5,4,"A,B,C,D",306,Yes,CL,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
8dib,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,2,"A,B",306,Yes,,TKX,5-bromo-3-[(4-chloro-3-nitrophenyl)methoxy]pyridine-2-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8dih,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,1,A,306,Yes,,U2B,"(1P,1'R)-1-(isoquinolin-4-yl)-2',3'-dihydrospiro[imidazolidine-4,1'-indene]-2,5-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7arf,Structure of SARS-CoV-2 Main Protease bound to thioglucose.,3C-like proteinase,1,A,306,Yes,"DMS
CL",RVW,"(2~{S},3~{R},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-sulfanyl-oxane-3,4,5-triol",non-polymer,,Yes,CYS156 A,6LU7_1|Chain,0,,100.00,0
7rvx,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI24,3C-like proteinase,2,"A,B",306,Yes,,7YI,benzyl [(1S)-1-cyclopropyl-2-{[(2S)-3-cyclopropyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]amino}-2-oxoethyl]carbamate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7brp,Crystal structure of the 2019-nCoV main protease complexed with Boceprevir,3C-like proteinase,2,"A,B",307,Yes,,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
5r7y,PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z45617795,3C-like proteinase,1,A,306,Yes,"DMS
CL",JFM,N-(2-phenylethyl)methanesulfonamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf2,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1741969146,3C-like proteinase,1,A,306,Yes,DMS,HVB,1-azanylpropylideneazanium,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8caj,Crystal structure of SARS-CoV-2 Mpro-E166V mutant in complex with 13b-K,Non-structural protein 11,1,A,302,Yes,,UAX,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{R})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E166V,98.37,4
8e4w,Crystal Structure of SARS CoV-2 Mpro mutant N142P with Pfizer Intravenous Inhibitor PF-00835231,3C-like proteinase nsp5,2,"A,B",306,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,N142P,99.67,0
5rev,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0103072,3C-like proteinase,1,A,306,Yes,DMS,T4J,N-[3-(thiomorpholine-4-carbonyl)phenyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8hht,Crystal structure of the SARS-CoV-2 main protease in complex with Hit-1,3C-like proteinase nsp5,1,A,306,Yes,DMS,LV0,"~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(1,3-thiazol-2-ylmethylamino)butan-2-yl]benzamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gi6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-4aa06b95-1 (Mpro-P0056),3C-like proteinase,2,"A,B",306,Yes,DMS,QD4,"(4R)-6-chloro-N~4~-(isoquinolin-4-yl)-3,4-dihydroquinoline-1,4(2H)-dicarboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-4f474d93-1 (Mpro-x12659),3C-like proteinase,1,A,306,Yes,DMS,OYF,"(4R)-6-chloro-N-(2,7-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gno,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-WEI-dcc3321b-4 (Mpro-P2838),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S3X,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-(2-{[(1S)-1-(4-nitrophenyl)ethyl]amino}-2-oxoethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8jck,The crystal structure of SARS-CoV-2 main protease in complex with Compound 32,3C-like proteinase nsp5,1,A,306,Yes,"GOL
H2S
DMS",A8J,tert-butyl 3-ethanoylbenzoate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mhf,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) at 100 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7aws,Structure of SARS-CoV-2 Main Protease bound to TH-302.,3C-like proteinase,1,A,306,Yes,"DMS
CL",S8E,"5-[[(2-bromoethylamino)-(ethylamino)phosphoryl]oxymethyl]-1-methyl-~{N},~{N}-bis(oxidanyl)imidazol-2-amine",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7au4,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 3,3C-like proteinase nsp5,1,A,306,Yes,DMS,RY5,"(3~{S})-6-chloranyl-3'-(1,2-oxazol-3-ylmethyl)spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gd7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ADA-UNI-f8e79267-2 (Mpro-x10889),3C-like proteinase,1,A,306,Yes,DMS,LZX,(2R)-4-[(methanesulfonyl)amino]-2-phenyl-N-(pyridin-3-yl)butanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jq4,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI7,3C-like proteinase,1,A,306,Yes,,XM2,N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7dgh,The co-crystal structure of SARS-CoV-2 main protease with peptidomimetic inhibitor N-((S)-3-methyl-1-(((S)-4-methyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopiperidin-3-yl)propan-2-yl)amino)pentan-2-yl)amino)-1-oxobutan-2-yl)-2-naphthamide,3C-like proteinase,1,A,306,Yes,,H6F,~{N}-[(2~{S})-3-methyl-1-[[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]pentan-2-yl]amino]-1-oxidanylidene-butan-2-yl]naphthalene-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7af0,Structure of SARS-CoV-2 Main Protease bound to Ipidacrine.,3C-like proteinase,1,A,306,Yes,"DMS
CL",R9W,"2,3,5,6,7,8-hexahydro-1~{H}-cyclopenta[b]quinolin-9-amine",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7e6k,Viral protease,3C-like proteinase,1,A,305,Yes,"DMS
SO4",HYR,N-(2-phenoxyethyl)methanethioamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7mb2,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM144,3C-like proteinase,2,"A,B",306,Yes,,YVM,4-fluoro-N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tq2,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 1c,3C-like proteinase,2,"A,B",309,Yes,,ISG,"N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-({[(1R,2R)-2-phenylcyclopropyl]methoxy}carbonyl)-L-leucinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
7gmb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-31 (Mpro-P2144),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RIU,2-(3-chlorophenyl)-N-{6-[2-(dimethylamino)ethoxy]isoquinolin-4-yl}acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fa06b69f-6 (Mpro-x11894),3C-like proteinase,1,A,306,Yes,DMS,OK9,N-{(1Z)-1-[5-(morpholin-4-yl)thiophen-2-yl]-3-oxoprop-1-en-2-yl}thiophene-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7glb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-015fb6b4-2 (Mpro-P1835),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R76,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7geq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UCB-1dbca3b4-15 (Mpro-x11498),3C-like proteinase,1,A,306,Yes,DMS,NSR,"(4R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8r14,Structure of compound 11 bound to SARS-CoV-2 main protease,3C-like proteinase,2,"A,B",306,Yes,"PGE
BR
CL
GOL
NA",XHW,"(5-chloranylpyridin-3-yl)-[4-[(2-chlorophenyl)methyl]-1,4-diazepan-1-yl]methanone",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9auj,Structure of SARS-CoV-2 Mpro mutant (S144A) in complex with Nirmatrelvir (PF-07321332),3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S144A,99.67,0
7gnn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-WEI-dcc3321b-3 (Mpro-P2775),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S39,"(4S)-2-{2-[(1,3-benzothiazol-5-yl)amino]-2-oxoethyl}-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ty5,MI-14 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,SQ3,"(1R,2S,5S)-3-[(2,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gn8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-c7726e07-5 (Mpro-P2385),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RPZ,"2-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfn,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102868,3C-like proteinase,1,A,306,Yes,DMS,T7P,"N-[(3R)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-(4-fluorophenyl)acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gdb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-968e8d9c-1 (Mpro-x10906),3C-like proteinase,1,A,306,Yes,DMS,M9U,"(4S)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7te0,Structure of the SARS-CoV-2 main protease in complex with inhibitor PF-07321332,3C-like proteinase,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7vk0,Crystal Structure of SARS-CoV-2 Mpro at 2.10 A resolution-6,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7cut,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with Z-VAD-FMK,3C protein,1,A,306,Yes,"DMS
GOL",PRD_002352,Z-VAD(OMe)-FMK,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-2eddb1ff-8 (Mpro-x11641),3C-like proteinase,1,A,306,Yes,DMS,O8L,(2S)-2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfo,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102972,3C-like proteinase,1,A,306,Yes,DMS,T7S,1-[4-(piperidine-1-carbonyl)piperidin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-9739a092-9 (Mpro-P0394),3C-like proteinase,2,"A,B",306,Yes,DMS,QOO,2-{3-chloro-5-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-6f6ae286-3 (Mpro-P1858),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R87,"(4S)-6-chloro-N-(7-fluoroisoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8uif,Crystal structure of SARS CoV-2 3CL protease in complex with GSK4365096A,3C-like proteinase nsp5,2,"A,B",306,Yes,,A1ADS,N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-{(2R)-1-[(2S)-oxolan-2-yl]-3-[(3S)-2-oxooxolan-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
8p56,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 150 micromolar X77.,3C-like proteinase nsp5,2,"A,B",306,Yes,"EDO
CL
DMS
NA",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rft,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102432,3C-like proteinase,1,A,306,Yes,DMS,T8A,"1-[(4S)-4-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gke,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-dd3ad2b5-3 (Mpro-P0851),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QW1,"(4S)-6-chloro-N~4~-(isoquinolin-4-yl)-3,4-dihydroisoquinoline-2,4(1H)-dicarboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bnu,Crystal Structure of T190I SARS-CoV-2 Main Protease,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,T190I,99.67,0
5rf0,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with POB0073,3C-like proteinase,1,A,306,Yes,DMS,T5D,[1-(pyridin-2-yl)cyclopentyl]methanol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8acd,Crystal structure of SARS-CoV-2 main protease (MPro) in complex with the non-covalent inhibitor GA-17S,3C-like proteinase nsp5,1,A,306,Yes,,LQ6,"(2~{S})-4-[[2,4-bis(oxidanylidene)-1~{H}-pyrimidin-6-yl]carbonyl]-1-(3,4-dichlorophenyl)-~{N}-(thiophen-2-ylmethyl)piperazine-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7zb7,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) variant Y54F at 1.63 A resolution,3C-like proteinase nsp5,1,A,306,No,"DMS
GOL",,,,,,,6LU7_1|Chain,1,Y54F,99.67,0
7cx9,Crystal structure of the SARS-CoV-2 main protease in complex with INZ-1,3C-like proteinase,1,A,306,Yes,"GOL
CL",GKF,3-iodanyl-1~{H}-indazole-7-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfe,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-6344a35d-1 (Mpro-x11642),3C-like proteinase,1,A,306,Yes,DMS,O9O,N-{3-chloro-5-[(6-methoxypyridin-2-yl)oxy]phenyl}-2-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mhh,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) at 277 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7mgr,SARS-CoV-2 main protease in complex with nsp8/9 substrate peptide,3C-like proteinase,1,A,306,Yes,,AVKLQNNEL,ALA-VAL-LYS-LEU-GLN-ASN-ASN-GLU,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
8y42,SARS-CoV-2 3CL protease (3CLpro) in complex with compound JZD-128,3C-like proteinase nsp5,4,"A,B,C,D",306,Yes,,A1D51,"~{N}-[(1~{S},2~{R})-2-[[4-cyclopropyl-2-(methylcarbamoyl)-6-nitro-phenyl]amino]cyclohexyl]-2-oxidanylidene-1~{H}-quinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tj0,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor SL-4-241,3C-like proteinase nsp5,1,A,306,Yes,ACT,S4L,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-3-cyclohexyl-L-alanyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gj9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c3a96089-4 (Mpro-P0186),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QL3,N-(6-acetamidopyridin-3-yl)-N-[(3-chlorophenyl)methyl]-2-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dav,The native crystal structure of COVID-19 main protease,COVID-19 MAIN PROTEASE,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gn4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-43f8f7d6-4 (Mpro-P2291),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RT4,"(4S)-6-chloro-2-[2-(cyclopropylamino)-2-oxoethyl]-N-(isoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hef,The Crystal structure of deuterated S-217622 (Ensitrelvir) bound to the main protease (3CLpro/Mpro) of SARS-CoV-2,3C-like proteinase,2,"A,B",301,Yes,GOL,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,98.37,5
7gk1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-9e38fd34-1 (Mpro-P0766),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QSF,"(3S)-5-chloro-N-(isoquinolin-4-yl)-3-methyl-2-oxo-2,3-dihydro-1H-indole-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gko,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-30 (Mpro-P0996),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QYN,"(4S)-6-chloro-2-(1H-imidazole-2-sulfonyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8f02,SARS-CoV-2 Main Protease (Mpro) in Complex with ML2006a4,3C-like proteinase nsp5,1,A,306,Yes,,X6T,"(1R,2S,5S)-N-{(2S,3R)-4-(3,3-dimethylazetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8jcm,The crystal structure of SARS-CoV-2 main protease in complex with Compound 55,3C-like proteinase nsp5,1,A,306,Yes,"DMS
H2S",AJF,methyl (2S)-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lzt,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 8b,3C-like proteinase,1,A,309,Yes,SO4,"YMY
YN1","(1R,2S)-1-hydroxy-2-((S)-4-methyl-2-(((((1s,4S)-4-propylcyclohexyl)methoxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-1-hydroxy-2-((S)-4-methyl-2-(((((1s,4S)-4-propylcyclohexyl)methoxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8uia,Crystal structure of SARS CoV-2 3CL protease in complex with GSK4365097A,3C-like proteinase nsp5,2,"A,B",306,Yes,"GOL
CL",WTV,N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-{(2R)-1-[(2R)-oxolan-2-yl]-3-[(3R)-2-oxooxolan-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8drz,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp13-nsp14 (C13) cut site sequence,3C-like proteinase nsp5,7,"A,B,C,D,E,F,G",306,No,"PEG
TRS
1PE
NA",,,,,,,6LU7_1|Chain,5,"C145A, S301N, G302V, V303A, F305L",98.37,0
7ge0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-6af13d92-2 (Mpro-x11276),3C-like proteinase,1,A,306,Yes,DMS,N3R,"5-fluoro-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5smn,PanDDA analysis group deposition of SARS-CoV-2 main protease ligands identified from single sequence-guideddeep generative framework -- Crystal structure of SARS-CoV-2 main protease in complex with Z1365651030 (Mpro-IBM0078),3C-like proteinase,1,A,306,Yes,DMS,O4F,N-(1-cyanocyclopropyl)-1-(3-methylpyridin-4-yl)piperidine-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bo0,Crystal Structure of T21I SARS-CoV-2 Main Protease in Complex with Compound Mpro61,3C-like proteinase,2,"A,B",306,Yes,,XEK,"(5P)-5-[(1P,3M,3'P)-3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl]-1-methylpyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,1,T21I,99.67,0
9at5,"Crystal structure of SARS-CoV-2 3CL protease in complex with a 1-methyl-4,4-difluorocyclohexyl 2-pyrrolidone inhibitor",3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,"A1AGO
A1AGP","(1R,2S)-2-({N-[({(2S)-1-[(4,4-difluorocyclohexyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-({N-[({(2S)-1-[(4,4-difluorocyclohexyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
8gws,SARS-CoV-2 Mpro 1-302 c145a in complex with peptide 4,Replicase polyprotein 1ab,2,"A,B",302,Yes,,VKLQAIFR,VAL-LYS-LEU-GLN-ALA-ILE-PHE-ARG,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,98.37,4
7lzu,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 12b,3C-like proteinase,2,"A,B",309,Yes,PG4,"YKM
YKP","(1R,2S)-2-((S)-2-((((S)-1-(4,4-difluorocyclohexyl)ethoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-((((S)-1-(4,4-difluorocyclohexyl)ethoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7max,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM137,3C-like proteinase,2,"A,B",306,Yes,,YV7,D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8c9u,Crystal structure of SARS-CoV-2 Mpro-Q189K mutant in complex with nirmatrelvir,Non-structural protein 11,1,A,305,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,Q189K,99.35,1
7gjn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-37aac4bd-4 (Mpro-P0602),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QP6,"(4S)-6,8-difluoro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gbd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-MED-2de63afb-2 (Mpro-x10322),3C-like proteinase,1,A,306,Yes,DMS,KT9,N-(3-methyl-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gg3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with AAR-RCN-748c104b-1 (Mpro-x12080),3C-like proteinase,1,A,306,Yes,DMS,OOL,"(E)-1-(4,6-dimethoxypyrimidin-2-yl)methanimine",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uua,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI8,3C-like proteinase nsp5,1,A,306,Yes,,NOL,N-[(BENZYLOXY)CARBONYL]-O-(TERT-BUTYL)-L-THREONYL-3-CYCLOHEXYL-N-[(1S)-2-HYDROXY-1-{[(3S)-2-OXOPYRROLIDIN-3-YL]METHYL}ETHYL]-L-ALANINAMIDE,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,L57E,99.67,0
7cam,SARS-CoV-2 main protease (Mpro) apo structure (space group P212121),3C-like proteinase,2,"A,B",307,No,,,,,,,,6LU7_1|Chain,0,,99.67,1
7c2q,The crystal structure of COVID-19 main protease in the apo state,3C-like proteinase,2,"A,B",296,No,,,,,,,,6LU7_1|Chain,0,,96.73,10
8p57,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 75 micromolar X77.,3C-like proteinase nsp5,2,"A,B",306,Yes,"CL
EDO
DMS
NA",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gk7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-ba1ac7b9-21 (Mpro-P0805),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QU9,"(4S)-6-chloro-4-(2-{(2R)-2-[(1H-imidazol-1-yl)methyl]pyrrolidin-1-yl}-2-oxoethyl)-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-971238d3-5 (Mpro-x12716),3C-like proteinase,1,A,306,Yes,DMS,PQ6,"(4R)-4-(aminomethyl)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-64a710fa-1 (Mpro-P0016),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OYX,N-(2-cyclohexylethyl)-2-(isoquinolin-4-yl)-N-[(thiophen-2-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8bga,Structure of Mpro in complex with FGA146,3C-like proteinase nsp5,2,"A,B",306,Yes,,QQL,4-methoxy-~{N}-[(2~{S})-4-methyl-1-[[(2~{S})-4-nitro-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-1-oxidanylidene-pentan-2-yl]-1~{H}-indole-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lfe,SARS-CoV-2 Main protease immature form - F2X Entry Library E03 fragment,3C-like proteinase,2,"A,B",309,Yes,"PEG
DMS",XWS,"(2R,4R)-1-phenylhexahydropyrimidine-2,4-diol",non-polymer,,No,,6LU7_1|Chain,0,,99.03,3
8tql,MPI54 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,JY0,"benzyl [(2S,3S)-3-tert-butoxy-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxobutan-2-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gby,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-5 (Mpro-x10473),3C-like proteinase,1,A,306,Yes,DMS,L5I,(2R)-3-cyclopropyl-2-methyl-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-5a013bed-4 (Mpro-x10604),3C-like proteinase,1,A,306,Yes,DMS,LKX,"2-(3-chlorophenyl)-N-(5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7z3u,Crystal structure of SARS-CoV-2 Main Protease after incubation with Sulfo-Calpeptin,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",PRD_002387,Calpetin,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbb,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAN-LON-a5fc619e-3 (Mpro-x10306),3C-like proteinase,1,A,306,Yes,DMS,KSI,1-[(3S)-4-[(3-chlorophenyl)methyl]-3-(2-methylpropyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7l12,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 14,3C-like proteinase,1,A,306,Yes,,XF4,"(5S)-5-{3-[3-(benzyloxy)-5-chlorophenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}pyrimidine-2,4(3H,5H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gi7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-6c284e65-1 (Mpro-P0057),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QD9,N-[(3-chlorophenyl)methyl]-N-[5-(dimethylamino)pyridin-2-yl]-2-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ght,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-c9c1e0d8-3 (Mpro-P0019),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OWC,(3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ifp,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 1,3C-like proteinase nsp5,1,A,306,Yes,,OZ6,"(1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethyl-butanoyl]-6,6-dimethyl-N-[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 145-(OZ6, .)",6LU7_1|Chain,0,,100.00,0
8cz4,Crystal structure of SARS-CoV-2 Mpro with compound C3,3C-like proteinase,4,"A,B,C,D",306,Yes,,P6R,N-(4-tert-butylphenyl)-N-[(4-chlorothiophen-2-yl)methyl]-2-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jt7,Crystal structure of SARS-CoV-2 3CL protease in complex with compound 4,3C-like proteinase,1,A,306,Yes,,TG3,"ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gcy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c59291d4-5 (Mpro-x10812),3C-like proteinase,1,A,306,Yes,DMS,LW6,1H-indole-4-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7grw,Crystal structure of SARS-CoV-2 main protease in complex with cpd-19,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",XZX,"(2S)-N-(3,5-dichlorophenyl)-2-hydroxypropanamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hvw,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with PF07304814,3C-like proteinase nsp5,2,"A,B",299,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,"CYS, 143-(80I, .)",6LU7_1|Chain,1,M49I,97.39,7
5rfa,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2643472210,3C-like proteinase,1,A,306,Yes,DMS,JGY,1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gh1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-2bb0cf2b-1 (Mpro-x12731),3C-like proteinase,1,A,306,Yes,DMS,PZ6,"(4S)-4-(aminomethyl)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gb8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-14 (Mpro-x10247),3C-like proteinase,1,A,306,Yes,DMS,KQL,N-(4-methylpyridin-3-yl)-2-[3-(trifluoromethyl)phenyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mb4,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp4/5 (P6-P1),3C-like proteinase,4,"A,B,C,D",306,Yes,,TSAVLQ,THR-SER-ALA-VAL-LEU-GLN,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7ntw,Crystal structure of the SARS-CoV-2 Main Protease with a Zinc ion coordinated in the active site,3C-like proteinase,1,A,306,No,"NA
DMS
FMT
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
8huw,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with S217622,3C-like proteinase nsp5,2,"A,B",299,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,1,K90R,97.39,7
8f2d,SARS-CoV-2 Main Protease (Mpro) in Complex with ML4006a,3C-like proteinase nsp5,1,A,306,Yes,CL,XA8,"(1R,2S,5S)-N-[(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-(2-oxopiperidin-1-yl)butan-2-yl]-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ggw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-2bb0cf2b-2 (Mpro-x12715),3C-like proteinase,1,A,306,Yes,"DMS
CL",PKW,"(4R)-6-chloro-N-(1-methyl-1H-imidazo[4,5-c]pyridin-7-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gl1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-8293a91a-8 (Mpro-P1507),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R3I,"(3S)-5-chloro-1'-(6-fluoroisoquinolin-4-yl)-2H-spiro[[1]benzofuran-3,3'-pyrrolidin]-2'-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bo2,Crystal Structure of A173V/L50F SARS-CoV-2 Main Protease in Complex with Compound Mpro61,3C-like proteinase nsp5,1,A,306,Yes,,XEK,"(5P)-5-[(1P,3M,3'P)-3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl]-1-methylpyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,2,"L50F, A173V",99.35,0
6xkf,The crystal structure of 3CL MainPro of SARS-CoV-2 with oxidized Cys145 (Sulfenic acid cysteine).,3C-like proteinase,2,"A,B",306,No,"EDO
CL",,,,,,,6LU7_1|Chain,0,,100.00,0
7lkd,X-ray crystal structure of the SARS-CoV-2 main protease in space group P21.,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
9auk,Structure of SARS-CoV-2 Mpro mutant (A173V) in complex with Nirmatrelvir (PF-07321332),3C-like proteinase nsp5,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,A173V,99.67,0
8r11,Structure of compound 7 bound to SARS-CoV-2 main protease,3C-like proteinase,2,"A,B",306,Yes,"GOL
BR
CL
EDO
NA",XI0,1-[(2~{S})-2-(3-chlorophenyl)pyrrolidin-1-yl]-2-(5-methylpyridin-3-yl)ethanone,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8h6n,Crystal structure of SARS-CoV-2 main protease (Mpro) Mutant (T21I) in complex with protease inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,"4WI
LQZ","(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide
2-(diethylamino)-N-(2,6-dimethylphenyl)ethanamide","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,1,T21I,99.67,0
7rn1,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor Jun9-62-2R,3C-like proteinase,1,A,306,Yes,"GOL
SO4",5ZF,"N-([1,1'-biphenyl]-4-yl)-2-chloro-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8wsk,"Crystal structure of SARS-Cov-2 main protease, pH=8.5",3C-like proteinase nsp5,2,"A,B",296,No,,,,,,,,6LU7_1|Chain,0,,96.73,10
8u3o,SARS-CoV-2 Main Protease A173V in complex with CDD-1819,ORF1a polyprotein,2,"A,B",307,Yes,,O69,"(2P)-2-(isoquinolin-4-yl)-1-[(1s,3R)-3-(methylcarbamoyl)cyclobutyl]-N-[(1S)-1-(naphthalen-2-yl)ethyl]-1H-benzimidazole-7-carboxamide",non-polymer,,No,,6LU7_1|Chain,1,A173V,99.35,1
8uab,SARS-CoV-2 main protease (Mpro) complex with AC1115,3C-like proteinase nsp5,1,A,306,Yes,,W28,N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8u9t,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI97,3C-like proteinase nsp5,1,A,306,Yes,,W1L,"(1R,2S,5S)-N~3~,N~3~-bis(4-chlorophenyl)-N~2~-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,3-dicarboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ifs,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 7,3C-like proteinase nsp5,2,"A,B",306,Yes,,OZL,"(8~{S})-7-[(2~{S})-2-(~{tert}-butylcarbamoylamino)-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-1-cyano-2-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]ethyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxamide",non-polymer,,Yes,"CYS, 145-(OZL, .)",6LU7_1|Chain,0,,100.00,0
7rw0,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI27,3C-like proteinase,1,A,306,Yes,,7YZ,N-{[(3-chlorophenyl)methoxy]carbonyl}-L-valyl-3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7gjm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-e4b030d8-11 (Mpro-P0601),3C-like proteinase,2,"A,B",306,Yes,DMS,QP0,"(3R,4R)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ukk,Room-temperature X-ray structure of SARS-CoV-2 main protease in complex with GC-376,3C-like proteinase,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ggo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-8b8a49e1-4 (Mpro-x12682),3C-like proteinase,1,A,306,Yes,DMS,P3L,"(4R)-6-chloro-N-[(4R)-2-oxopiperidin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ysa,The co-crystal structure of SARS-CoV-2 Mpro in complex with compound H102,3C-like proteinase nsp5,1,A,306,Yes,,(BOC)(TBG)F(ELL),BOC-TBG-PHE-ELL,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfy,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102974,3C-like proteinase,1,A,306,Yes,DMS,T8S,1-acetyl-N-methyl-N-(propan-2-yl)piperidine-4-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rex,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102287,3C-like proteinase,1,A,306,Yes,DMS,T4V,1-{4-[(naphthalen-1-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gs0,Crystal structure of SARS-CoV-2 main protease in complex with cpd-23,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",XZE,(pyridin-2-yl)(quinolin-2-yl)methanone,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6zrt,Crystal structure of SARS CoV2 main protease in complex with inhibitor Telaprevir,Main Protease,1,A,306,Yes,DMS,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mat,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor dFFR,3C-like proteinase,2,"A,B",306,Yes,SO4,H37,D-phenylalanyl-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-L-phenylalaninamide,peptide-like,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
8dk8,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,T190I,99.67,0
7ggv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-91acba05-6 (Mpro-x12710),3C-like proteinase,1,A,306,Yes,DMS,PJX,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1-methyl-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s3s,Room temperature X-ray structure of SARS-CoV-2 main protease in complex with compound Z1530724813,3C-like proteinase,1,A,306,Yes,,860,2-(3-chlorophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s70,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI34,3C-like proteinase,1,A,306,Yes,,8H3,"(1R,2S,5S)-N-{(2S,3R)-4-(butylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7en8,Crystal structure of SARS-CoV-2 3CLpro in complex with the non-covalent inhibitor WU-04,3C-like proteinase,2,"A,B",306,Yes,GOL,J7R,"~{N}-[(1~{S},2~{R})-2-[[4-bromanyl-2-(methylcarbamoyl)-6-nitro-phenyl]amino]cyclohexyl]isoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NOR-30067bb9-15 (Mpro-x11204),3C-like proteinase,1,A,306,Yes,DMS,MWN,"methyl (3R)-5-bromo-3-hydroxy-2-oxo-2,3-dihydro-1H-indole-7-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gdl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-15 (Mpro-x11041),3C-like proteinase,1,A,306,Yes,DMS,MKI,2-(3-chlorophenyl)-N-methyl-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ddm,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) E166R Mutant in Complex with Inhibitor GC376,3C-like proteinase nsp5,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,E166R,99.67,0
7tuu,Structure of the SARS-CoV-2 main protease in complex with halicin,3C-like proteinase nsp5,1,A,306,Yes,,U88,"5-nitro-1,3-thiazole",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gi1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0e5afe9d-3 (Mpro-P0038),3C-like proteinase,2,"A,B",306,Yes,DMS,PJ6,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAR-DIA-eace69ff-36 (Mpro-x3351),3C-like proteinase,1,A,306,Yes,DMS,Q8I,1-(5-fluoro-1H-indol-3-yl)-N-methylmethanamine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8tpc,"Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease",Non-structural protein 7,1,A,305,Yes,,JJC,N-[(1R)-2-(benzylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-[4-(2-chloroacetamido)phenyl]furan-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
8okm,Crystal structure of F2F-2020197-00X bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase nsp5,2,"A,B",306,Yes,"CL
BR
DMS
EDO
NA","84C
MPD","tert-butyl-N-[(2S)-1-[(3S,3aS,6aR)-3-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate
(4S)-2-METHYL-2,4-PENTANEDIOL","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7lme,SARS-CoV-2 3CLPro in complex with N-[4-[[2-(benzotriazol-1-yl)acetyl]-(3-thienylmethyl)amino]phenyl]cyclopropanecarboxamide,3C-like proteinase,2,"A,B",306,Yes,,Y6J,~{N}-[4-[2-(benzotriazol-1-yl)ethanoyl-(thiophen-3-ylmethyl)amino]phenyl]cyclopropanecarboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8sxr,Crystal structure of SARS-CoV-2 Mpro with C5a,3C-like proteinase nsp5,2,"A,B",306,Yes,,WZK,N-[(4-chlorothiophen-2-yl)methyl]-N-[4-(dimethylamino)phenyl]-2-(5-hydroxyisoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvr,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI18,3C-like proteinase,1,A,306,Yes,,7W5,N-[(benzyloxy)carbonyl]-3-methyl-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7vlp,Crystal structure of SARS-Cov-2 main protease in complex with PF07321332 in spacegroup P1211,Replicase polyprotein 1a,2,"A,B",305,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 144-(4WI, .)",6LU7_1|Chain,0,,99.67,1
7lks,1.70 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 2f,3C-like proteinase,2,"A,B",309,Yes,PG4,"Y7G
Y4P","(1S,2S)-2-((S)-2-(((((1R,2S,4S)-bicyclo[2.2.1]heptan-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-(((((1R,2S,4S)-bicyclo[2.2.1]heptan-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8e65,Crystal structure of SARS-CoV-2 3CL protease in complex with a p-chlorodimethyl oxybenzene inhibitor,3C-like proteinase,1,A,309,Yes,,WF5,"(1S,2S)-2-[(N-{[2-(4-chlorophenoxy)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
7gbx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-5a013bed-2 (Mpro-x10466),3C-like proteinase,1,A,306,Yes,DMS,L6D,N-(1H-benzimidazol-1-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hvn,Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with PF07321332,3C-like proteinase nsp5,2,"A,B",298,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",7TOB_1|Chain,0,,97.39,8
5rfr,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102169,3C-like proteinase,1,A,306,Yes,DMS,T81,1-{4-[(5-bromothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-3 (Mpro-x10377),3C-like proteinase,1,A,306,Yes,DMS,KX9,(2R)-2-(3-chlorophenyl)-N-[(4M)-4-(1H-pyrazol-1-yl)pyridin-3-yl]propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8f44,Crystal structure of SARS-CoV-2 3CL protease in complex with a dimethyl phenyl sulfane inhibitor,3C-like proteinase,2,"A,B",309,Yes,PG4,"XFF
XFR","(2-methyl-2-phenylsulfanyl-propyl) ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate
(1R,2S)-1-hydroxy-2-[(N-{[2-methyl-2-(phenylsulfanyl)propoxy]carbonyl}-L-leucyl)amino]-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7rfs,Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor,3C-like proteinase,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7bal,Crystal structure of SARS-CoV-2 main protease treated with ebselen derivative of MR6-31-2,Main Protease,1,A,306,No,SE,,,,,,,6LU7_1|Chain,0,,100.00,0
8iny,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) K90R Mutant in Complex with Inhibitor ensitrelvir,3C-like proteinase,1,A,306,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,1,K90R,99.67,0
6z2e,"Crystal structure of SARS-CoV-2 Mpro in complex with the activity-based probe, biotin-PEG(4)-Abu-Tle-Leu-Gln-vinylsulfone",3C-like proteinase,1,A,306,Yes,"CL
NA",Q5T,"(4~{S})-4-[[(2~{S})-2-[[(2~{S})-2-[[(2~{S})-2-[3-[2-[2-[2-[2-[5-[(3~{a}~{S},4~{R},6~{a}~{R})-2-oxidanylidene-3,3~{a},4,6~{a}-tetrahydro-1~{H}-thieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]butanoyl]amino]-3,3-dimethyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-6-methylsulfonyl-hexanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ged,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-cedd89ab-2 (Mpro-x11426),3C-like proteinase,1,A,306,Yes,DMS,NGX,"(2S)-1-(3-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mbg,SARS-CoV-2 Main protease in orthorhombic space group,3C-like proteinase,2,"A,B",306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
6xb1,Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is highly reactive: Insights for enzyme mechanism and drug design,3C-like proteinase,1,A,306,Yes,,NEN,"1-ETHYL-PYRROLIDINE-2,5-DIONE",non-polymer,,Yes,CYS156 A,6LU7_1|Chain,0,,100.00,0
7t9y,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 8/9,3C-like proteinase,2,"A,B",306,Yes,GOL,SAVKLQNNEL,Nonstructural protein 8/9,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gjd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-3b97339c-2 (Mpro-P0208),3C-like proteinase,2,"A,B",306,Yes,DMS,QM9,"(4S)-4-amino-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vlq,Crystal structure of SARS-Cov-2 main protease in complex with PF07321332 in spacegroup P212121,3C-like proteinase,2,"A,B",300,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",6LU7_1|Chain,0,,98.04,6
7glz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-14 (Mpro-P2067),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",REU,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(2S)-1-(methylamino)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s71,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI35,3C-like proteinase,1,A,306,Yes,,8H9,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-(hexylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7vk2,Crystal Structure of SARS-CoV-2 Mpro at 2.0 A resolution -9,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8j35,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,G15S,97.39,7
8f46,Crystal structure of SARS-CoV-2 3CL protease in complex with a dimethyl phenyl sulfane inhibitor (cyano warhead),3C-like proteinase,2,"A,B",309,Yes,PG4,XCK,"N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[2-methyl-2-(phenylsulfanyl)propoxy]carbonyl}-L-leucinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
7gkf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-UNI-8d415491-6 (Mpro-P0872),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QWL,"(4R)-6,7-dichloro-N-(6-fluoroisoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5res,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102281,3C-like proteinase,1,A,306,Yes,DMS,T3V,1-{4-[(2-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7abu,Structure of SARS-CoV-2 Main Protease bound to RS102895,3C-like proteinase,1,A,306,Yes,"IMD
DMS",R6Q,"1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1~{H}-3,1-benzoxazine-4,4'-piperidine]-2-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ezz,SARS-CoV-2 Main Protease (Mpro) in Complex with ML2006a2,3C-like proteinase nsp5,1,A,306,Yes,CL,X70,"(1R,2S,5S)-N-{(2S,3R)-4-(3,3-difluoroazetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7sd9,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI48,3C-like proteinase,1,A,306,Yes,,8T6,"N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7gkv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-23 (Mpro-P1090),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R0F,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7alh,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 at 1.65A resolution (spacegroup C2).,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
5re5,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z33545544,3C-like proteinase,1,A,306,Yes,DMS,T0J,"N~1~-phenylpiperidine-1,4-dicarboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8udj,Crystal structure of SARS-CoV-2 3CL protease with inhibitor DEL_2,3C-like proteinase nsp5,1,A,306,Yes,,WB5,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-(methylamino)-4-oxo-1-phenylbutan-2-yl]-D-phenylalaninamide",non-polymer,,Yes,"CYS, 145-(WB5, .)",6LU7_1|Chain,0,,100.00,0
8dsu,Crystal Structure of SARS CoV-2 Mpro with Pfizer Intravenous Inhibitor PF-00835231,3C-like proteinase nsp5,2,"A,B",306,Yes,"GOL
DMS",V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gla,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-86c60949-2 (Mpro-P1812),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R7F,"(4R)-6-chloro-N-[6-(2-hydroxypropan-2-yl)isoquinolin-4-yl]-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rfr,Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor,3C-like proteinase,2,"A,B",306,Yes,,4W8,"(1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-(4-methoxy-1H-indole-2-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6w79,Structure of SARS-CoV main protease bound to potent broad-spectrum non-covalent inhibitor X77,Main protease,1,A,306,Yes,"DMS
MES",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,12,"V35T, S46A, N65S, V86L, K88R, A94S, F134H, N180K, V202L, S267A, A285T, L286I",96.08,0
7gf5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-7 (Mpro-x11562),3C-like proteinase,1,A,306,Yes,DMS,O2R,2-(2-butoxy-5-chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7z59,SARS-CoV-2 main protease (Mpro) covalently modified with a penicillin derivative,3C-like proteinase nsp5,1,A,305,Yes,EDO,IFO,"(3S)-4-[[2,4-bis(fluoranyl)phenyl]methoxy]-2-methyl-4-oxidanylidene-3-[[(Z)-3-oxidanylidene-2-(2-phenoxyethanoylamino)prop-1-enyl]amino]butane-2-sulfinic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
8hqh,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with inhibitor YH-53,3C-like proteinase nsp5,2,"A,B",299,Yes,,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"CYS, 143-(HUR, .)",6LU7_1|Chain,1,M49I,97.39,7
7nuk,Crystal structure of SARS CoV2 main protease in complex with EG009 (modelled using PanDDA event map),3C-like proteinase,2,"A,B",306,Yes,DMS,USH,2-[2-chloranylethanoyl(propyl)amino]-~{N}-(2-methoxyphenyl)ethanamide,non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
7gk2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-ba1ac7b9-13 (Mpro-P0772),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QSX,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-{2-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-oxoethyl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5re9,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2856434836,3C-like proteinase,1,A,306,Yes,DMS,LPZ,2-(4-methylphenoxy)-1-(4-methylpiperazin-4-ium-1-yl)ethanone,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gia,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-33 (Mpro-P0063),3C-like proteinase,2,"A,B",306,Yes,DMS,QE3,2-(5-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gc8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-18 (Mpro-x10535),3C-like proteinase,1,A,306,Yes,DMS,L9F,"(3P,5R)-3-(3-chlorophenyl)-5-(pyridin-3-yl)imidazolidine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8a4q,"crystal structures of diastereomer (R,S,S)-13b (13b-H) in complex with the SARS-CoV-2 Mpro.",3C-like proteinase nsp5,1,A,306,Yes,"DMS
CL",V9R,"~{tert}-butyl ~{N}-[1-[(2~{R})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5r80,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z18197050,3C-like proteinase,1,A,306,Yes,DMS,RZG,methyl 4-sulfamoylbenzoate,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8j32,Crystal structure of SARS-Cov-2 main protease in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,97.71,7
7s74,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI38,3C-like proteinase,2,"A,B",306,Yes,,I68,N-(tert-butylcarbamoyl)-3-methyl-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7b5z,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 6,3C-like proteinase nsp5,1,A,306,Yes,DMS,SYH,"2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(4-methylenepiperidin-1-yl)ethan-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9asz,Crystal structure of SARS-CoV-2 3CL protease in complex with a phenylethyl 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,,A1AGG,"(1S,2S)-1-hydroxy-2-{[N-({[(2S)-5-oxo-1-(2-phenylethyl)pyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.06,6
5rf5,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z3241250482,3C-like proteinase,1,A,306,Yes,DMS,HV2,"1,1-bis(oxidanylidene)thietan-3-ol",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-23 (Mpro-x10575),3C-like proteinase,1,A,306,Yes,DMS,LCU,"2-[(1R,3s,5S)-bicyclo[3.1.0]hexan-3-yl]-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s6z,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI33,3C-like proteinase,1,A,306,Yes,,I71,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-(ethylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7nt2,Crystal structure of SARS CoV2 main protease in complex with FSP006,3C-like proteinase,2,"A,B",306,Yes,"DMS
CL
PEG",URK,"[(1S)-2-[(2,3-dimethoxyphenyl)methylamino]-1-(4-nitrophenyl)-2-oxidanylidene-ethyl] prop-2-enoate",non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
8drw,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp9-nsp10 (C9) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp9-nsp10 (C9) cut site,14,"A,B,C,D,E,F,G,H,I,J,K,L,M,N",306,No,"NA
1PE
PEG
PO4",,,,,,,6LU7_1|Chain,5,"C145A, S301A, G302T, T304R, F305L",98.37,0
7axm,Structure of SARS-CoV-2 Main Protease bound to Pelitinib,3C-like proteinase,1,A,306,Yes,"DMS
IMD",93J,(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8uh8,Crystal structure of SARS-CoV-2 main protease E166V (Apo structure),ORF1a polyprotein,1,A,302,No,,,,,,,,6LU7_1|Chain,1,E166V,98.37,4
8drx,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp10-nsp11 (C10) cut site sequence (form 2),Fusion protein of 3C-like proteinase nsp5 and nsp10-nsp11 (C10) cut site,2,"A,B",306,No,NA,,,,,,,6LU7_1|Chain,6,"C145A, S301R, G302E, V303P, T304M, F305L",98.04,0
7jq3,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI6,3C-like proteinase,1,A,306,Yes,,VHP,N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mb8,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp8/9 (P6-P1),3C-like proteinase,4,"A,B,C,D",306,Yes,,SAVKLQ,SER-ALA-VAL-LYS-LEU-GLN,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gh5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-714-12 (Mpro-x2908),3C-like proteinase,1,A,306,Yes,DMS,Q2G,N-(3-chlorophenyl)-N'-(4-methylpyridin-3-yl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UCB-29506327-1 (Mpro-x12686),3C-like proteinase,1,A,306,Yes,DMS,P4R,"(1'M,4S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,4'-imidazolidine]-2',5'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-c7771779-1 (Mpro-x12695),3C-like proteinase,1,A,306,Yes,DMS,P6O,"(4S)-6-chloro-4-hydroxy-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9art,Crystal structure of SARS-CoV-2 main protease A191T mutant in complex with an inhibitor 5h,3C-like proteinase nsp5,2,"A,B",305,Yes,,V7G,"N-[(2S)-1-({(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,A191T,99.35,1
5rhc,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Cov_HetLib053 (Mpro-x2119),3C-like proteinase,1,A,306,Yes,DMS,USA,(E)-1-(1H-imidazol-2-yl)methanimine,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7aga,Structure of SARS-CoV-2 Main Protease bound to AT7519,3C-like proteinase,1,A,306,Yes,"CL
DMS",LZE,"4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rls,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-68,3C-like proteinase,1,A,306,Yes,,5YN,"6-[4-(3,4,5-trichlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-4fff0a85-3 (Mpro-P1983),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R9R,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(3-methyl-1,1-dioxo-1lambda~6~-thietan-3-yl)methanesulfonyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8p86,"Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 5 mM MG-132, from an ""old"" crystal.",3C-like proteinase nsp5,2,"A,B",306,Yes,"EDO
PEG
NA
CL",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8upw,Structure of SARS-Cov2 3CLPro in complex with Compound 34,3C-like proteinase nsp5,1,A,306,Yes,,X8F,"methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6S)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8djj,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,A7T,99.67,0
7com,Crystal structure of the SARS-CoV-2 main protease in complex with Boceprevir (space group P212121),3C-like proteinase,2,"A,B",306,Yes,,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7avd,Structure of SARS-CoV-2 Main Protease bound to SEN1269 ligand,3C-like proteinase,2,"A,B",306,Yes,CL,S1W,3-[[5-[3-(dimethylamino)phenoxy]pyrimidin-2-yl]amino]phenol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gjr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e9e99895-11 (Mpro-P0630),3C-like proteinase,2,"A,B",306,Yes,DMS,QQF,"2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)-N~2~-(methoxyacetyl)-L-alaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7u28,Structure of SARS-CoV-2 Mpro Lambda (G15S) in complex with Nirmatrelvir (PF-07321332),3C-like proteinase nsp5,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,G15S,99.67,0
8dox,Crystal structure of SARS-CoV-2 main protease in complex with an inhibitor TKB-245,3C-like proteinase nsp5,1,A,303,Yes,DMS,T2L,"(1R,2S,5S)-N-{(1S,2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.37,5
5reb,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2856434899,3C-like proteinase,1,A,306,Yes,DMS,T0Y,1-[(thiophen-3-yl)methyl]piperidin-4-ol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dd1,SARS-CoV-2 Main Protease (Mpro) H164N Mutant in Complex with Inhibitor GC376,3C-like proteinase nsp5,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,H164N,99.67,0
7rmt,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-70,3C-like proteinase,1,A,306,Yes,,5ZN,"2-chloro-4-[4-(2,6-dioxo-1,2,5,6-tetrahydropyrimidine-4-carbonyl)piperazin-1-yl]benzaldehyde",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gc7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-39 (Mpro-x10525),3C-like proteinase,1,A,306,Yes,DMS,L93,"6-fluoro-N-[(2R)-2-(2-methoxyphenoxy)propyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7n5z,SARS-CoV-2 Main protease C145S mutant,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,1,C145S,99.67,0
7v1t,A dual Inhibitor Against Main Protease,3C-like proteinase,1,A,306,Yes,,5IL,"5,8-bis(oxidanylidene)-7-[(2-piperazin-1-ylphenyl)amino]naphthalene-1-sulfonamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8c9p,"Crystal structure of SARS-CoV-2 Mpro-E166V mutant, free enzyme",3C-like proteinase nsp5,1,A,305,No,,,,,,,,6LU7_1|Chain,1,E166V,99.35,1
5rfj,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0103067,3C-like proteinase,1,A,306,Yes,DMS,T7A,"N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gxh,The crystal structure of SARS-CoV-2 main protease in complex with 14b,3C-like proteinase nsp5,1,A,306,Yes,,0AX,"N-[(2S)-3-cyclohexyl-1-oxidanylidene-1-[[(2S,3R)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gs3,Crystal structure of SARS-CoV-2 main protease in complex with cpd-26,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",JAH,(6-phenylpyridin-3-yl)methanamine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7sda,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI49,3C-like proteinase,1,A,306,Yes,,8UI,"N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7gbs,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-95b75b4d-1 (Mpro-x10417),3C-like proteinase,1,A,306,Yes,DMS,KZX,2-(3-fluorophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xqs,Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Telaprevir,3C-like proteinase,1,A,306,Yes,,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfc,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z979145504,3C-like proteinase,1,A,306,Yes,DMS,K1Y,"methyl (2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gri,Crystal structure of SARS-CoV-2 main protease in complex with cpd-5,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",Y1R,(1S)-1-(1H-pyrazol-5-yl)ethan-1-ol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7t2t,SARS-CoV2 Mpro native form,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gbv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-22 (Mpro-x10422),3C-like proteinase,1,A,306,Yes,DMS,L3I,2-(3-chlorophenyl)-2-methyl-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-59 (Mpro-x10645),3C-like proteinase,1,A,306,Yes,DMS,LR0,"(7R)-N-(4-acetamidopyridin-3-yl)-4-fluorobicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7hud,PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B08 from the F2X-Entry Screen in monoclinic space group,3C-like proteinase nsp5,1,A,306,Yes,DMS,T9S,"ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7qka,Crystal structure of SARS-CoV-2 Main Protease in complex with covalently bound GC376,3C-like proteinase nsp5,1,A,306,Yes,DMS,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-UNI-8e43a71e-8 (Mpro-P0238),3C-like proteinase,2,"A,B",306,Yes,DMS,QN9,"(4S)-6-chloro-4-{2-[4-(3-hydroxypropyl)piperazin-1-yl]-2-oxoethyl}-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfq,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102179,3C-like proteinase,1,A,306,Yes,DMS,T7Y,N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbe,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-a3ef7265-20 (Mpro-x10324),3C-like proteinase,1,A,306,Yes,DMS,KU6,"(4R)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vh8,Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332,3C-like proteinase,1,A,306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8jcl,The crystal structure of SARS-CoV-2 main protease in complex with Compound 52,3C-like proteinase nsp5,1,A,306,Yes,H2S,AIE,3-ethanoyl-N-phenyl-benzamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8uh9,Crystal structure of SARS-CoV-2 main protease E166V mutant in complex with an inhibitor TKB-272,3C-like proteinase nsp5,1,A,306,Yes,PEG,WOK,"(1R,2S,5S)-N-{(1S,2S)-1-(5-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E166V,99.67,0
7gmd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-7174c657-6 (Mpro-P2176),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R2X,"(2S,5R)-N-{(1R)-1-(3-chlorophenyl)-2-[(isoquinolin-4-yl)amino]-2-oxoethyl}-5-(pyrrolidine-1-carbonyl)oxolane-2-carboxamide (non-preferred name)",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7kvl,SARS-CoV-2 Main protease immature form - FMAX Library E01 fragment,3C-like proteinase,2,"A,B",309,Yes,"PEG
DMS
SER",X4P,2-chloropyridine-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,99.03,3
7d1m,CRYSTAL STRUCTURE OF THE SARS-CoV-2 MAIN PROTEASE COMPLEXED WITH GC376,3C-like proteinase,2,"A,B",307,Yes,DMS,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
8c9q,Crystal structure of SARS-CoV-2 Mpro-Q189K mutant in complex with 13b-K,Non-structural protein 11,2,"A,B",303,Yes,,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,Q189K,98.69,3
7ltn,Crystal structure of Mpro in complex with inhibitor CDD-1713,3C-like proteinase,1,A,306,Yes,,YCV,"2-[4-(1~{H}-indazol-4-yl)-2-methanoyl-6-methoxy-phenoxy]-~{N},~{N}-dimethyl-ethanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gfu,"Room temperature X-ray structure of truncated SARS-CoV-2 main protease C145A mutant, residues 1-304, in complex with nirmatrelvir (NMV)",3C-like proteinase nsp5,1,A,304,Yes,,ZGW,Nirmatrelvir,non-polymer,,No,,6LU7_1|Chain,1,C145A,99.02,2
8hvl,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with PF07321332,3C-like proteinase nsp5,2,"A,B",299,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",6LU7_1|Chain,1,M49I,97.39,7
8h6i,The crystal structure of SARS-CoV-2 3C-like protease Double Mutant (L50F and E166V) in complex with a traditional Chinese Medicine Inhibitors,3C-like proteinase nsp5,1,A,306,Yes,,ODN,"(1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,3,"L50F, K100L, E166V",99.02,0
7zqv,Structure of the SARS-CoV-2 main protease in complex with AG7404,3C-like proteinase nsp5,2,"A,B",306,Yes,,XNV,"ethyl (4R)-4-({(2S)-2-[3-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-2-oxopyridin-1(2H)-yl]pent-4-ynoyl}amino)-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7rbz,X-ray Structure of SARS-CoV-2 main protease covalently modified by compound GRL-017-20,3C-like proteinase,1,A,306,Yes,,4IJ,"5-chloropyridin-3-yl 2,3-dihydro-1H-indole-4-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gn9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-12c4873b-2 (Mpro-P2402),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RVL,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[1-(methylcarbamoyl)cyclopropyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jyc,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor Narlaprevir,3C-like proteinase,1,A,306,Yes,"DMS
NA",NNA,"(1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gna,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-4483ae88-4 (Mpro-P2415),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RVR,"(4S)-6-chloro-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-21 (Mpro-x11025),3C-like proteinase,1,A,306,Yes,DMS,MJR,2-(3-chlorophenyl)-N-(3-methyl-1H-pyrazol-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfz,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102274,3C-like proteinase,1,A,306,Yes,DMS,T8V,N-(2-chloropyridin-3-yl)acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mlg,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) Covalently Bound to Compound C63,3C-like proteinase,1,A,306,Yes,,ZJ1,(2R)-2-[(4-tert-butylphenyl)(ethanesulfonyl)amino]-N-cyclohexyl-2-(pyridin-3-yl)acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8skh,Co-structure of SARS-CoV-2 (COVID-19 with covalent pyrazoline based inhibitors,3C-like proteinase nsp5,1,A,306,Yes,,A1W,"2-chloro-1-[(4R,5R)-3,4,5-triphenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8dz0,Crystal Structure of SARS-CoV-2 Main protease in complex with Ensitrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7huc,PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B07 from the F2X-Entry Screen in monoclinic space group,3C-like proteinase nsp5,1,A,306,Yes,DMS,UIS,N-[3-(diethylamino)phenyl]ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-6479a3a9-2 (Mpro-P2028),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RD5,2-(5-chloro-2-{[(methanesulfonyl)amino]methyl}phenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gef,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-93268d01-11 (Mpro-x11428),3C-like proteinase,1,A,306,Yes,DMS,NJE,N-(4-methylpyridin-3-yl)-2-(piperidin-1-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ntq,Crystal structure of the SARS-CoV-2 Main Protease complexed with N-(pyridin-3-ylmethyl)thioformamide,3C-like proteinase,1,A,306,Yes,"NA
FMT
DMS",35J,N-(pyridin-3-ylmethyl)thioformamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8w1t,SARS-CoV-2 Main protease bound to a non-covalent non-peptidic HTS hit,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
EDO
SO4
GOL","A1A21
A1AFD","(5-bromopyridin-3-yl){4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}methanone
(5-bromopyridin-3-yl){4-[(S)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}methanone","non-polymer
non-polymer","
","No
No","
",6LU7_1|Chain,0,,100.00,0
8hol,Crystal Structure of SARS-CoV-2 Omicron Main Protease (Mpro),3C-like proteinase nsp5,1,A,306,No,,,,,,,,7TOB_1|Chain,0,,100.00,0
7c8b,Crystal structure of the SARS-CoV-2 main protease in complex with Z-VAD(OMe)-FMK,3C-like proteinase,1,A,306,Yes,CL,PRD_002352,Z-VAD(OMe)-FMK,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7kph,SARS-CoV-2 Main Protease in mature form,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8gzb,SARS-CoV-2 3CLpro,3C-like proteinase nsp5,1,A,306,Yes,EDO,KM6,"2-(4-chlorophenyl)-1,3,4-oxadiazole",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gg4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-52b62a6f-11 (Mpro-x12136),3C-like proteinase,1,A,306,Yes,DMS,OPU,"(4R)-6-chloro-N-[(4S)-7-methyl[1,2,4]triazolo[4,3-a]pyridin-8-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5re7,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z30932204,3C-like proteinase,1,A,306,Yes,DMS,T0S,N-[(4-sulfamoylphenyl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gm1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-2e8b2191-10 (Mpro-P2072),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RFR,"(4S)-6-chloro-N-{6-[(methanesulfonyl)amino]isoquinolin-4-yl}-2-[2-(methylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8p55,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 75 micromolar MG-132.,3C-like proteinase nsp5,2,"A,B",306,Yes,"NA
EDO
DMS
CL",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ta4,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 9/10,3C-like proteinase,2,"A,B",306,Yes,,ATVRLQAGNA,Nonstructural protein 9/10,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7d3i,Crystal structure of SARS-CoV-2 main protease in complex with MI-23,3C-like proteinase,1,A,306,Yes,TRS,GQU,"(3~{S},3~{a}~{S},6~{a}~{R})-2-[3-[3,5-bis(fluoranyl)phenyl]propanoyl]-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gc4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-18 (Mpro-x10494),3C-like proteinase,1,A,306,Yes,DMS,L83,N-(2-amino-4-methylpyridin-3-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jkv,Crystal Structure of SARS-CoV-2 main protease in complex with an inhibitor GRL-2420,3C-like proteinase,2,"A,B",307,Yes,1PE,V7G,"N-[(2S)-1-({(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7d64,The crystal structure of SARS-CoV-2 3CLpro with Zinc,3C-like proteinase,1,A,306,No,ZN,,,,,,,6LU7_1|Chain,0,,100.00,0
7gix,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UNK-cf7facf1-1 (Mpro-P0143),3C-like proteinase,2,"A,B",306,Yes,DMS,P4R,"(1'M,4S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,4'-imidazolidine]-2',5'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gca,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-18 (Mpro-x10559),3C-like proteinase,1,A,306,Yes,DMS,LB0,"(1r,3r)-3-cyclopropyl-N-(4-methylpyridin-3-yl)cyclobutane-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gg7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with CHO-MSK-00c5269a-2 (Mpro-x12177),3C-like proteinase,1,A,306,Yes,DMS,OQX,2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-(4-methoxyphenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gj3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-29afea89-2 (Mpro-P0157),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",PJ6,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ehj,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H172Q Mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,H172Q,99.67,0
7gnq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-WEI-dcc3321b-6 (Mpro-P2916),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S5L,"(4S)-2-[2-(4-acetamidoanilino)-2-oxoethyl]-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dg6,Structure of SARS-Cov2-Mpro-1-302,Replicase polyprotein 1ab,1,A,302,No,,,,,,,,6LU7_1|Chain,1,C145A,98.37,4
7gk8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-dd3ad2b5-2 (Mpro-P0808),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QUQ,"(4S)-2-acetyl-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAR-DIA-23aa0b97-14 (Mpro-x10996),3C-like proteinase,1,A,306,Yes,DMS,M6I,N-(3-chlorophenyl)-N'-(pyridin-3-yl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ds0,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp14-nsp15 (C14) cut site sequence (form 2),3C-like proteinase nsp5,2,"A,B",306,No,PEG,,,,,,,6LU7_1|Chain,1,C145A,97.73,6
7c6s,Crystal structure of the SARS-CoV-2 main protease complexed with Boceprevir,3C-like proteinase,1,A,306,Yes,,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rh6,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4439011588 (Mpro-x2703),3C-like proteinase,1,A,306,Yes,DMS,UHY,N-[(1R)-2-[(2-ethyl-6-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]-N-[6-(propan-2-yl)pyridin-3-yl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ge5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-5b47150d-6 (Mpro-x11339),3C-like proteinase,1,A,306,Yes,DMS,N7L,"(1R,2R)-2-(fluoromethyl)-N-(4-methylpyridin-3-yl)cyclopropane-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-08cd9c58-1 (Mpro-P2010),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",O0X,"2-(3-chlorophenyl)-N-(1,7-naphthyridin-5-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gn7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-1cbc2fae-2 (Mpro-P2381),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RV0,"(4S)-6-chloro-4-ethyl-N-(isoquinolin-4-yl)-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gge,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-6d04362c-1 (Mpro-x12419),3C-like proteinase,1,A,306,Yes,DMS,OV4,2-(1H-benzotriazol-1-yl)-N-benzyl-N-[4-(dimethylamino)phenyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gju,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e9e99895-6 (Mpro-P0655),3C-like proteinase,2,"A,B",306,Yes,DMS,QR5,"(2R)-2-[2-(3-cyclopropyl-2-oxoimidazolidin-1-yl)acetamido]-2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)propanamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hqj,Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with inhibitor YH-53,3C-like proteinase nsp5,2,"A,B",299,Yes,,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"CYS, 143-(HUR, .)",6LU7_1|Chain,1,Y54C,97.39,7
7v7m,crystal structure of SARS-CoV-2 3CL protease,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7ujg,Room-temperature X-ray structure of monomeric SARS-CoV-2 main protease catalytic domain (MPro1-196) in complex with GC-376,3C-like proteinase nsp5,2,"A,B",191,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,62.42,115
7gcg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-21 (Mpro-x10606),3C-like proteinase,1,A,306,Yes,DMS,LKI,3-chloro-N-(4-methylpyridin-3-yl)benzene-1-sulfonamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-d899bab6-1 (Mpro-P2201),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RKR,2-(3-chlorophenyl)-N-[6-(dimethylamino)isoquinolin-4-yl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dic,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,2,"A,B",306,Yes,,TNI,5-bromo-3-[(3-bromo-4-chlorophenyl)methoxy]pyridine-2-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gi0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-92e193ae-1 (Mpro-P0034),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OQL,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gm8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-7889e8da-3 (Mpro-P2101),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RI6,"(4S)-6-chloro-N-(7-chloroisoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ddl,SARS-CoV-2 Main Protease (Mpro) H163A Mutant Apo Structure,"ORF1a polyprotein
ORF1a polyprotein",2,"A,B","306, 306",No,"PGE
NA
PEG
EDO",,,,,,,6LU7_1|Chain,"1
1","H163A
H163A","99.67
99.67","0
0"
7ghi,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAN-PUR-6788a628-2 (Mpro-x3333),3C-like proteinase,1,A,306,Yes,DMS,Q7C,"N~3~-acetyl-N~3~-[(3S)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-beta-alaninamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7sf1,SARS-CoV-2 Main Protease (Mpro) in Complex with ML1001,3C-like proteinase,1,A,306,Yes,,8ZI,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(3,3-dimethylbutanoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7t4a,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 11c,3C-like proteinase,2,"A,B",309,Yes,"PO4
PG4","EQS
EO6","(1S,2S)-2-[(N-{[(7-cyano-7-azaspiro[3.5]nonan-2-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-[(N-{[(7-cyano-7-azaspiro[3.5]nonan-2-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8int,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) K90R Mutant,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,1,K90R,99.67,0
8j39,Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,V186F,97.39,7
7gce,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-93268d01-7 (Mpro-x10598),3C-like proteinase,1,A,306,Yes,DMS,LDX,3-(2-fluorophenyl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7p51,CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE COMPLEXED WITH FRAGMENT F01,3C-like proteinase,1,A,306,Yes,"NA
DMS",5P9,"N-(5-chloropyridin-2-yl)-3-oxo-2,3-dihydro-1H-indene-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-ba1ac7b9-19 (Mpro-P0904),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QXI,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-{2-[(4R,8S)-8-methyl-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-oxoethyl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vk1,Crystal Structure of SARS-CoV-2 Mpro at 1.93 A resolution-5,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7ggi,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-14ad9fe9-1 (Mpro-x12640),3C-like proteinase,1,A,306,Yes,DMS,OWX,"2-(3-chlorophenyl)-N-(1,2,3,4-tetrahydro-1,7-naphthyridin-5-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7wq9,Crystal structure of SARS-CoV-2 main protease in complex with Z-IETD-FMK,3C-like proteinase,1,A,307,Yes,,(P6S)I(GME)T(FL6)(CF0),Z-IETD-FMK,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7gh6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-916-2 (Mpro-x2910),3C-like proteinase,1,A,306,Yes,DMS,Q2U,"N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7z4s,Crystal structure of SARS-CoV-2 Mpro in complex with cyclic peptide GM4 including unnatural amino acids.,3C-like proteinase nsp5,2,"A,B",306,Yes,"PEG
DMS
EDO
PGE",(ACE)(DTY)FH(II7)LNLGYRPGC(NH2),Macrocyclic peptide inhibitor,polypeptide(L),,No,,6LU7_1|Chain,0,,100.00,0
8okc,SARS-CoV2 NSP5 in complex with a GC-376 based peptidomimetic PROTAC,3C-like proteinase nsp5,1,A,306,Yes,,VQN,"(phenylmethyl) ~{N}-[(2~{R})-1-[[(~{Z},2~{S})-5-[4-[[1-[2-[(3~{R})-2,6-bis(oxidanylidene)piperidin-3-yl]-6-fluoranyl-1,3-bis(oxidanylidene)isoindol-5-yl]piperidin-4-yl]methyl]piperazin-1-yl]-5-oxidanylidene-1-[(3~{R})-2-oxidanylidenepyrrolidin-3-yl]pent-3-en-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8inq,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) G15S Mutant,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,1,G15S,99.67,0
5rer,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102615,3C-like proteinase,1,A,306,Yes,DMS,T3J,1-[(2R)-2-(4-fluorophenyl)morpholin-4-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7awr,Structure of SARS-CoV-2 Main Protease bound to Tegafur,3C-like proteinase,1,A,306,Yes,DMS,S7W,TEGAFUR,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7kyu,The crystal structure of SARS-CoV-2 Main Protease with the formation of Cys145-1H-indole-5-carboxylate,3C-like proteinase,1,A,306,Yes,EDO,XC4,1-[(1H-indole-5-carbonyl)oxy]-1H-benzotriazole,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gb3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAV-CRI-3edb475e-6 (Mpro-x10172),3C-like proteinase,1,A,306,Yes,DMS,KNU,N-[(1S)-1-(3-chloro-5-fluorophenyl)ethyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7pxz,Reduced form of SARS-CoV-2 Main Protease determined by XFEL radiation,3C-like proteinase nsp5,1,A,306,No,CL,,,,,,,6LU7_1|Chain,0,,100.00,0
8doy,Crystal structure of SARS-CoV-2 main protease in complex with an inhibitor TKB-198,3C-like proteinase nsp5,2,"A,B",302,Yes,"1PE
MES
DMS","PG0
T1X","2-(2-METHOXYETHOXY)ETHANOL
7-fluoro-N-[(2S)-1-({(1S,2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide","non-polymer
non-polymer","
","Yes
Yes","CYS, 146-(T1X, .)
CYS145 A",6LU7_1|Chain,0,,98.05,6
7m8y,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 15,3C-like proteinase,1,A,306,Yes,,YTM,"5-{3-[3-chloro-5-(2-phenylethoxy)phenyl]-2-oxo-2H-[1,3'-bipyridin]-5-yl}pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-19 (Mpro-x10626),3C-like proteinase,1,A,306,Yes,DMS,LJ0,"(1R,6S,7r)-N-(4-methylpyridin-3-yl)bicyclo[4.1.0]heptane-7-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8wur,Crystal structure of SARS-Cov-2 main protease D48N mutant in complex with shikonin,3C-like proteinase nsp5,2,"A,B",296,Yes,,FNO,"2-[(1R)-4-methyl-1-oxidanyl-pent-3-enyl]-5,8-bis(oxidanyl)naphthalene-1,4-dione",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,2,"D48N, N142A",96.08,10
7us4,Sars-Cov2 Main Protease in complex with CDD-1819,3C-like proteinase,1,A,307,Yes,,O69,"(2P)-2-(isoquinolin-4-yl)-1-[(1s,3R)-3-(methylcarbamoyl)cyclobutyl]-N-[(1S)-1-(naphthalen-2-yl)ethyl]-1H-benzimidazole-7-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,99.67,1
7lb7,Joint X-ray/neutron structure of SARS-CoV-2 main protease (3CL Mpro) in complex with Telaprevir,3C-like proteinase,1,A,306,Yes,,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gec,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UCB-00f2c2b3-7 (Mpro-x11424),3C-like proteinase,1,A,306,Yes,DMS,NEL,2-(3-chlorophenyl)-N-(1H-indazol-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JIN-POS-6dc588a4-6 (Mpro-P0906),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QXR,N-(4-tert-butoxypyridin-3-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-b38839dc-1 (Mpro-P1981),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R9E,2-(3-chlorophenyl)-N-(7-fluoro-6-methoxyisoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NOR-30067bb9-6 (Mpro-x11258),3C-like proteinase,1,A,306,Yes,DMS,N2X,"(3S)-5-bromo-1-[(2-ethoxyphenyl)methyl]-3-hydroxy-1,3-dihydro-2H-indol-2-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7cwb,Ambient-Temperature Serial Femtosecond X-ray Crystal structure of SARS-CoV-2 Main Protease at 1.9 A Resolution (C121),3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7aol,Structure of SARS-CoV-2 Main Protease bound to Climbazole,3C-like proteinase,1,A,306,Yes,"DMS
IMD",RQH,"(1~{S})-1-(4-chloranylphenoxy)-1-imidazol-1-yl-3,3-dimethyl-butan-2-one",non-polymer,,No,,6LU7_1|Chain,1,N72L,99.67,0
6y2e,Crystal structure of the free enzyme of the SARS-CoV-2 (2019-nCoV) main protease,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8e5c,Crystal Structure of SARS CoV-2 Mpro mutant L50F with Nirmatrelvir captured in two conformational states,3C-like proteinase nsp5,1,A,306,Yes,"DMS
NA
CL",4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,1,L50F,99.67,0
5rfp,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102190,3C-like proteinase,1,A,306,Yes,DMS,T7V,N-[(1S)-1-(3-chlorophenyl)ethyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8vqx,Structure of SARS-CoV-2 main protease with potent peptide aldehyde inhibitor,3C-like proteinase nsp5,1,A,326,Yes,"NA
EDO
PEG",A1ADM,"N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-1-(1H-indole-2-carbonyl)-4,4-dimethyl-L-prolinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,93.87,20
8k18,Neutralization antibody ZCP4C9 bound with SARS-CoV-2 Omicron BA.5 RBD,"Spike protein S1
ZCP4C9 heavy chain
ZCP4C9 light chain",3,"A,B,C","193, 119, 107",No,,,,,,,,6LU7_1|Chain,"85
55
51","S1E, G2V, R4N, K5A, M6T, A7K, N53A, Y54W, V77K, L87A, K88D, L89Y, K90S, K100L, K102N, Q107T, S113F, V114A, L115F, A116K, C128S, G143D, S144L, G146F, G149S, N151V, I152V, D153K, Y154G, C156D, M165Q, E166I, L167A, V171N, H172I, E178P, G179D, N180D, Y182M, F185C, Q192L, A194W, G195N, T198A, I200S, V202G, D216Y, W218Y, F219R, N221F, Y237S, T243K, Q244P, D245F, H246E, V247R, G258E, M264Y, C265Q, S267G, L268N, L272P, Q273C, M276V, N277A, T280V, I281N, L282C, G283Y, S284F, A285P, L287Q, E288S, D289Y, E290S, T292R, F294Y, D295G, V297G, R298H, C300P, S301Y, G302R, F305C, Q306G
N63G, H64G, A70P, V73G, Q74S, K88S, L89C, K90E, P108S, S113I, L115S, A116R, C117N, P122M, G124W, Y126R, S139Q, F140G, S144E, C145W, G146L, D153I, T169G, G174S, G183A, P184E, F185S, Q189F, A193I, A194S, G195R, T196P, T198S, T199K, I200N, N228Q, D229M, F230N, N231S, V233R, L262T, D263Y, M264F, E290W, F291R, T292Y, P293G, F294Q, V297W, R298G, C300G, S301T, G302T, F305S, Q306S
F3D, R4I, K5Q, A7Q, F8S, G11A, K12S, C16D, M17R, Q19T, V20I, C44Q, T45A, E47Q, P52V, F66W, L67Y, V68Q, T98A, A116L, C117I, P168E, E178S, G179S, N180K, Y182S, Q192S, A193G, A194S, D197H, T198F, I200L, V202I, N203S, V204S, A206Q, W207P, L208E, Y209D, A210I, T243C, T257Y, M264H, C265Q, Q273S, N274F, R279G, G302K, T304E, F305I, Q306K","22.12
20.13
16.40","179
191
209"
7gdr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NOR-30067bb9-2 (Mpro-x11208),3C-like proteinase,1,A,306,Yes,DMS,MX9,"(3-methylphenyl)methyl (3R)-3-hydroxy-2-oxo-2,3-dihydro-1H-indole-7-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8cyz,Crystal structure of SARS-CoV-2 Mpro with compound C4,3C-like proteinase,4,"A,B,C,D",306,Yes,,P6I,N-[(4-chlorothiophen-2-yl)methyl]-2-(isoquinolin-4-yl)-N-[4-(methylsulfanyl)phenyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gen,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-1e5f28a7-1 (Mpro-x11488),3C-like proteinase,1,A,306,Yes,DMS,NRC,methyl (2R)-2-(3-chlorophenyl)-3-[(4-methylpyridin-3-yl)amino]-3-oxopropanoate,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9aun,"Structure of SARS-CoV-2 Mpro mutant (T21I,T304I)",3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,2,"T21I, T304I",99.35,0
5r8t,"PanDDA analysis group deposition of ground-state model of SARS-CoV-2 main protease screened against DSI poised (Enamine), Fraglites and Peplites (Newcastle university), Mini Frags (Astex), York 3D (York university), electrophile cysteine covalent (Weizman institute) fragment libraries",3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
5smm,PanDDA analysis group deposition of SARS-CoV-2 main protease ligands identified from single sequence-guideddeep generative framework -- Crystal structure of SARS-CoV-2 main protease in complex with Z1633315555 (Mpro-IBM0058),3C-like proteinase,1,A,306,Yes,DMS,O46,N-[4-(3-fluorophenyl)oxan-4-yl]-2-(3-hydroxyphenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7maz,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM139,3C-like proteinase,2,"A,B",306,Yes,,YVD,4-fluoro-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide,non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
7s4b,Room temperature X-ray structure of SARS-CoV-2 main protease in complex with compound Z1530724963,3C-like proteinase,1,A,306,Yes,,87H,(2R)-2-(3-fluorophenyl)-N-(isoquinolin-4-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7sgh,SARS-CoV-2 Main Protease (Mpro) in Complex with ML124N,3C-like proteinase,4,"A,B,C,D",306,Yes,,99W,"(S)-N-((S)-1-imino-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-4-methyl-2-(2-((2,4,6-trifluorophenyl)amino)acetamido)pentanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ghc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with GAB-REV-70cc3ca5-13 (Mpro-x3108),3C-like proteinase,1,A,306,Yes,DMS,Q5C,N-(4-methylpyridin-3-yl)-N~2~-[(pyridin-3-yl)acetyl]glycinamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ge8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-7e92b6ca-16 (Mpro-x11366),3C-like proteinase,1,A,306,Yes,DMS,NB0,4-[4-(2-fluorophenyl)piperazine-1-carbonyl]quinolin-2(1H)-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ar5,"Structure of apo SARS-CoV-2 Main Protease with small beta angle, space group C2.",3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
7gjs,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e9e99895-2 (Mpro-P0640),3C-like proteinase,2,"A,B",306,Yes,DMS,QQO,"(2R)-N-{(2R)-2-(3,4-dichlorophenyl)-1-[(isoquinolin-4-yl)amino]-1-oxopropan-2-yl}-4-(propan-2-yl)morpholine-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8k67,Crystal structure of SARS-CoV-2 3CLpro M165V mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,M165V,99.67,0
7dvx,SARS-CoV-2 Mpro mutant (H41A) in complex with nsp6|7 peptidyl substrate,"3C-like proteinase
nsp6/7 peptidyl substrate",2,"A,B","306, 20",No,,,,,,,,6LU7_1|Chain,"1
3","H41A
D92A, G138M, A266T","99.67
5.56","0
286"
7gjy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e9e99895-13 (Mpro-P0747),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QRS,"(3S)-N-{(2R)-2-(3,4-dichlorophenyl)-1-[(isoquinolin-4-yl)amino]-1-oxopropan-2-yl}-1-methylpyrrolidine-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7l8i,SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21),3C-like proteinase,2,"A,B",306,Yes,,AG7,4-{2-(4-FLUORO-BENZYL)-6-METHYL-5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-4-OXO-HEPTANOYLAMINO}-5-(2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8cdc,Native 3CLpro from SARS-CoV-2 at 1.54 A,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gbn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-MED-2de63afb-14 (Mpro-x10387),3C-like proteinase,1,A,306,Yes,DMS,KXR,N-(3-fluoro-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gs4,Crystal structure of SARS-CoV-2 main protease in complex with cpd-27,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
SO4
NA",XZ6,"7-(hydroxymethyl)-3-methyl-6~{H}-[1,3]thiazolo[3,2-a]pyrimidin-5-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gf7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TAT-ENA-80bfd3e5-7 (Mpro-x11579),3C-like proteinase,1,A,306,Yes,DMS,O3U,"N-[(1R)-1,5-dicyano-4-(methylsulfanyl)-3-azaspiro[5.5]undeca-2,4-dien-2-yl]acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gd0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-23 (Mpro-x10834),3C-like proteinase,1,A,306,Yes,DMS,M4L,(2S)-2-(3-bromophenyl)-2-hydroxy-N-(4-methoxypyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rep,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102201,3C-like proteinase,1,A,306,Yes,DMS,T3G,"1-{4-[(2,6-difluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ltj,Room-temperature X-ray structure of SARS-CoV-2 main protease (3CL Mpro) in complex with a non-covalent inhibitor Mcule-5948770040,3C-like proteinase,1,A,306,Yes,,YD1,"6-[4-(3,4-dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8gw4,SARS-CoV-2 Mpro 1-302/C145A in complex with peptide 8-1,Replicase polyprotein 1ab,2,"A,B",302,Yes,,TSVKLQAEFRKM,peptide 8-1,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,98.37,4
7gc9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-22 (Mpro-x10555),3C-like proteinase,1,A,306,Yes,DMS,L9O,(1S)-N-(4-methylpyridin-3-yl)spiro[3.3]heptane-1-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7khp,Acyl-enzyme intermediate structure of SARS-CoV-2 Mpro in complex with its C-terminal autoprocessing sequence.,3C-like proteinase,2,"A,B",306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
8b0s,SARS-COV-2 Main Protease adduct with Au(NHC)Cl,3C-like proteinase nsp5,1,A,301,No,AU,,,,,,,6LU7_1|Chain,0,,98.37,5
7vjw,Crystal Structure of SARS-CoV-2 Mpro at 2.20 A resolution-10,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gbc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-2eddb1ff-1 (Mpro-x10314),3C-like proteinase,1,A,306,Yes,DMS,KSX,2-(5-cyanopyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7n8c,Joint X-ray/neutron structure of SARS-CoV-2 main protease (Mpro) in complex with Mcule5948770040,3C-like proteinase,1,A,306,Yes,,YD1,"6-[4-(3,4-dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione",non-polymer,,Yes,"GLY, 143-(YD1, .); HIS, 163-(YD1, .)",6LU7_1|Chain,0,,100.00,0
7gcq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-2eddb1ff-2 (Mpro-x10723),3C-like proteinase,1,A,306,Yes,DMS,LRC,2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8upv,Structure of SARS-Cov2 3CLPro in complex with Compound 33,3C-like proteinase nsp5,1,A,306,Yes,,X83,"methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6R)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f7918075-8 (Mpro-x11742),3C-like proteinase,1,A,306,Yes,DMS,OBO,"2-(3-chlorophenyl)-N-(1H-imidazo[4,5-c]pyridin-7-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8gtv,SARS-CoV-2 3CL protease (3CLpro) in complex with compound JZD-07,3C-like proteinase,2,"A,B",306,Yes,,KAE,"4-[(2~{S})-4-(3,4-dichlorophenyl)-2-(morpholin-4-ylmethyl)piperazin-1-yl]carbonyl-1~{H}-quinolin-2-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e119ab4f-3 (Mpro-P2178),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RJF,"(4S)-6-chloro-2-[2-(methylamino)-2-oxoethyl]-N-(5-methylisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8s9z,Mpro inhibitors of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,(P6S)(ZU0)F(ZV7)(NH2),Mpro inhibitor,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8okl,Crystal structure of F2F-2020185-01X bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase nsp5,2,"A,B",306,Yes,"EDO
FMT
NA
CL","83N
MPD","tert-butyl-N-[(2S)-1-[(2S,4S)-4-methoxy-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate
(4S)-2-METHYL-2,4-PENTANEDIOL","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
6xbg,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW246,3C-like proteinase,2,"A,B",308,Yes,"GOL
NA",PRD_002392,inhibitor UAW246,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
8i4s,the complex structure of SARS-CoV-2 Mpro with D8,ORF1a polyprotein,1,A,335,Yes,,OU3,"3-(4-fluoranyl-3-methyl-phenyl)-2-(2-methylpropyl)-5,6,7-tris(oxidanyl)quinazolin-4-one",non-polymer,,No,,6LU7_1|Chain,0,,91.34,29
7giz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-5d232de5-4 (Mpro-P0148),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",PUU,"(4R)-1-acetyl-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-4f474d93-1 (Mpro-P0012),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OYF,"(4R)-6-chloro-N-(2,7-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rel,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102340,3C-like proteinase,1,A,306,Yes,DMS,T2G,1-{4-[(3-methylphenyl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7x6k,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3w,3C-like proteinase,1,A,306,Yes,,9FF,1H-indole-2-carbaldehyde,non-polymer,,Yes,"CYS, 145-(9FF, .)",6LU7_1|Chain,0,,100.00,0
7rn0,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor Jun9-57-3R,3C-like proteinase,1,A,306,Yes,GOL,5ZB,(2R)-2-{acetyl[4-(1H-pyrrol-1-yl)phenyl]amino}-N-[(1S)-1-phenylethyl]-2-(pyridin-3-yl)acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7t2u,SARS-CoV2 3C-Like protease complexed with Nemo peptide,3C-Like Protease,4,"A,B,D,F",319,Yes,,KLAQLQVAYH,NEMO peptide,polypeptide(L),,No,,6LU7_1|Chain,1,C145S,95.61,13
7gkl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with SAM-UNK-2684b532-12 (Mpro-P0925),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QXX,2-(3-chlorophenyl)-N-[4-(trifluoromethyl)pyridin-3-yl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gjf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-8c98ee63-2 (Mpro-P0224),3C-like proteinase,2,"A,B",306,Yes,DMS,QMX,"(4R)-6-chloro-N-(isoquinolin-4-yl)-4-({[(1-methyl-1H-pyrazol-3-yl)methyl]amino}methyl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xqu,Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Boceprevir,3C-like proteinase,1,A,306,Yes,,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8hvy,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with PF07304814,3C-like proteinase nsp5,2,"A,B",299,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,THR190 A,6LU7_1|Chain,1,K90R,97.39,7
5rha,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z147647874 (Mpro-x2779),3C-like proteinase,1,A,306,Yes,DMS,T8M,1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gvd,SARS-CoV-2 Mpro in complex with D-4-38,3C-like proteinase nsp5,1,A,306,Yes,,(ACY)AI(0A9),"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE",polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gtw,SARS-CoV-2 3CL protease (3CLpro) in complex with compound JZD-26,3C-like proteinase,2,"A,B",306,Yes,,K9U,"(2S)-4-(3,4-dichlorophenyl)-1-[(2-oxidanylidene-1H-quinolin-4-yl)carbonyl]-N-[3,3,3-tris(fluoranyl)propyl]piperazine-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7geu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-50fe53e8-1 (Mpro-x11508),3C-like proteinase,1,A,306,Yes,DMS,NVO,2-(3-chlorophenyl)-N-(phthalazin-1-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7nbr,Crystal structure of SARS-CoV-2 main protease (Mpro) in complex with the HCV NS3/4A inhibitor boceprevir,3C-like proteinase,1,A,306,Yes,CL,U5G,boceprevir (bound form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7grs,Crystal structure of SARS-CoV-2 main protease in complex with cpd-15,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",NT9,~{N}-methyl-1-(4-thiophen-2-ylphenyl)methanamine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvs,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI19,3C-like proteinase,1,A,306,Yes,,81L,N-[(benzyloxy)carbonyl]-3-methyl-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gnf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIK-ENA-5d9157e9-5 (Mpro-P2606),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RWT,"(4S)-6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gjz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-9739a092-6 (Mpro-P0764),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QRF,2-{3-chloro-5-[4-(furan-2-carbonyl)piperazin-1-yl]phenyl}-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8cyu,Crystal structure of SARS-CoV-2 Mpro with compound C5,3C-like proteinase,4,"A,B,C,D",306,Yes,,P5X,N-[(4-chlorothiophen-2-yl)methyl]-N-[4-(dimethylamino)phenyl]-2-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rnh,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-45,3C-like proteinase,1,A,306,Yes,,5ZW,"6-[4-(4-chlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8cac,Crystal structure of SARS-CoV-2 Mpro-H172Y mutant in complex with 13b-K,3C-like proteinase nsp5,2,"A,B",302,Yes,CL,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,H172Y,98.37,4
5rgo,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102248 (Mpro-x0736),3C-like proteinase,1,A,306,Yes,DMS,U1G,1-[4-(furan-2-carbonyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7m8o,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 19,3C-like proteinase,2,"A,B",306,Yes,,YSM,"5-(3-{3-chloro-5-[(3-fluorophenyl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ign,Crystal structure of SARS-CoV-2 main protease in complex with RAY1216,3C-like proteinase nsp5,2,"A,B",306,Yes,,7ON,"(3~{S},3~{a}~{S},6~{a}~{R})-2-[(2~{S})-2-cyclohexyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]ethanoyl]-~{N}-[(2~{S})-4-(cyclopentylamino)-3,4-bis(oxidanylidene)-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tiv,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor EB48,3C-like proteinase nsp5,1,A,306,Yes,MG,W48,"(1S,2S)-2-[(N-{[(3-chlorophenyl)methoxy]carbonyl}-3-cyclohexyl-L-alanyl)amino]-1-hydroxy-3-[(3R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uug,SARS-CoV-2 Main Protease S144A (Mpro S144A) in Complex with ML1006a,3C-like proteinase nsp5,1,A,306,Yes,CL,M0C,"(1R,2S,5S)-N-{(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S144A,99.67,0
7glp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ADA-UCB-6c2cb422-1 (Mpro-P2005),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",860,2-(3-chlorophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gnr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e48723dc-2 (Mpro-P3038),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RZU,"1-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylcyclopropane-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8b2t,SARS-CoV-2 Main Protease (Mpro) in complex with nirmatrelvir alkyne,3C-like proteinase nsp5,1,A,305,Yes,,OW1,Nirmatrelvir (reacted form),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7tgr,Structure of SARS-CoV-2 main protease in complex with GC376,3C-like proteinase,1,A,304,Yes,"EDO
CL
K
NA","K36
B1S","(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","peptide-like
peptide-like","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,99.35,2
8d4j,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H172Y Mutant,3C-like proteinase nsp5,2,"A,B",306,No,GOL,,,,,,,6LU7_1|Chain,1,H172Y,99.67,0
7qt8,Room temperature In-situ SARS-CoV-2 MPRO with bound ABT-957,3C-like proteinase,2,"A,B",306,Yes,,R8H,"(2~{R})-5-oxidanylidene-~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl]-1-(phenylmethyl)pyrrolidine-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gf9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TAT-ENA-80bfd3e5-4 (Mpro-x11590),3C-like proteinase,1,A,306,Yes,DMS,O5C,1-[(4S)-3-(4-fluorobenzoyl)-2-methylindolizin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gd8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-119787ef-1 (Mpro-x10898),3C-like proteinase,1,A,306,Yes,DMS,KU6,"(4R)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dkh,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,A260V,99.67,0
8e4j,Room-temperature X-ray structure of SARS-CoV-2 main protease H41A miniprecursor mutant,Replicase polyprotein 1ab,2,"A,B",314,No,,,,,,,,6LU7_1|Chain,1,H41A,97.13,8
7gbz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-11 (Mpro-x10474),3C-like proteinase,1,A,306,Yes,DMS,L4U,"(3S)-3,4-dimethyl-N-(4-methylpyridin-3-yl)pentanamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rej,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102241,3C-like proteinase,1,A,306,Yes,DMS,T1V,1-{4-[(thiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gln,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-16 (Mpro-P1991),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RBX,"(4S)-6-chloro-2-[ethyl(methyl)sulfamoyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9at1,Crystal structure of SARS-CoV-2 3CL protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (R-enantiomer),3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,A1AGZ,"(1S,2S)-2-{[N-({[(2R)-1-(cyclohexylmethyl)-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.06,6
7gee,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-93268d01-5 (Mpro-x11427),3C-like proteinase,1,A,306,Yes,DMS,NIJ,3-(3-fluorophenyl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7aeg,"SARS-CoV-2 main protease in a covalent complex with SDZ 224015 derivative, compound 5",3C-like proteinase,1,A,305,Yes,DMS,PRD_000338,N-[(benzyloxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7t70,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 4/5,3C-like proteinase,2,"A,B",306,Yes,"GOL
DMS",TSAVLQSGFRKM,Nonstructural protein 4/5,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gco,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-7e92b6ca-1 (Mpro-x10700),3C-like proteinase,1,A,306,Yes,DMS,LO0,"N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-2,3-dihydropyridine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8inx,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) G15S Mutant in Complex with Inhibitor ensitrelvir,3C-like proteinase,1,A,306,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,1,G15S,99.67,0
7ca8,The crystal structure of COVID-19 main protease in complex with an inhibitor Shikonin,3C-like proteinase,2,"A,B",298,Yes,,FNO,"2-[(1R)-4-methyl-1-oxidanyl-pent-3-enyl]-5,8-bis(oxidanyl)naphthalene-1,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,97.39,8
7ghm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-ce40166b-17 (Mpro-P0008),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",Q99,"N-[2-(3-chloro-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8j3b,Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S46F,97.39,7
7m8x,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 6,3C-like proteinase,1,A,306,Yes,,YTJ,"2-{3-[3-chloro-5-(2-methoxyethoxy)phenyl]-2-oxo-2H-[1,3'-bipyridin]-5-yl}benzonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bnw,Crystal Structure of A173V/L50F SARS-CoV-2 Main Protease,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,2,"L50F, A173V",99.35,0
7qt6,Room temperature In-situ SARS-CoV-2 MPRO with bound Z1367324110,3C-like proteinase nsp5,1,A,305,Yes,DMS,RZJ,"1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide",non-polymer,,No,,6LU7_1|Chain,0,,99.67,1
8k68,Crystal structure of SARS-CoV-2 3CLpro M49K mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,M49K,99.67,0
7gb9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-11 (Mpro-x10248),3C-like proteinase,1,A,306,Yes,DMS,KQX,2-(4-methylphenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gm5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-2 (Mpro-P2089),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RGX,"(4S)-6-chloro-2-(cyclopropylsulfamoyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7uu8,Crystal structure of the SARS-CoV-2 main protease in its apo-form,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gdp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NAU-LAT-8502cac5-2 (Mpro-x11186),3C-like proteinase,1,A,306,Yes,DMS,MVX,"(3S)-5-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-2,3-dihydro-1-benzofuran-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8bfq,Structure of the apo form of Mpro from SARS-CoV-2,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7dgb,The co-crystal structure of SARS-CoV-2 main protease with (S)-2-cinnamamido-4-methyl-N-((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)pentanamide,3C-like proteinase,1,A,306,Yes,,EOF,(2~{S})-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]pentanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gdv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NAU-LAT-8502cac5-6 (Mpro-x11231),3C-like proteinase,1,A,306,Yes,DMS,N0O,"(3S)-5-chloro-N-(4-phenyl-4H-1,2,4-triazol-3-yl)-2,3-dihydro-1-benzofuran-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ng6,Crystal structure of MG-132 covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 in spacegroup P1 in absence of DTT.,3C-like proteinase,2,"A,B",306,Yes,"ACT
CL",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rgi,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z369936976 (Mpro-x0397),3C-like proteinase,1,A,306,Yes,DMS,U0P,"N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7nbs,Crystal structure of SARS-CoV-2 main protease (Mpro) in complex with the HCV NS3/4A inhibitor telaprevir,3C-like proteinase,1,A,306,Yes,CL,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7u92,SARS-CoV-2 Main Protease (Mpro) in Complex with ML1006a,3C-like proteinase,1,A,306,Yes,CL,M0C,"(1R,2S,5S)-N-{(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-a0b0dbcb-8 (Mpro-x12025),3C-like proteinase,1,A,306,Yes,DMS,ONU,4-[3-(2-methoxyanilino)azetidine-1-carbonyl]quinolin-2(1H)-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7m02,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 17c,3C-like proteinase,2,"A,B",309,Yes,PG4,"YL7
YKY","(1S,2S)-2-((S)-2-((((2-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-((((2-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7sh8,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI88,3C-like proteinase nsp5,1,A,306,Yes,,GJ3,"benzyl [(2S,3R)-1-{[(2S)-1-(2-acetyl-2-{[(3S)-2-oxopyrrolidin-3-yl]methyl}hydrazinyl)-3-cyclohexyl-1-oxopropan-2-yl]amino}-3-tert-butoxy-1-oxobutan-2-yl]carbamate (non-preferred name)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9at6,Crystal structure of SARS-CoV-2 3CL protease in complex with a methylbicyclo[2.2.1]heptene 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,"A1AGQ
A1AGR","(1R,2S)-2-{[N-({[(2S)-1-{[(1R,2S,4R)-bicyclo[2.2.1]hept-5-en-2-yl]methyl}-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-{[N-({[(2S)-1-{[(1R,2S,4R)-bicyclo[2.2.1]hept-5-en-2-yl]methyl}-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
8hi9,SARS-CoV-2 3CL protease (3CLpro) in complex with Robinetin,3C-like proteinase nsp5,2,"A,B",306,Yes,,LKR,"3,7-bis(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one",non-polymer,,Yes,"CYS, 145-(LKR, .)",6LU7_1|Chain,0,,100.00,0
7gip,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-8416115c-5 (Mpro-P0122),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QI7,"(4R)-6-chloro-1-[(1H-imidazol-2-yl)methyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dgb,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Q192T Mutant in Complex with Inhibitor GC376,3C-like proteinase nsp5,2,"A,B",306,Yes,,B1S,"(1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,Q192T,99.67,0
6lze,The crystal structure of COVID-19 main protease in complex with an inhibitor 11a,3C-like proteinase,1,A,303,Yes,DMS,FHR,~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,99.02,3
8sty,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI60,3C-like proteinase nsp5,1,A,306,Yes,,WGE,benzyl (3S)-3-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-2-azaspiro[4.4]nonane-2-carboxylate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gmw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e119ab4f-1 (Mpro-P2224),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RQ6,"(4S)-6-chloro-N-(7-fluoroisoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8f45,Crystal structure of SARS-CoV-2 3CL protease in complex with a phenyl dimethyl sulfane inhibitor (cyclopropyl ketoamide warhead),3C-like proteinase,2,"A,B",309,Yes,,XF8,"(2-methyl-2-phenylsulfanyl-propyl) ~{N}-[(2~{S})-1-[[(2~{S},3~{S})-3-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-4-(cyclopropylamino)-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
7gjq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-78e1d523-1 (Mpro-P0627),3C-like proteinase,2,"A,B",306,Yes,DMS,QQ6,"(4R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzothiopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gez,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-6747fa38-1 (Mpro-x11541),3C-like proteinase,1,A,306,Yes,DMS,NZK,2-(4-acetylpiperazin-1-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grp,Crystal structure of SARS-CoV-2 main protease in complex with cpd-12,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",VXQ,"1-(2,3-dihydro-1-benzofuran-5-yl)methanamine",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gi2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-971238d3-5 (Mpro-P0039),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",PQ6,"(4R)-4-(aminomethyl)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dw0,SARS-CoV-2 Mpro mutant (H41A) in complex with nsp14|15 peptidyl substrate,"3C-like proteinase
nsp14/15 peptidyl substrate",2,"A,B","306, 20",No,,,,,,,,6LU7_1|Chain,"1
2","H41A
S113T, V114R","99.67
5.88","0
286"
7sfi,SARS-CoV-2 Main Protease (Mpro) in Complex with ML104,3C-like proteinase,1,A,306,Yes,"CL
CA",91Z,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[N-(2,4,6-trifluorophenyl)glycyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7jw8,Crystal structure of SARS-CoV-2 3CL protease in complex with compound 4 in space group P1,3C-like proteinase,4,"A,B,C,D",306,Yes,BTB,TG3,"ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7wq8,Crystal structure of SARS-CoV-2 main protease in complex with Z-DEVD-FMK,3C-like proteinase,1,A,307,Yes,,(P6S)(FL6)(GME)V(FL6)(CF0),Z-DEVD-FMK,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7gd5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-d2866bdf-1 (Mpro-x10876),3C-like proteinase,1,A,306,Yes,DMS,M0X,2-(1H-benzotriazol-1-yl)-N-[4-(dimethylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e6dd326d-8 (Mpro-P1073),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QZU,"(4R)-6-chloro-N-(isoquinolin-4-yl)-4-[(prop-2-enamido)methyl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gd1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-58 (Mpro-x10856),3C-like proteinase,1,A,306,Yes,DMS,M2X,(2R)-2-amino-2-(5-bromo-2-methoxyphenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8d4l,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) S144A Mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,S144A,99.67,0
5re8,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2737076969,3C-like proteinase,1,A,306,Yes,DMS,T0V,1-(3-fluorophenyl)-N-[(furan-2-yl)methyl]methanamine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7geo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-50fe53e8-3 (Mpro-x11493),3C-like proteinase,1,A,306,Yes,DMS,NRX,"2-(3-chlorophenyl)-N-[(4S)-imidazo[1,5-a]pyridin-1-yl]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rnk,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-71,3C-like proteinase,1,A,306,Yes,,5ZT,"6-{4-[3-chloro-4-(hydroxymethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(3H,5H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s6w,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI29,3C-like proteinase,2,"A,B",306,Yes,,8G9,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8bs2,Room-temperature structure of SARS-CoV-2 Main protease at 104 MPa helium gas pressure in a sapphire capillary,3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
8h51,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (T21I and E166V) in Complex with Inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,3,"T21I, K102V, E166V",99.02,0
6y2f,"Crystal structure (monoclinic form) of the complex resulting from the reaction between SARS-CoV-2 (2019-nCoV) main protease and tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate (alpha-ketoamide 13b)",3C-like proteinase,1,A,306,Yes,DMS,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ql8,SARS-COV2 Main Protease in complex with inhibitor MG78,3C-like proteinase nsp5,1,A,301,Yes,"CL
NA",I70,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.37,5
7c8t,Complex Structure of SARS-CoV-2 3CL Protease with TG-0205221,3C-like proteinase,1,A,306,Yes,,NOL,N-[(BENZYLOXY)CARBONYL]-O-(TERT-BUTYL)-L-THREONYL-3-CYCLOHEXYL-N-[(1S)-2-HYDROXY-1-{[(3S)-2-OXOPYRROLIDIN-3-YL]METHYL}ETHYL]-L-ALANINAMIDE,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7l14,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 26,3C-like proteinase,2,"A,B",306,Yes,,XFD,"2-{3-[3-chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gi5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BRU-THA-92256091-17 (Mpro-P0053),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QCO,N-[(1R)-2-{[2-(3-fluorophenyl)ethyl]amino}-2-oxo-1-(pyridin-3-yl)ethyl]-N-{4-[(propan-2-yl)oxy]phenyl}-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jt0,Crystal structure of SARS-CoV-2 3CL protease in complex with MAC5576,3C-like proteinase,1,A,306,Yes,PO4,LW1,thiophene-2-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-f2e727cd-5 (Mpro-P0240),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QNU,"(4S)-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8i30,Crystal structure of the SARS-CoV-2 main protease in complex with 32j,3C-like proteinase nsp5,1,A,306,Yes,CL,OF9,"(2~{R})-1-[4,4-bis(fluoranyl)cyclohexyl]carbonyl-4,4-bis(fluoranyl)-~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl]pyrrolidine-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-b3e365b9-3 (Mpro-x11809),3C-like proteinase,1,A,306,Yes,DMS,OI4,"(4R)-6-chloro-N-(4-methylpyridin-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mb0,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM141,3C-like proteinase,2,"A,B",306,Yes,,YVG,D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gel,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-cedd89ab-1 (Mpro-x11475),3C-like proteinase,1,A,306,Yes,DMS,NQ3,"(1M,3P)-1-(3-chlorophenyl)-3-(4-methylpyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gh3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-3c65e9ce-4 (Mpro-x12740),3C-like proteinase,1,A,306,Yes,DMS,Q1C,2-(4-methylpiperidin-1-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TOB-UNK-c2aba166-1 (Mpro-x3325),3C-like proteinase,1,A,306,Yes,DMS,Q6U,1-[4-(prop-2-yn-1-yl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8v4u,Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor,3C-like proteinase nsp5,2,"A,B",306,Yes,,YDL,"N-(methoxycarbonyl)-3-methyl-L-valyl-(4R)-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-(trifluoromethyl)-L-prolinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gd6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-38 (Mpro-x10888),3C-like proteinase,1,A,306,Yes,DMS,M0G,(2S)-2-(3-chlorophenyl)-2-hydroxy-N-(4-methylpyridin-3-yl)butanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-4e090d3a-57 (Mpro-x3298),3C-like proteinase,1,A,306,Yes,"DMS
CL",Q5K,(2S)-N-{2-[(4-fluorobenzene-1-sulfonyl)amino]phenyl}-2-hydroxy-2-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NOR-30067bb9-7 (Mpro-x11254),3C-like proteinase,1,A,306,Yes,DMS,N1U,"(3S)-5-bromo-1-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-7-methyl-1,3-dihydro-2H-indol-2-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6wtm,Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7dvp,SARS-CoV-2 Mpro mutant (H41A) in complex with nsp4|5 peptidyl substrate,"3C-like proteinase
nsp4/5 peptidyl substrate",2,"A,B","306, 20",No,,,,,,,,6LU7_1|Chain,"1
2","H41A
G124A, Y126L","99.67
5.88","0
286"
7shb,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI79,3C-like proteinase nsp5,1,A,306,Yes,,I64,benzyl [(2S)-1-({(2S)-1-[2-(3-amino-3-oxopropyl)-2-propanoylhydrazinyl]-4-methyl-1-oxopentan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]carbamate (non-preferred name),non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tiz,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor NK01-63,3C-like proteinase nsp5,1,A,306,Yes,"NA
EDO","N63
SCN","(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[3-(trifluoromethyl)phenyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid
THIOCYANATE ION","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7x6y,TRIM7 in complex with C-terminal peptide of NSP5,E3 ubiquitin-protein ligase TRIM7,1,A,174,Yes,,CSGVTFQ,peptide,polypeptide(L),,No,,6LU7_1|Chain,79,"S10E, G11E, W31T, M49T, L50A, L57R, K61L, V68D, Q69L, A70K, Q74R, H80E, S81R, M82A, K90R, V91F, V148S, M162R, M165W, H172E, A173V, T175K, N180W, F181A, Y182F, D187A, Q189E, T190S, A191V, Q192R, A193R, A194K, D197P, T198F, I200P, T201E, V202E, N203G, L205W, W207Q, A210W, I213T, N214S, G215P, D216E, W218S, F219P, F223S, T224C, T225G, T226H, D229S, F230R, N231V, L232R, H246E, Q256V, T257S, G258F, I259Y, L262E, K269R, E270H, L272Y, Q273T, N274F, G275R, M276V, L286F, L287Q, D289R, E290V, T292P, P293L, D295S, G302T, V303G, F305W, Q306P",23.77,168
7gct,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BRU-LEF-c49414a7-1 (Mpro-x10756),3C-like proteinase,1,A,306,Yes,DMS,LSF,N-(4-methylpyridin-3-yl)-2-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7sdc,Structure of the SARS-CoV-2 main protease in complex with inhibitor MI-09,3C-like proteinase,1,A,306,Yes,,I80,"(1R,2S,5S)-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-{[4-(trifluoromethoxy)phenoxy]acetyl}-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
8e1y,Crystal Structure of SARS-CoV-2 Main protease A193S mutant in complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,A193S,99.67,0
7ghg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAV-CRI-3edb475e-4 (Mpro-x3324),3C-like proteinase,1,A,306,Yes,DMS,Q69,N-[(1R)-1-(3-chlorophenyl)-2-hydroxyethyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rh0,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1286870272 (Mpro-x2608),3C-like proteinase,1,A,306,Yes,DMS,UH4,N-(5-methylthiophen-2-yl)-N'-pyridin-3-ylurea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gml,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-28 (Mpro-P2203),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RL0,2-(3-chlorophenyl)-N-{6-[(methanesulfonyl)(methyl)amino]isoquinolin-4-yl}acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7p35,Structure of the SARS-CoV-2 3CL protease in complex with rupintrivir,3C-like proteinase,2,"A,B",306,Yes,,AG7,4-{2-(4-FLUORO-BENZYL)-6-METHYL-5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-4-OXO-HEPTANOYLAMINO}-5-(2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7urb,Sars-Cov2 Main Protease in complex with CDD-1733,3C-like proteinase,1,A,307,Yes,,O5O,"(2P)-2-(isoquinolin-4-yl)-1-[(1s,3R)-3-(methylcarbamoyl)cyclobutyl]-N-{(1S)-1-[4-(trifluoromethyl)phenyl]butyl}-1H-benzimidazole-7-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,99.67,1
8okn,Crystal structure of F2F-2020198-00X bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase nsp5,2,"A,B",306,Yes,"CL
NA
EDO","83W
MPD","tert-butyl-N-[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2S)-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate
(4S)-2-METHYL-2,4-PENTANEDIOL","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
8hvm,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with PF07321332,3C-like proteinase nsp5,2,"A,B",302,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",6LU7_1|Chain,2,"K90R, Q306V",98.04,4
7gcv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-2eddb1ff-7 (Mpro-x10789),3C-like proteinase,1,A,306,Yes,DMS,LUC,2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6yb7,"SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19).",3C-like proteinase,1,A,305,No,"DMS
PEG",,,,,,,6LU7_1|Chain,0,,99.67,1
8hvk,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with PF07321332,3C-like proteinase nsp5,2,"A,B",298,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",6LU7_1|Chain,1,G15S,97.06,8
8v7t,Room-temperature X-ray structure of SARS-CoV-2 main protease catalytic domain (residues 1-199),Non-structural protein 7,2,"A,B",199,No,,,,,,,,6LU7_1|Chain,0,,65.03,107
7lct,Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability,3C-like proteinase,1,A,306,Yes,,XU4,N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[(1S)-1-phenylethoxy]carbonyl}-L-leucinamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvp,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI14,3C-like proteinase,2,"A,B",306,Yes,,7VQ,N-[(benzyloxy)carbonyl]-L-valyl-3-furan-2-yl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
5rf8,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z271004858,3C-like proteinase,1,A,306,Yes,DMS,SFY,4-amino-N-(pyridin-2-yl)benzenesulfonamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5reu,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102395,3C-like proteinase,1,A,306,Yes,DMS,T4D,2-[(4-acetylpiperazin-1-yl)sulfonyl]benzonitrile,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7t8m,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 5/6,3C-like proteinase,2,"A,B",306,Yes,"GOL
DMS",GVTFQSAVKR,Nonstructural protein 5/6,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
8dlb,Room temperature X-ray structure of SARS-CoV-2 main protease in complex with compound Z2799209083,3C-like proteinase,1,A,306,Yes,,SRU,"1-[(5S)-5-(3,4-dimethoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8y4d,Crystal structure of SARS-Cov-2 main protease in complex with Bofutrelvir,3C-like proteinase nsp5,2,"A,B",296,Yes,,FHR,~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide,peptide-like,,Yes,CYS145 B,6LU7_1|Chain,1,N142A,96.41,10
7ta7,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 10/11,3C-like proteinase,2,"A,B",306,Yes,GOL,REPMLQSADAQ,Nonstructural protein 10/11,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7q5f,Crystal structure of F2F-2020216-01X bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase,2,"A,B",306,Yes,"SO4
EDO
CL
NO3
NA",90X,"(S)-1-(2-(2,4-dichlorophenoxy)acetyl)-N-((S)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-4-(phenethylamino)butan-2-yl)pyrrolidine-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gfo,"Room temperature X-ray structure of truncated SARS-CoV-2 main protease C145A mutant, residues 1-304, in complex with GC373",3C-like proteinase nsp5,1,A,304,Yes,,ZH0,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,No,,6LU7_1|Chain,1,C145A,99.02,2
7gmv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-8bb691af-4 (Mpro-P2222),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RPZ,"2-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dvy,SARS-CoV-2 Mpro mutant (H41A) in complex with nsp9|10 peptidyl substrate,"3C-like proteinase
nsp9/10 peptidyl substrate",2,"A,B","306, 20",No,,,,,,,,6LU7_1|Chain,"1
5","H41A
N274A, G302E, T304P, F305A, Q306N","99.67
4.90","0
286"
7rmb,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-78,3C-like proteinase,1,A,306,Yes,,5Z7,"6-[4-(4-bromo-3-chlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tia,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor NK01-14,3C-like proteinase nsp5,1,A,306,Yes,,"XTP
SCN","benzyl [(2S)-3-cyclopropyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate
THIOCYANATE ION","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7zb8,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) variant K61A at 2.48 A resolution,3C-like proteinase nsp5,2,"A,B",306,No,DMS,,,,,,,6LU7_1|Chain,1,K61A,99.67,0
7ge6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-a3ef7265-18 (Mpro-x11346),3C-like proteinase,1,A,306,Yes,DMS,N8X,"2-(3,5-dimethylphenyl)-N-(4-methyl-4H-1,2,4-triazol-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7nwx,SARS-COV2 NSP5 in the presence of Zn2+,Replicase polyprotein 1a,1,A,306,No,ZN,,,,,,,6LU7_1|Chain,0,,100.00,0
7a1u,Structure of SARS-CoV-2 Main Protease bound to Fusidic Acid.,3C-like proteinase,1,A,306,Yes,"DMS
IMD",FUA,FUSIDIC ACID,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lco,Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability,3C-like proteinase,1,A,306,Yes,,XTJ,(3-fluorophenyl)methyl [(2S)-3-cyclopropyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]carbamate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ca8,"Crystal structure of SARS-CoV-2 Mpro-H172Y mutant, free enzyme",3C-like proteinase nsp5,1,A,302,No,CL,,,,,,,6LU7_1|Chain,3,"D92E, I136V, H172Y",97.71,4
7gl8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-dc2604c4-1 (Mpro-P1788),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",KG9,"(4S)-6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xbh,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW247,3C-like proteinase,1,A,308,Yes,"GOL
NA",PRD_002393,inhibitor UAW247,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
8htv,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3a,3C-like proteinase,1,A,306,Yes,,UZF,"1-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-2-sulfanyl-ethanone",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vu6,The crystal structure of SARS-CoV-2 3CL protease in complex with compound 3,3C-like proteinase,2,"A,B",308,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,99.35,2
7x6j,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3af,3C-like proteinase,1,A,306,Yes,,QNC,quinoline-2-carboxylic acid,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gb1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with STE-KUL-2e0d2e88-2 (Mpro-x10150),3C-like proteinase,1,A,306,Yes,DMS,KMF,N-[2-(4-acetylpiperazin-1-yl)ethyl]naphthalene-1-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9aum,"Structure of SARS-CoV-2 Mpro mutant (T21I,S144A,T304I) in complex with Nirmatrelvir (PF-07321332)",3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,3,"T21I, S144A, T304I",99.02,0
7kvr,SARS-CoV-2 Main protease immature form - FMAX Library E09 fragment,3C-like proteinase,2,"A,B",309,Yes,"DMS
PEG",X4V,"N~4~,N~4~-dimethylpyridine-2,4-diamine",non-polymer,,No,,6LU7_1|Chain,0,,99.03,3
7gbi,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-a3ef7265-3 (Mpro-x10338),3C-like proteinase,1,A,306,Yes,DMS,KVX,"(3S)-5-chloro-N-[4-(hydroxymethyl)pyridin-3-yl]-2,3-dihydro-1-benzofuran-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7sfh,SARS-CoV-2 Main Protease (Mpro) in Complex with ML102,3C-like proteinase,1,A,306,Yes,CA,91I,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-(3-phenylpropanoyl)-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mb9,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp10/11 (P6-P1),3C-like proteinase,2,"A,B",306,Yes,,REPMLQ,ARG-GLU-PRO-MET-LEU-GLN,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gih,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-16 (Mpro-P0075),3C-like proteinase,2,"A,B",306,Yes,DMS,QG3,"2-(3,5-difluorophenyl)-N-(isoquinolin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8czw,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 15d,3C-like proteinase,2,"A,B",309,Yes,PG4,"P8U
P8L","[(1~{S},2~{R})-2-cyclohexylcyclopropyl]methyl ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate
[(1~{S},2~{R})-2-cyclohexylcyclopropyl]methyl ~{N}-[(2~{S})-1-[[(1~{R},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7grh,Crystal structure of SARS-CoV-2 main protease in complex with cpd-4,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",Y25,5-chloropyridin-3-ol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ur9,Crystal Structure of the SARS-CoV-2 Main Protease in Complex with Compound 61,3C-like proteinase nsp5,2,"A,B",306,Yes,,XEK,"(5P)-5-[(1P,3M,3'P)-3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl]-1-methylpyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vk4,Crystal Structure of SARS-CoV-2 Mpro at 2.10 A resolution-3,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gbp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-10 (Mpro-x10395),3C-like proteinase,1,A,306,Yes,DMS,KYC,(2S)-2-(3-chlorophenyl)-2-(dimethylamino)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7n6n,SARS-CoV-2 Main protease C145S mutant in complex with N and C-terminal residues,3C-like proteinase,2,"A,B",314,Yes,,GAMSAVLQ,3C-like proteinase,polypeptide(L),,No,,6LU7_1|Chain,1,C145S,97.13,8
8ykn,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with X77,Non-structural protein 11,1,A,303,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,1,K90R,98.69,3
7giw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f9802937-7 (Mpro-P0141),3C-like proteinase,2,"A,B",306,Yes,DMS,QJF,"(4R)-6-chloro-N-(6-methoxyisoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bny,Crystal Structure of E166V/L50F SARS-CoV-2 Main Protease,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,2,"L50F, E166V",99.35,0
7m03,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 18c,3C-like proteinase,2,"A,B",309,Yes,,"YLD
YLJ","(1R,2S)-2-((S)-2-((((3-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-((((3-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8r24,"SARS-CoV-2 Mpro (Omicron, P132H+T169S) free enzyme",3C-like proteinase nsp5,1,A,306,No,,,,,,,,7TOB_1|Chain,1,T169S,99.67,0
7gm3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-c20a539d-4 (Mpro-P2075),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RG9,2-(3-chlorophenyl)-N-[7-(2-hydroxypropan-2-yl)isoquinolin-4-yl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s6x,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI30,3C-like proteinase,1,A,306,Yes,,I70,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7ans,Structure of SARS-CoV-2 Main Protease bound to Adrafinil.,3C-like proteinase,1,A,306,Yes,DMS,RNW,2-[(diphenylmethyl)-oxidanyl-$l^{3}-sulfanyl]-~{N}-oxidanyl-ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8spj,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) N28T Mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,N28T,99.67,0
8tpi,"Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease",Non-structural protein 7,1,A,305,Yes,,JWO,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-2-hydroxy-2-methylpropanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7gmx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-21 (Mpro-P2229),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RQO,"4-[2-(3-chlorophenyl)acetamido]-N,N-dimethylisoquinoline-6-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7faz,Crystal structure of the SARS-CoV-2 main protease in complex with Y180,3C-like proteinase,2,"A,B",306,Yes,NA,2RI,(2~{R})-~{N}-dibenzofuran-3-yl-~{N}-[(1~{R})-2-[[(1~{S})-1-(4-fluorophenyl)ethyl]amino]-2-oxidanylidene-1-pyridin-3-yl-ethyl]-2-oxidanyl-propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7m91,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 25,3C-like proteinase,1,A,306,Yes,,YU4,"5-{3-[3-chloro-5-(3,3,3-trifluoropropoxy)phenyl]-2-oxo-2H-[1,3'-bipyridin]-5-yl}pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfs,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102739,3C-like proteinase,1,A,306,Yes,DMS,T84,1-{4-[(thiophen-3-yl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7vvt,SARS-CoV-2 3CL protease (3CLpro) in complex with a covalent inhibitor,3C-like proteinase,2,"A,B",306,Yes,,80X,N-(3-chlorophenyl)-2-[(2R)-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanamide,non-polymer,,Yes,"CYS, 145-(80X, .)",6LU7_1|Chain,0,,100.00,0
7gmp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-7 (Mpro-P2207),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RM3,2-(3-chlorophenyl)-N-[7-(dimethylamino)isoquinolin-4-yl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rei,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2856434856,3C-like proteinase,1,A,306,Yes,DMS,T1S,4-[(3-chlorophenyl)methyl]morpholine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f2460aef-1 (Mpro-P0009),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QBR,N-(4-tert-butylphenyl)-N-[(1R)-2-{[2-(3-fluorophenyl)ethyl]amino}-2-oxo-1-(pyridin-3-yl)ethyl]furan-2-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7zb6,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) variant C44S at 2.12 A resolution,3C-like proteinase nsp5,2,"A,B",306,No,DMS,,,,,,,6LU7_1|Chain,1,C44S,99.67,0
7tll,Structure of SARS-CoV-2 Mpro Omicron P132H in complex with Nirmatrelvir (PF-07321332),3C-like proteinase nsp5,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
7gl7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-6bf93aa8-1 (Mpro-P1783),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R6L,"(4S)-6-chloro-4-methoxy-N-[7-(methylsulfamoyl)isoquinolin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6yvf,Structure of SARS-CoV-2 Main Protease bound to AZD6482.,3C-like proteinase,1,A,306,Yes,"CL
DMS
PEG
CA",A82,"2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxidanylidene-pyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-18 (Mpro-P1010),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QZ0,"(4S)-6-chloro-N~4~-(isoquinolin-4-yl)-N~2~,N~2~-dimethyl-3,4-dihydroisoquinoline-2,4(1H)-dicarboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5reo,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102578,3C-like proteinase,1,A,306,Yes,DMS,T2Y,"N-[(2H-1,3-benzodioxol-5-yl)methyl]acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8uei,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 28,3C-like proteinase nsp5,1,A,306,Yes,,WF2,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-1-(4-fluorophenyl)-4-oxo-4-{[4-(pyrrolidin-1-yl)butyl]amino}butan-2-yl]-D-phenylalaninamide",non-polymer,,Yes,"CSO, 145-(WF2, .)",6LU7_1|Chain,0,,100.00,0
5ret,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102269,3C-like proteinase,1,A,306,Yes,DMS,T47,1-{4-[(3-chlorophenyl)methyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8dkk,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,G283S,99.67,0
7lcs,Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability,3C-like proteinase,1,A,306,Yes,,XTP,benzyl [(2S)-3-cyclopropyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7e18,Crystal structure of SAR-CoV-2 3CL protease complex with inhibitor YH-53,Replicase polyprotein 1ab,1,A,306,Yes,EDO,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"CYS, 145-(HUR, .)",6LU7_1|Chain,0,,100.00,0
7ge1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-6af13d92-3 (Mpro-x11294),3C-like proteinase,1,A,306,Yes,DMS,N43,"5-methoxy-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ey2,Cryo-EM structure of SARS-CoV-2 Main protease C145S in complex with N-terminal peptide,3C-like proteinase,4,"A,B,C,D",314,No,,,,,,,,6LU7_1|Chain,1,C145S,97.13,8
7qbb,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 18,3C-like proteinase nsp5,1,A,306,Yes,DMS,V1B,"7-isoquinolin-4-yl-2-phenyl-5,7-diazaspiro[3.4]octane-6,8-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ty3,MI-31 ligand bound to SARS-CoV-2 Mpro,3C-like proteinase nsp5,1,A,306,Yes,,SJF,"(1S,3aR,6aS)-2-[(3,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}octahydrocyclopenta[c]pyrrole-1-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7s6y,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI32,3C-like proteinase,1,A,306,Yes,,8GW,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-[(cyclopropylmethyl)amino]-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
8dkj,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,K90R,99.67,0
5red,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2856434865,3C-like proteinase,1,A,306,Yes,DMS,JJG,4-[2-(phenylsulfanyl)ethyl]morpholine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7w9g,Complex structure of Mpro with ebselen-derivative inhibitor,3C-like proteinase nsp5,1,A,307,No,SE,,,,,,,6LU7_1|Chain,0,,99.67,1
7gfu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bbbbc21a-3 (Mpro-x11831),3C-like proteinase,1,A,306,Yes,DMS,OJ9,2-(5-chloro-1-benzofuran-7-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gks,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-11 (Mpro-P1062),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QZL,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(3R)-3-methylpyrrolidine-1-sulfonyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-UNI-8d415491-1 (Mpro-P0884),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QX3,"(4R)-6,7-dichloro-N-(4-cyclopropylpyridin-3-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gjc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-BAS-c2bc0d80-6 (Mpro-P0207),3C-like proteinase,2,"A,B",306,Yes,DMS,QM3,"(1'P,3'S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,3'-pyrrolidine]-2',5'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7hue,PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment D08 from the F2X-Entry Screen in monoclinic space group,3C-like proteinase nsp5,1,A,306,Yes,DMS,A1BNP,"N-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N,N',N'-trimethylurea",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c59291d4-4 (Mpro-x10820),3C-like proteinase,1,A,306,Yes,DMS,LWO,2-(1H-benzotriazol-1-yl)-N-[4-(methylamino)phenyl]-N-[(thiophen-3-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8wti,Crystal structure of the SARS-CoV-2 main protease in complex with 20j,3C-like proteinase nsp5,2,"A,B",306,Yes,"PEG
SO4",X1Z,"~{N}-[(1~{R})-1-cyclohexyl-2-[[(2~{R})-3-methoxy-1-oxidanylidene-1-[[1-[(1~{S})-1-oxidanyl-2-oxidanylidene-2-(1,3-thiazol-2-ylmethylamino)ethyl]cyclobutyl]amino]propan-2-yl]amino]-2-oxidanylidene-ethyl]-4,4-bis(fluoranyl)cyclohexane-1-carboxamide",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
8c9o,Crystal structure of SARS-CoV-2 Mpro-S144A mutant in complex with 13b-K,3C-like proteinase nsp5,2,"A,B",306,Yes,,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S144A,99.67,0
7gft,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAR-UCB-f313ec4d-2 (Mpro-x11813),3C-like proteinase,1,A,306,Yes,DMS,OIX,N-[2-(2-methoxyphenoxy)ethyl]isoquinoline-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gf8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TAT-ENA-80bfd3e5-37 (Mpro-x11587),3C-like proteinase,1,A,306,Yes,DMS,O4L,"N-(3-acetyl-2,5-dimethyl-1H-pyrrol-1-yl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6xhu,Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gcx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-24 (Mpro-x10801),3C-like proteinase,1,A,306,Yes,DMS,LVM,N-(4-methylpyridin-3-yl)-2-(spiro[2.3]hexan-5-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lzz,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 5c,3C-like proteinase,1,A,309,Yes,,"YMS
YMV","(1R,2S)-1-hydroxy-2-((S)-4-methyl-2-(((((1r,4S)-4-phenylcyclohexyl)oxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-1-hydroxy-2-((S)-4-methyl-2-(((((1r,4S)-4-phenylcyclohexyl)oxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7ur9,SARS-Cov2 Main protease in complex with inhibitor CDD-1845,3C-like proteinase nsp5,2,"A,B",306,Yes,,O5F,(2P)-2-(isoquinolin-4-yl)-1-[4-(methylamino)-4-oxobutyl]-N-[(1S)-1-(naphthalen-2-yl)ethyl]-1H-benzimidazole-7-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grz,Crystal structure of SARS-CoV-2 main protease in complex with cpd-22,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
PO4",XZI,"N,N-dimethyl-2-[(naphthalen-2-yl)oxy]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gd9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DUN-NEW-f8ce3686-23 (Mpro-x10899),3C-like proteinase,1,A,306,Yes,DMS,LXF,"N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-32 (Mpro-x10355),3C-like proteinase,1,A,306,Yes,DMS,KW9,"7-fluoro-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gha,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DAN-LON-a5fc619e-8 (Mpro-x3077),3C-like proteinase,1,A,306,Yes,DMS,Q4F,"1-{(1S,4S)-5-[(3-chlorophenyl)methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl}ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7wym,Structure of the SARS-COV-2 main protease with 337 inhibitor,3C-like proteinase nsp5,1,A,306,Yes,,G7L,"N-methyl-N-[[4-(trifluoromethyl)-1,3-thiazol-2-yl]methyl]prop-2-enamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gij,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5d65ec79-1 (Mpro-P0097),3C-like proteinase,2,"A,B",306,Yes,DMS,QGO,"(4S)-6-chloro-4-[2-(dimethylamino)-2-oxoethyl]-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8udm,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 16,3C-like proteinase nsp5,1,A,306,Yes,EDO,WBE,"2-cyano-D-phenylalanyl-N-[(2S)-4-({3-[(5-amino-4H-1,2,4-triazol-3-yl)amino]propyl}amino)-1-(4-fluorophenyl)-4-oxobutan-2-yl]-2,4-dichloro-D-phenylalaninamide",non-polymer,,Yes,"CSO, 145-(WBE, .)",6LU7_1|Chain,0,,100.00,0
8udx,Crystal structure of SARS-CoV-2 3CL protease with C145 sulfinic acid in complex with inhibitor 17,3C-like proteinase,1,A,306,Yes,,WCZ,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-1-(4-fluorophenyl)-4-{[3-(4-methylpiperazin-1-yl)propyl]amino}-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gif,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-7 (Mpro-P0069),3C-like proteinase,2,"A,B",306,Yes,DMS,QFL,2-(4-fluorophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8e25,Crystal Structure of SARS-CoV-2 Main Protease M49I mutant in complex with Nirmatrelvir,Replicase polyprotein 1ab,2,"A,B",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,M49I,99.67,0
7s82,Cryo-EM structure of SARS-CoV-2 Main protease C145S in complex with N-terminal peptide,3C-like proteinase,4,"A,B,C,D",314,No,,,,,,,,6LU7_1|Chain,1,C145S,97.13,8
7vjz,Crystal Structure of SARS-CoV-2 Mpro at 1.90 A resolution-7,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7ghr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-ce760d3f-8 (Mpro-P0017),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OZC,(3S)-3-(4-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ej7,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,E47K,99.67,0
7gei,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-8df914d1-2 (Mpro-x11454),3C-like proteinase,1,A,306,Yes,DMS,NM0,"2-(3-chlorophenyl)-N-[(4R)-imidazo[1,2-a]pyridin-3-yl]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8e64,Crystal structure of SARS-CoV-2 3CL protease in complex with a benzimidazole dimethyl sulfane inhibitor,3C-like proteinase,2,"A,B",309,Yes,,"WEL
WEQ","(1S,2S)-2-{[N-({2-[(1H-benzimidazol-2-yl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1~{R},2~{S})-2-[[(2~{S})-2-[[2-(1~{H}-benzimidazol-2-ylsulfanyl)-2-methyl-propoxy]carbonylamino]-4-methyl-pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid;molecular oxygen","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 B",6LU7_1|Chain,0,,98.39,5
7adw,"Structure of SARS-CoV-2 Main Protease bound to 2,4'-Dimethylpropiophenone.",3C-like proteinase,1,A,306,Yes,"DMS
IMD
CL",R7Q,2-methyl-1-(4-methylphenyl)propan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8drr,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp4-nsp5 (C4) cut site sequence,3C-like proteinase nsp5,3,"A,B,C",306,No,NA,,,,,,,6LU7_1|Chain,3,"C145A, G302A, F305L",98.37,2
5rh4,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1530425063 (Mpro-x2659),3C-like proteinase,1,A,306,Yes,DMS,UHG,(2R)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vk3,Crystal Structure of SARS-CoV-2 Mpro at 2.10 A resolution-2,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8udy,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 25,3C-like proteinase nsp5,1,A,306,Yes,"NA
CA",WD6,"2-cyano-D-phenylalanyl-2,4-dichloro-N-{(2S)-1-(4-fluorophenyl)-4-oxo-4-[(prop-2-yn-1-yl)amino]butan-2-yl}-D-phenylalaninamide",non-polymer,,Yes,"CSO, 145-(WD6, .)",6LU7_1|Chain,0,,100.00,0
7ger,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f7918075-5 (Mpro-x11499),3C-like proteinase,1,A,306,Yes,DMS,NU0,"2-(3-chlorophenyl)-N-(2,6-naphthyridin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7cuu,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with MG132,3C protein,2,"A,B",306,Yes,"DMS
GOL",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-c0c213c9-1 (Mpro-x11757),3C-like proteinase,1,A,306,Yes,DMS,OD7,2-(6-methoxy-1H-benzotriazol-1-yl)-N-[4-(piperidin-4-yl)phenyl]-N-[(pyridin-2-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8h5p,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,2,"L50F, E166V",99.35,0
5rfk,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102575,3C-like proteinase,1,A,306,Yes,DMS,T7D,N-(1-acetylpiperidin-4-yl)benzamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tiw,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor EB54,3C-like proteinase nsp5,1,A,306,Yes,PO4,I54,"(1S,2S)-2-[(N-{[(2-chlorophenyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gde,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-12 (Mpro-x10976),3C-like proteinase,1,A,306,Yes,DMS,M7X,2-(3-chlorophenyl)-N-(5-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf6,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1348371854,3C-like proteinase,1,A,306,Yes,DMS,NTG,"5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7b83,Structure of SARS-CoV-2 Main Protease bound to pyrithione zinc,3C-like proteinase,1,A,306,Yes,"IMD
DMS
CL",PK8,"9-oxa-7-thia-1-azonia-8$l^{2}-zincabicyclo[4.3.0]nona-1,3,5-triene",non-polymer,,No,,6LU7_1|Chain,1,N72L,99.67,0
7gk0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-BAS-c2bc0d80-7 (Mpro-P0765),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QS3,"(1'M,4S)-6-chloro-1'-(isoquinolin-4-yl)-3'-methyl-2,3-dihydrospiro[[1]benzopyran-4,4'-imidazolidine]-2',5'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jq1,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI4,3C-like proteinase,1,A,306,Yes,,VHJ,"N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-L-phenylalaninamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gej,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-c9c1e0d8-2 (Mpro-x11458),3C-like proteinase,1,A,306,Yes,DMS,NO0,2-(3-ethynylphenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgn,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102759 (Mpro-x0731),3C-like proteinase,1,A,306,Yes,DMS,U1A,1-{4-[(4-methylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7aph,Structure of SARS-CoV-2 Main Protease bound to Tofogliflozin.,3C-like proteinase,1,A,306,Yes,"DMS
CL",RT2,Tofogliflozin,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jr3,SARS-CoV-2 3CL protease crystallized under reducing conditions,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7qt5,Room temperature In-situ SARS-CoV-2 MPRO with bound Z31792168,3C-like proteinase nsp5,1,A,305,Yes,DMS,GWS,2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,99.67,1
8h3k,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,GOL,"7YY
VIB","6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM","non-polymer
non-polymer","
","No
No","
",6LU7_1|Chain,2,"L50F, E166V",99.35,0
8okk,Crystal structure of F2F-2020184-00X bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase nsp5,2,"A,B",306,Yes,"ACT
EDO
FMT
NA
CL
DMS","83F
MPD","tert-butyl-N-[(2S)-3-methyl-1-[(2S,4S)-4-methyl-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]carbamate
(4S)-2-METHYL-2,4-PENTANEDIOL","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7grt,Crystal structure of SARS-CoV-2 main protease in complex with cpd-16,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",Y0L,"N-[(2,3-dihydro-1-benzofuran-5-yl)methyl]benzamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mhi,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) at 298 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7e5x,THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE apo form at 2.2 angstrom,3C-like proteinase,4,"A,B,C,D",306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8igx,"SARS-CoV-2 3CL protease (3CLpro) in complex with compound 9 (simnotrelvir, SIM0417, SSD8432)",3C-like proteinase nsp5,1,A,306,Yes,,PQL,"(8~{S})-~{N}-[(1~{S})-1-cyano-2-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]ethyl]-7-[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxamide",non-polymer,,Yes,"CYS, 145-(PQL, .)",6LU7_1|Chain,0,,100.00,0
7gev,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-f13221e1-4 (Mpro-x11513),3C-like proteinase,1,A,306,Yes,DMS,NW0,3-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7t8r,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 7/8,3C-like proteinase,1,A,306,Yes,"EDO
GOL",NRATLQAI,Nonstructural protein 7/8,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
5rgj,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1401276297 (Mpro-x0425),3C-like proteinase,1,A,306,Yes,DMS,U0S,(5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dpp,SARS-CoV-2 3CL protease (3CLpro) in complex with myricetin,3C-like proteinase,1,A,301,Yes,,MYC,"3,5,7-TRIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.37,5
8h82,Crystal structure of SARS-CoV-2 main protease (Mpro) Mutant (E166V) in complex with protease inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E166V,99.67,0
7mpb,SARS Coronavirus-2 Main Protease 3CL-pro binding Ascorbate,3C-like proteinase,2,"A,B",314,No,"ASC
ETF",,,,,,,6LU7_1|Chain,0,,97.45,8
7gc2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-93268d01-13 (Mpro-x10484),3C-like proteinase,1,A,306,Yes,DMS,L7Q,3-methyl-N-(4-methylpyridin-3-yl)-3-phenylbutanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rm2,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with Mcule-CSR-494190-S1,3C-like proteinase,1,A,306,Yes,,5YJ,"6-[4-(3,5-dichloro-4-methylphenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mb7,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp7/8 (P6-P1),3C-like proteinase,1,A,306,Yes,,NRATLQ,ASN-ARG-ALA-THR-LEU-GLN,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7bfb,Crystal structure of ebselen covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,Main Protease,2,"A,B",306,Yes,"EDO
NA",9JT,N-phenyl-2-selanylbenzamide,non-polymer,,Yes,CYS44 A,6LU7_1|Chain,0,,100.00,0
9at7,"Crystal structure of SARS-CoV-2 3CL protease in complex with a 2,2-difluoro-5-methylbenzo[1,3]dioxole 2-pyrrolidone inhibitor",3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,"A1AGS
A1AGT","(1R,2S)-2-({N-[({(2S)-1-[(2,2-difluoro-2H-1,3-benzodioxol-5-yl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-({N-[({(2S)-1-[(2,2-difluoro-2H-1,3-benzodioxol-5-yl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
7gmt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-19 (Mpro-P2218),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",ROZ,4-[2-(3-chlorophenyl)acetamido]isoquinoline-6-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gem,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-15 (Mpro-x11485),3C-like proteinase,1,A,306,Yes,DMS,NQO,2-(3-chlorophenyl)-N-(4-methylpyridazin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grj,Crystal structure of SARS-CoV-2 main protease in complex with cpd-6,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",Y1L,(5-chloro-1-benzothiophen-3-yl)methanol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ldl,Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability,3C-like proteinase,2,"A,B",306,Yes,,XV4,N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8w1u,SARS-CoV-2 Main protease bound to non-covalent lead molecule NZ-804,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,A1AFE,"11-[1-(1H-pyrrolo[3,2-c]pyridine-7-carbonyl)piperidin-4-ylidene]-6,11-dihydro-5H-5lambda~6~-dibenzo[b,e]thiepine-5,5-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8gwj,SARS CoV-2 Mpro 1-302 C145A in complex with peptide 7,Replicase polyprotein 1ab,2,"A,B",302,Yes,,VKLQAVFR,VAL-LYS-LEU-GLN-ALA-VAL-PHE-ARG,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,98.37,4
5rfl,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102389,3C-like proteinase,1,A,306,Yes,DMS,T7G,1-acetyl-N-(2-hydroxyphenyl)piperidine-4-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ehm,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) S144F Mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,S144F,99.67,0
7gho,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-c9c1e0d8-4 (Mpro-P0010),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QC3,(3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)pyrrolidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-22 (Mpro-P1978),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R8X,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(2-methoxyethyl)(methyl)sulfamoyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gbr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-7e92b6ca-4 (Mpro-x10403),3C-like proteinase,1,A,306,Yes,DMS,KZC,"N-(2-anilinoethyl)-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8p5b,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 500 micromolar X77 enantiomer S.,3C-like proteinase nsp5,2,"A,B",306,No,"DMS
EDO
CL
NA",,,,,,,6LU7_1|Chain,0,,100.00,0
8e5z,Crystal structure of SARS-CoV-2 3CL protease in complex with a dimethyl sulfonyl benzene inhibitor,3C-like proteinase,2,"A,B",309,Yes,,"WJB
UQO","(1R,2S)-2-[(N-{[2-(benzenesulfonyl)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-[(N-{[2-(benzenesulfonyl)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8ri4,"Crystal structure of the SARS-CoV-2 Main Protease inhibited by (2-methylsulfanyl-6,7-dihydro-[1,4]dioxino[2,3-f]benzimidazol-3-yl)-(p-tolyl)methanone",3C-like proteinase nsp5,1,A,306,Yes,"DMS
GOL
FMT
NA",4MA,4-METHYLBENZOIC ACID,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-a0b0dbcb-4 (Mpro-x11616),3C-like proteinase,1,A,306,Yes,DMS,O87,4-{4-[3-(trifluoromethyl)phenyl]piperazine-1-carbonyl}quinolin-2(1H)-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grq,Crystal structure of SARS-CoV-2 main protease in complex with cpd-13,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",Y0S,N-[(3-methylthiophen-2-yl)methyl]benzamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gic,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-13 (Mpro-P0065),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QEX,N-(isoquinolin-4-yl)-2-(3-methylphenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7giq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-c852c98b-5 (Mpro-P0124),3C-like proteinase,2,"A,B",306,Yes,DMS,QIM,"(4R)-6-chloro-N-[6-(methanesulfonyl)isoquinolin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7uuc,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI19,3C-like proteinase nsp5,1,A,306,Yes,,81L,N-[(benzyloxy)carbonyl]-3-methyl-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8dmn,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,S284G,99.67,0
9bnv,Crystal Structure of A173V SARS-CoV-2 Main Protease,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,A173V,99.67,0
7ghw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-8b8a49e1-4 (Mpro-P0026),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",P3L,"(4R)-6-chloro-N-[(4R)-2-oxopiperidin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ups,Structure of SARS-Cov2 3CLPro in complex with Compound 5,3C-like proteinase nsp5,1,A,306,Yes,PO4,I70,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-7e92b6ca-2 (Mpro-x10419),3C-like proteinase,1,A,306,Yes,DMS,L1F,"N-[2-(2-methoxyphenoxy)ethyl]-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8drs,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp6-nsp7 (C6) cut site sequence,3C-like proteinase nsp5,3,"A,B,C",306,No,,,,,,,,6LU7_1|Chain,5,"C145A, S301K, G302V, V303A, F305V",98.37,0
8swh,Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab,"Spike glycoprotein
TXG-0078 Fab Heavy chain
TXG-0078 Fab Light chain",3,"A,B,C","1280, 147, 132",Yes,NAG,"beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,",beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,"oligosaccharide,",,(N-Glycosylation),ASN122 A,6LU7_1|Chain,"112
68
59","G2T, F3T, K5P, M6P, P9T, S10R, E14F, G15R, C16S, M17S, C22S, L27S, L30T, W31T, D34N, Y37F, R40Y, I43N, S46F, D48Y, M49V, L50S, N51Q, N53F, Y54L, E55M, R60F, N63K, G71P, N72L, Q74D, V77P, M82L, N84P, C85R, V86T, L87F, K88L, T93C, N95D, P99L, Y101S, K102F, F103T, I106V, Q110E, T111V, N119G, G120V, Y126R, C128I, N133G, F134Q, I136G, G138I, S139A, F140D, L141Y, C145L, G146D, F150G, I152Y, D153N, S158G, M162Q, H163S, H164Y, M165G, E166F, L167Q, D176N, E178N, G179F, Y182N, R188P, A191V, Q192I, A193T, A194P, D197N, I200P, W207S, Y209G, N214C, R217G, W218S, F223A, T224L, N228A, V233L, K236A, T243L, H246V, P252R, A255L, G258E, M264F, A266G, S267K, L268G, K269Y, E270H, M276S, G283D, A285F, L286K, L287E, E290Y, P293S, F294P, C300G, T304L
T21D, Q69A, N72Q, D92S, T93G, N95E, P96V, F112A, G143V, C156K, C160G, H163T, H164L, M165T, P168I, T169H, G170W, H172Q, T175K, D176G, F181W, Y182M, P184G, R188P, Q189E, T190D, T198E, A211Q, V212Q, I213F, N214Q, W218V, F219S, L220M, N221T, R222E, F223D, T225S, V233T, Y239M, G251S, P252S, A255E, Q256D, D263Y, M264Y, S267T, L268A, K269F, E270A, L271I, L272T, Q273T, N274V, M276T, G278Y, R279Y, T280Y, I281Y, L282Y, F294M, V297W, R298G, C300G, S301T, G302T, F305S, Q306S
F3M, K5L, M6L, N28L, D33M, D34L, V35W, C44E, T45S, E47G, M49V, N51T, N63S, H64P, N65V, F66T, V68G, A70P, G71A, N72S, V73I, Q74S, L75C, M82S, N84S, C85L, K90H, V91S, A94G, K102L, F103S, V104W, R105L, I106Q, N133R, F134L, T135L, G138I, G149R, Q189F, T190S, A191G, Q192S, A193G, T198F, V202S, N203R, L205E, A210E, A211D, N221Y, R222Y, F223C, V233Q, G251F, Q256H, I281R, F305I, Q306K","14.80
21.84
20.70","982
179
190"
7ghu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UCB-29506327-1 (Mpro-P0022),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",P4R,"(1'M,4S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,4'-imidazolidine]-2',5'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7k6d,SARS-CoV-2 Main Protease Co-Crystal Structure with Telaprevir Determined from Crystals Grown with 40 nL Acoustically Ejected Mpro Droplets at 1.48 A Resolution (Cryo-protected),3C-like proteinase,1,A,306,Yes,DMS,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ghv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-afd4d4fd-2 (Mpro-P0025),3C-like proteinase,2,"A,B",306,Yes,DMS,OZX,2-(6-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7k0e,1.90 A resolution structure of SARS-CoV-2 3CL protease in complex with deuterated GC376,3C-like proteinase,2,"A,B",309,Yes,PG4,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
8u9m,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI95,3C-like proteinase nsp5,1,A,306,Yes,,VZT,"bis(4-fluorophenyl)methyl (1R,2S,5R)-2-({(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6m03,The crystal structure of COVID-19 main protease in apo form,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gfn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-7374c256-2 (Mpro-x11797),3C-like proteinase,1,A,306,Yes,DMS,OFX,2-(1H-benzotriazol-1-yl)-N-[4-(dimethylamino)phenyl]-N-[(1H-pyrazol-5-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gnk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-ecbed2ba-12 (Mpro-P2730),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S0X,"2-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-(cyclopropylmethyl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-22 (Mpro-P2219),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RPK,N-(6-acetamidoisoquinolin-4-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-16 (Mpro-x11013),3C-like proteinase,1,A,306,Yes,DMS,M50,2-(3-chlorophenyl)-N-(5-methylpyridazin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xch,Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Leupeptin,3C-like proteinase,1,A,306,Yes,,(ACE)LL(AR7),Leupeptin,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8hvo,Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with PF07321332,3C-like proteinase nsp5,2,"A,B",299,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",6LU7_1|Chain,1,V186F,97.39,7
7gbk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-95b75b4d-2 (Mpro-x10359),3C-like proteinase,1,A,306,Yes,DMS,KXF,2-(3-hydroxyphenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ifr,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3,3C-like proteinase nsp5,1,A,306,Yes,,P0O,"(1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethyl-butanoyl]-6,6-dimethyl-N-[(2S)-5-oxidanylidene-1-[(3S)-2-oxidanylidenepyrrolidin-3-yl]hex-3-en-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 145-(P0O, .)",6LU7_1|Chain,0,,100.00,0
7gav,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f7918075-2 (SARS2_MproA-x0854),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",KFU,"(3S)-5-chloro-N-(isoquinolin-4-yl)-2,3-dihydro-1-benzofuran-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-d6de1f3c-1 (Mpro-x12679),3C-like proteinase,1,A,306,Yes,DMS,P0X,4-[4-(3-chlorophenyl)-3-oxopiperazine-1-carbonyl]quinolin-2(1H)-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7e19,Crystal structure of SAR-CoV-2 3CL protease complex with inhibitor SH-5,3C-like proteinase,1,A,306,Yes,,HUO,"(phenylmethyl) N-[(2S)-1-[[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate",non-polymer,,Yes,"CYS, 145-(HUO, .)",6LU7_1|Chain,0,,100.00,0
7gmn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-14 (Mpro-P2205),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RLH,2-(3-chlorophenyl)-N-{7-[2-(pyrrolidin-1-yl)ethoxy]isoquinolin-4-yl}acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8e5x,Crystal structure of SARS-CoV-2 3CL protease in complex with a dimethyl sulfinyl benzene inhibitor,3C-like proteinase,2,"A,B",309,Yes,PG4,"UO9
URR","(2~{S})-2-[[(2~{S})-4-methyl-2-[[2-methyl-2-[oxidanyl(phenyl)-$l^{3}-sulfanyl]propoxy]carbonylamino]pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid
N~2~-(ethoxycarbonyl)-N-{(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}-L-leucinamide","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8vd7,MicroED structure of SARS-CoV-2 main protease (MPro/3CLPro) with missing cone eliminated by suspended drop,3C-like proteinase nsp5,1,A,306,No,CL,,,,,,,6LU7_1|Chain,0,,100.00,0
7xq6,The complex structure of mutant Mpro with inhibitor,3C-like proteinase nsp5,1,A,307,No,CL,,,,,,,6LU7_1|Chain,1,H41N,99.35,1
8hom,Crystal Structure of SARS-CoV-2 Omicron Main Protease (Mpro) in Complex with Ensitrelvir,3C-like proteinase nsp5,1,A,306,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,7TOB_1|Chain,0,,100.00,0
7gg5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-87c86d55-1 (Mpro-x12143),3C-like proteinase,1,A,306,Yes,DMS,OQF,"2-(1H-benzotriazol-1-yl)-N-[4-(dimethylamino)phenyl]-N-[(1,3-thiazol-4-yl)methyl]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dz1,Crystal Structure of SARS-CoV-2 Main protease mutant M49I in complex with Ensitrelvir,Replicase polyprotein 1ab,2,"A,B",306,Yes,DMS,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,1,M49I,99.67,0
8ca6,"Crystal structure of SARS-CoV-2 Mpro-Q189K mutant, free enzyme",Non-structural protein 11,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,Q189K,99.67,0
7gi3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-090737b9-1 (Mpro-P0041),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL
CA",Q0I,"(4R)-6-chloro-N-(isoquinolin-4-yl)-N-propanoyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7dhj,The co-crystal structure of SARS-CoV-2 main protease with the peptidomimetic inhibitor (S)-2-cinnamamido-N-((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)pent-4-ynamide,3C-like proteinase,1,A,306,Yes,,H6R,(2~{S})-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(~{E})-3-phenylprop-2-enoyl]amino]pent-4-ynamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7buy,The crystal structure of COVID-19 main protease in complex with carmofur,3C-like proteinase,1,A,306,Yes,DMS,JRY,hexylcarbamic acid,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ig9,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with GC376,3C-like proteinase nsp5,2,"A,B",299,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,M49I,97.39,7
7jun,Joint neutron/X-ray structure of SARS-CoV-2 3CL Mpro at room temperature,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7mng,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy),3C-like proteinase,1,A,306,Yes,DMS,ZL7,"(2R,3S)-N-cyclopropyl-3-{[(2R)-3-(cyclopropylmethanesulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanoyl]amino}-2-hydroxypentanamide (non-preferred name)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7dau,The crystal structure of COVID-19 main protease treated by GA,COVID-19 MAIN PROTEASE,1,A,306,No,AU,,,,,,,6LU7_1|Chain,0,,100.00,0
7gmz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-c3ea9889-6 (Mpro-P2243),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RR0,"(2r,4r)-6-chloro-N-(7-fluoroisoquinolin-4-yl)-2,3-dihydro-4H-2,4-methano-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rg1,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with NCL-00024905,3C-like proteinase,1,A,306,Yes,DMS,T9J,Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf1,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with NCL-00023830,3C-like proteinase,1,A,306,Yes,DMS,T5G,4-bromobenzene-1-sulfonamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gga,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-e4b030d8-13 (Mpro-x12207),3C-like proteinase,1,A,306,Yes,DMS,OSI,"(4R)-6-chloro-N-(isoquinolin-4-yl)-4-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dat,The crystal structure of COVID-19 main protease treated by AF,COVID-19 MAIN PROTEASE,1,A,306,No,AU,,,,,,,6LU7_1|Chain,0,,100.00,0
7gl2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-1981ceba-4 (Mpro-P1623),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R43,"(4S)-6-chloro-2-(3-cyanoazetidine-1-sulfonyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf9,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z217038356,3C-like proteinase,1,A,306,Yes,DMS,S7D,1-[(2~{S})-2-methylmorpholin-4-yl]-2-pyrazol-1-yl-ethanone,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grv,Crystal structure of SARS-CoV-2 main protease in complex with cpd-18,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",Y0C,"(2S)-2-(2-fluorophenyl)-1,3-thiazolidin-4-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmi,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-2 (Mpro-P2185),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RK6,4-[2-(3-chlorophenyl)acetamido]-N-methylisoquinoline-7-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ykj,Crystal structure of SARS-Cov-2 main protease in complex with X77,Non-structural protein 11,2,"A,B",301,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,98.37,5
7cbt,The crystal structure of SARS-CoV-2 main protease in complex with GC376,3C-like proteinase,2,"A,B",333,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,91.89,27
7t43,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 3c,3C-like proteinase,2,"A,B",309,Yes,PG4,"FN2
FP8","(1S,2S)-1-hydroxy-2-[(N-{[(2-methyl-2-azaspiro[3.3]heptan-6-yl)oxy]carbonyl}-L-leucyl)amino]-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-1-hydroxy-2-[(N-{[(2-methyl-2-azaspiro[3.3]heptan-6-yl)oxy]carbonyl}-L-leucyl)amino]-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gk6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fb82b63d-1 (Mpro-P0800),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QTL,"(1R)-7-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7r7h,Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors,3C-like proteinase,2,"A,B",306,Yes,,4IT,"N-[(2S)-1-({(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6wqf,Structural Plasticity of the SARS-CoV-2 3CL Mpro Active Site Cavity Revealed by Room Temperature X-ray Crystallography,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8ykp,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with X77,3C-like proteinase nsp5,1,A,301,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,1,M49I,98.04,5
7z2k,Crystal structure of SARS-CoV-2 Main Protease in orthorhombic space group p212121,3C-like proteinase nsp5,2,"A,B",306,No,"CL
DMS
MLI",,,,,,,6LU7_1|Chain,0,,100.00,0
8p58,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 500 micromolar X77 enantiomer R.,3C-like proteinase nsp5,2,"A,B",306,Yes,"EDO
CL
DMS
NA",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ueh,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 31,3C-like proteinase nsp5,1,A,306,Yes,CL,WEX,"2-cyano-D-phenylalanyl-2,4-dichloro-N-{(2S)-1-(4-fluorophenyl)-4-oxo-4-[(2-phenylethyl)amino]butan-2-yl}-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lkx,1.60 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3e,3C-like proteinase,2,"A,B",309,Yes,PG4,"Y51
Y71","(1R,2S)-2-((S)-2-(((((1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8y44,SARS-CoV-2 3CL protease (3CLpro) in complex with compound JZD-122,3C-like proteinase nsp5,2,"A,B",306,Yes,,A1D50,"~{N}-[(1~{S},2~{R})-2-[(4-bromanyl-2-morpholin-4-ylcarbonyl-6-nitro-phenyl)amino]cyclohexyl]-2-oxidanylidene-1~{H}-quinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lyh,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAWJ9-36-1,3C-like proteinase,1,A,306,Yes,GOL,YHJ,"benzyl (1S,3aR,6aS)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7lmc,Structure of SARS CoV-2 main protease shows simultaneous processing of its N- and C-terminii,3C-like proteinase,4,"B,C,E,F",306,Yes,,TSAVLQ,Non-structural protein 4 peptide,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gjl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-UNI-3735e77e-1 (Mpro-P0600),3C-like proteinase,2,"A,B",306,Yes,DMS,QOC,"(3R)-3-(3,4-dichlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-21 (Mpro-P1990),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RBM,"(4S)-6-chloro-2-[(2-cyanoethyl)(methyl)sulfamoyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rn4,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with HL-3-69,3C-like proteinase,1,A,306,Yes,,H69,"6-[4-(3,4-dichlorophenyl)piperidine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tvx,The Crystal Structure of SARS-CoV-2 Omicron Mpro (P132H) in complex with masitinib,3C-like proteinase nsp5,1,A,306,Yes,,G65,Masitinib,non-polymer,,No,,7TOB_1|Chain,0,,100.00,0
7teh,Room temperature X-ray structure of SARS-CoV-2 main protease (3CL Mpro) in complex with BBH-2,3C-like proteinase,1,A,306,Yes,,I1Z,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7aww,Structure of SARS-CoV-2 Main Protease bound to Clonidine,3C-like proteinase,1,A,306,Yes,DMS,CLU,"2,6-DICHLORO-N-IMIDAZOLIDIN-2-YLIDENEANILINE",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gg0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-e44ffd04-1 (Mpro-x12026),3C-like proteinase,1,A,306,Yes,DMS,OGV,"2-(3-chlorophenyl)-N-[(4S)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ntt,Crystal structure of the SARS-CoV-2 Main Protease,3C-like proteinase,2,"A,B",306,No,"NA
FMT",,,,,,,6LU7_1|Chain,0,,100.00,0
7gme,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-38 (Mpro-P2177),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RJ3,4-[2-(3-chlorophenyl)acetamido]isoquinoline-7-carboxylic acid,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bo7,Crystal Structure of L50F SARS-CoV-2 Main Protease in Complex with Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,L50F,99.67,0
8b0t,SARS-CoV-2 Main Protease adduct with Au(PEt3)Br,3C-like proteinase nsp5,1,A,301,No,AU,,,,,,,6LU7_1|Chain,0,,98.37,5
7jst,Crystal structure of SARS-CoV-2 3CL in apo form,3C-like proteinase,1,A,306,No,PO4,,,,,,,6LU7_1|Chain,0,,100.00,0
7geg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-a364e151-1 (Mpro-x11431),3C-like proteinase,1,A,306,Yes,DMS,NJU,"2-(3-chlorophenyl)-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gck,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-48 (Mpro-x10638),3C-like proteinase,1,A,306,Yes,DMS,LF3,"2-(6-chloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rhb,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Cov_HetLib030 (Mpro-x2097),3C-like proteinase,1,A,306,Yes,DMS,USD,(E)-1-(pyrimidin-2-yl)methanimine,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8a4t,"crystal structures of diastereomer (S,S,S)-13b (13b-K) in complex with the SARS-CoV-2 Mpro",3C-like proteinase nsp5,2,"A,B",305,Yes,CL,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7lyi,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAWJ9-36-3,3C-like proteinase,1,A,308,Yes,"GOL
NA",YHI,"benzyl (1R,2S,5S)-2-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
7be7,Crystal structure of MG-132 covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase,2,"A,B",306,Yes,"EDO
PEG
NA
CL",ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mhm,Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 240 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7zv5,Crystal structure of SARS Cov-2 main protease in complex with an inhibitor 4,3C-like proteinase nsp5,1,A,306,Yes,DMS,PRD_002413,inhibitor TRIP5,Peptide-like,?,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8eir,SARS-CoV-2 polyprotein substrate regulates the stepwise Mpro cleavage reaction,"3C-like proteinase nsp5
nsp7-nsp10 of Replicase polyprotein 1a",4,"A,B,C,D","306, 533",No,,,,,,,,6LU7_1|Chain,"1
165","C145A
A7V, F8E, P9S, G11S, V13L, E14W, G15A, C16Q, M17C, V20L, T21A, C22K, G23D, T26L, N28S, G29V, D33S, D34M, V35Q, V36G, Y37A, C38V, P39D, R40I, H41N, V42K, I43L, D48E, P52D, Y54R, E55A, D56T, L58Q, I59A, R60I, K61A, N63E, H64F, N65S, F66S, V68A, A70E, G71A, N72Y, V73E, L75A, R76V, V77A, I78N, H80D, N84E, C85V, T93A, N95L, P96E, P99Q, K100M, F103Q, V104A, I106T, Q107S, P108A, G109M, S113T, V114M, Y118L, G120I, S121I, S123L, G124T, V125T, Y126A, Q127A, C128K, A129L, R131I, I136Y, F140A, N142W, G143E, S144I, C145Q, G146Q, S147V, Y154A, C156I, F159E, C160I, Y161S, H163N, H164S, M165P, E166N, T169L, G170I, H172T, G174A, T175V, D176K, E178Q, G179N, F181E, Y182L, G183S, F185V, V186A, D187L, T190M, A191S, Q192C, D197Q, T199A, I200C, V202D, V204A, A210Y, A211N, V212T, I213T, N214K, D216G, W218F, F219V, N221A, T226E, N228C, D229R, A234K, M235V, N238L, E240N, P241N, T243N, Q244R, D245G, H246M, P252S, S254A, T257A, I259N, D263S, M264F, S267A, L268Y, E270D, L271Y, Q273A, N274S, N277T, R279Q, T280A, L282F, S284G, E288N, E290G, P293L, F294K, D295N, V296T, R298Y, Q299G, G302E, V303P, T304M, F305L","99.67
21.88","0
267"
8wsi,"Crystal structure of SARS-Cov-2 main protease, pH=6.0",3C-like proteinase nsp5,2,"A,B",298,No,,,,,,,,6LU7_1|Chain,0,,97.39,8
7m01,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 14c,3C-like proteinase,2,"A,B",309,Yes,,"YKV
YKS","(1S,2S)-2-((S)-2-((((S)-1-(4,4-difluorocyclohexyl)-2-phenylethoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-((((S)-1-(4,4-difluorocyclohexyl)-2-phenylethoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7grf,Crystal structure of SARS-CoV-2 main protease in complex with cpd-2,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
NA",XWZ,5-bromopyridin-3-amine,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gng,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-705e09b8-1 (Mpro-P2607),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RXU,"2-[(3'S)-6-chloro-2'-oxo-1'-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-b5746674-38 (Mpro-x12350),3C-like proteinase,1,A,306,Yes,DMS,OUF,"N-[(furan-2-yl)methyl]-N'-(2-methyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-N-{3-[(propan-2-yl)oxy]propyl}urea",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7lku,1.65 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3b (deuterated analog of inhibitor 2a),3C-like proteinase,2,"A,B",309,Yes,,"Y4D
Y5S
Y8Y
Y91","(1R,2S)-2-((S)-2-(((((1R,3s,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1R,3s,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1R,2S)-2-((S)-2-(((((1R,3r,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1R,3r,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer
non-polymer
non-polymer","


","Yes
Yes
Yes
Yes","CYS145 A
CYS145 A
CYS145 B
CYS145 B",6LU7_1|Chain,0,,98.39,5
8igb,Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with GC376,3C-like proteinase nsp5,2,"A,B",299,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,97.71,7
7gj6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fce787c2-4 (Mpro-P0178),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QKI,"(2S)-2-(3,4-dichlorophenyl)-2-hydroxy-N-(isoquinolin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gnj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-976a33d5-1 (Mpro-P2724),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RZU,"1-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylcyclopropane-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tix,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor EB56,3C-like proteinase nsp5,1,A,306,Yes,MG,Q56,N~2~-{[(naphthalen-2-yl)methoxy]carbonyl}-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7nw2,Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-47,3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",USZ,~{N}-(4-~{tert}-butylphenyl)-~{N}-[(1~{R})-2-[2-(3-fluorophenyl)ethylamino]-2-oxidanylidene-1-pyridin-3-yl-ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7geh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-06d94977-2 (Mpro-x11432),3C-like proteinase,1,A,306,Yes,DMS,NKU,2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-methylacetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gh9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-362d364a-10 (Mpro-x2971),3C-like proteinase,1,A,306,Yes,DMS,Q45,2-[(2S)-2-{2-[(methanesulfonyl)amino]ethyl}piperidin-1-yl]-N-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rl4,PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-3 (Mpro-x3124),3C-like proteinase,1,A,306,Yes,DMS,VEV,N-(4-tert-butylphenyl)-N-[(1R)-2-(methylamino)-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7zv7,Crystal structure of SARS Cov-2 main protease in complex with an inhibitor 57,3C-like proteinase nsp5,1,A,306,Yes,DMS,PRD_002411,inhibitor 57,Peptide-like,Enzyme inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7l10,CRYSTAL STRUCTURE OF THE SARS-COV-2 (2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 4,3C-like proteinase,1,A,306,Yes,,XEY,"2-[3-(3,5-dichlorophenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rh5,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4439011520 (Mpro-x2694),3C-like proteinase,1,A,306,Yes,DMS,UHV,"N-(5-tert-butyl-1,2-oxazol-3-yl)-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6ynq,Structure of SARS-CoV-2 Main Protease bound to 2-Methyl-1-tetralone.,3C-like proteinase,1,A,306,Yes,"DMS
CL",P6N,"(2~{S})-2-methyl-3,4-dihydro-2~{H}-naphthalen-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gle,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5cd9ea36-13 (Mpro-P1889),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R8O,"(4S)-6-chloro-2-[2-(cyclopropylamino)-2-oxoethyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8uea,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 29,3C-like proteinase nsp5,1,A,306,Yes,"CL
EDO
NA",WDQ,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-1-(4-fluorophenyl)-4-oxo-4-{[3-(pyridin-3-yl)propyl]amino}butan-2-yl]-D-phenylalaninamide",non-polymer,,Yes,"CSO, 145-(WDQ, .)",6LU7_1|Chain,0,,100.00,0
7glw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-1cbc2fae-1 (Mpro-P2036),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RDK,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-methyl-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grn,Crystal structure of SARS-CoV-2 main protease in complex with cpd-10,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA",Y0W,2-[(3S)-pyrrolidin-3-yl]-5-(trifluoromethyl)-1H-benzimidazole,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8fiv,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor Jun10541R,3C-like proteinase nsp5,1,A,306,Yes,,Y0I,"(3Z)-N-([1,1'-biphenyl]-4-yl)-3-imino-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]propanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8gxg,The crystal structure of SARS-CoV-2 main protease in complex with 14a,3C-like proteinase nsp5,1,A,306,Yes,,06Q,"N-[(2S)-3-(4-fluorophenyl)-1-oxidanylidene-1-[[(2S,3S)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7rvz,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI26,3C-like proteinase,1,A,306,Yes,,7YW,O-tert-butyl-N-{[(3-chlorophenyl)methoxy]carbonyl}-L-threonyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
5rew,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102275,3C-like proteinase,1,A,306,Yes,DMS,T4M,N-[(1R)-1-(naphthalen-1-yl)ethyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7rc0,X-ray Structure of SARS-CoV-2 main protease covalently modified by compound GRL-091-20,3C-like proteinase,1,A,306,Yes,NA,4I9,5-chloro-4-methylpyridin-3-yl 1H-indole-4-carboxylate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7cwc,Ambient-Temperature Serial Femtosecond X-ray Crystal structure of SARS-CoV-2 Main Protease at 2.1 A Resolution (P212121),3C-like proteinase,2,"A,B",310,No,,,,,,,,6LU7_1|Chain,0,,98.71,4
8bfo,Structure of the apo form of Mpro from SARS-CoV-2,3C-like proteinase nsp5,1,A,305,No,,,,,,,,6LU7_1|Chain,0,,99.67,1
7gm4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-6f6ae286-5 (Mpro-P2080),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RGQ,"(4S)-6-chloro-N-(7-fluoroisoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ds2,Structure of SARS-CoV-2 Mpro in complex with the nsp13-nsp14 (C13) cut site sequence (form 2),3C-like proteinase nsp5,2,"A,B",306,No,"GOL
NA",,,,,,,6LU7_1|Chain,4,"S301N, G302V, V303A, F305L",98.69,0
7neo,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 15,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,U9H,"2-cyclobutyl-7-(5-fluoropyridin-3-yl)-5,7-diazaspiro[3.4]octane-6,8-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gj5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-5d232de5-5 (Mpro-P0171),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",PJX,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1-methyl-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gda,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-2eddb1ff-3 (Mpro-x10900),3C-like proteinase,1,A,306,Yes,DMS,MF0,(2R)-2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8tqj,MPI57 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,YHI,"benzyl (1R,2S,5S)-2-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7t46,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 8c,3C-like proteinase,2,"A,B",309,Yes,,"F8C
F5L","(1S,2S)-1-hydroxy-2-{[N-({[7-(2-methylpropanoyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-1-hydroxy-2-{[N-({[7-(2-methylpropanoyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
6xhm,"Covalent complex of SARS-CoV-2 main protease with N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",3C-like proteinase,2,"A,B",306,Yes,EDO,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7l5d,The crystal structure of SARS-CoV-2 Main Protease in complex with demethylated analog of masitinib,3C-like proteinase,1,A,306,Yes,"DMS
GOL",XNJ,"N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(piperazin-1-yl)methyl]benzamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gbl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-MED-2de63afb-1 (Mpro-x10371),3C-like proteinase,1,A,306,Yes,DMS,KWR,N-(3-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gff,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-5d20d11c-1 (Mpro-x11708),3C-like proteinase,1,A,306,Yes,DMS,O9X,(2R)-2-(difluoromethoxy)-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8c9l,"Crystal structure of SARS-CoV-2 Mpro-S144A mutant, free enzyme",3C-like proteinase nsp5,1,A,302,No,,,,,,,,6LU7_1|Chain,1,S144A,98.37,4
7gnt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-50a80394-2 (Mpro-P3054),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S7C,"1-{[(3'S,4'R)-6-chloro-4'-ethyl-1'-(isoquinolin-4-yl)-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidine]-2(3H)-sulfonyl]methyl}cyclopropane-1-carbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6w63,Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77,3C-like proteinase,1,A,306,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9avq,Crystal structure of SARS-CoV-2 main protease A191T mutant in complex with an inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,PEG,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,A191T,99.67,0
7gik,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-1f3f1a6f-1 (Mpro-P0098),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QGX,"(2R)-2-amino-2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7xar,Crystal structure of 3C-like protease from SARS-CoV-2 in complex with covalent inhibitor,3C-like proteinase,2,"A,B",306,Yes,"NI
CL",BOV,4-fluoranyl-~{N}-[(2~{S})-1-[2-(2-fluoranylethanoyl)-2-[[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]methyl]hydrazinyl]-4-methyl-1-oxidanylidene-pentan-2-yl]-1~{H}-indole-2-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ws3,"Crystal structure of SARS-CoV-2 Main Protease (Mpro) with covalent inhibitor 5,8-Dihydroxy-1,4-naphthoquinone",3C-like proteinase nsp5,2,"A,B",306,Yes,"PEG
DMS",X7F,"5,8-bis(oxidanyl)naphthalene-1,4-dione",non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
7ghj,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with SIM-SYN-f15aaa3a-1 (Mpro-x3348),3C-like proteinase,1,A,306,Yes,DMS,Q7R,1-[4-(diphenylmethyl)piperazin-1-yl]ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7b3e,Crystal structure of myricetin covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2,Main Protease,2,"A,B",306,Yes,"EDO
CL
NA",MYC,"3,5,7-TRIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gg1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-a0b0dbcb-9 (Mpro-x12064),3C-like proteinase,1,A,306,Yes,DMS,OGO,4-[3-(2-methoxyphenoxy)azetidine-1-carbonyl]quinolin-2(1H)-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gc0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-21 (Mpro-x10476),3C-like proteinase,1,A,306,Yes,DMS,L4N,(5R)-N-(4-methylpyridin-3-yl)spiro[2.4]heptane-5-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghs,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-d6de1f3c-2 (Mpro-P0018),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OVX,1-(3-chlorophenyl)-4-(isoquinoline-4-carbonyl)piperazin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6wtk,Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication,3C-like proteinase,1,A,306,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ghy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BEN-DND-c852c98b-10 (Mpro-P0031),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",P9O,"(4R)-6-chloro-N-(5,6,7,8-tetrahydro-2,6-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6m2q,SARS-CoV-2 3CL protease (3CL pro) apo structure (space group C21),3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gf1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-95b75b4d-5 (Mpro-x11543),3C-like proteinase,1,A,306,Yes,DMS,O0R,2-(3-chlorophenyl)-N-(4-cyclopropylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7s72,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI36,3C-like proteinase,1,A,306,Yes,,8I0,"(1R,2S,5S)-N-{(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7tbt,Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 13/14,3C-like proteinase,1,A,306,Yes,,NVATLQAENV,Nonstructural protein 13/14,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7gnc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-8bb691af-8 (Mpro-P2487),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RW9,"2-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jr4,SARS-CoV-2 3CL protease with alternative conformation of the active site promoted by methylene-bridged cysteine and lysine residues,3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
7gj2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-70ae9412-1 (Mpro-P0154),3C-like proteinase,2,"A,B",306,Yes,DMS,QK3,"(4R)-6-chloro-4-{[2-(1H-imidazol-1-yl)acetamido]methyl}-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gd2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-3 (Mpro-x10862),3C-like proteinase,1,A,306,Yes,DMS,M26,"N-[(1R)-1-(3-bromophenyl)-2-methoxyethyl]-2-[(3S)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7l13,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 21,3C-like proteinase,2,"A,B",306,Yes,,XF7,"(5S)-5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2H-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(3H,5H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mb6,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp6/7 (P6-P1),3C-like proteinase,2,"A,B",306,Yes,,KVATVQ,LYS-VAL-ALA-THR-VAL-GLN,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
7t44,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 4c,3C-like proteinase,2,"A,B",309,Yes,PG4,"ESS
ET6","(1R,2S)-2-[(N-{[(2-azaspiro[3.3]heptan-6-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-1-hydroxy-2-{[N-({[2-(methanesulfonyl)-2-azaspiro[3.3]heptan-6-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7ghz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-91acba05-6 (Mpro-P0033),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",PJX,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1-methyl-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf4,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1741982125,3C-like proteinase,1,A,306,Yes,DMS,T5Y,pyridin-2-ol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gk3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fb82b63d-3 (Mpro-P0776),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QT3,"(1R)-7-chloro-N-(isoquinolin-4-yl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8rjz,Crystal structure of SARS-CoV-2 main protease (MPro) in complex with the non-covalent inhibitor GUE-3801 (compound 80 in publication),3C-like proteinase nsp5,2,"A,B",306,Yes,CL,"A1H1I
B3P","(7~{S})-6-[2-[2,4-bis(chloranyl)phenoxy]ethanoyl]-14-fluoranyl-10-(iminomethyl)-9-methyl-7-(phenylmethyl)-2-oxa-6,9,10-triazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-8-one
2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7ge3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-714a760b-3 (Mpro-x11317),3C-like proteinase,1,A,306,Yes,DMS,N5L,N-(5-amino-4-methylpyridin-3-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dkz,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,L50F,99.67,0
8h3l,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (T21I and E166V) in Complex with Inhibitor Enstrelvir,3C-like proteinase nsp5,4,"A,B,C,D",306,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,2,"T21I, E166V",99.35,0
7gb2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MED-COV-4280ac29-25 (Mpro-x10155),3C-like proteinase,1,A,306,Yes,DMS,KMX,"1-{4-[(2-benzyl-1,3-thiazol-5-yl)methyl]piperazin-1-yl}ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9at3,Crystal structure of SARS-CoV-2 3CL protease in complex with an ethylcyclohexyl 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,CA,"A1AGK
A1AGL","(1R,2S)-2-{[N-({[(2S)-1-(2-cyclohexylethyl)-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-{[N-({[(2S)-1-(2-cyclohexylethyl)-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
7n89,Room-temperature X-ray structure of SARS-CoV-2 main protease C145A mutant in complex with substrate Ac-SAVLQSGF-CONH2,3C-like proteinase,2,"A,B",306,Yes,,(ACE)SAVLQSGF(NH2),ACE-SER-ALA-VAL-LEU-GLN-SER-GLY-PHE-NH2,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
8drt,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp6-nsp7 (C6) cut site sequence (form 2),3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,5,"C145A, S301K, G302V, V303A, F305V",98.37,0
7giv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-de59a476-2 (Mpro-P0135),3C-like proteinase,2,"A,B",306,Yes,DMS,QJ6,"(2R)-2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)-2-methoxyacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7joy,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with its C-terminal autoprocessing sequence.,3C-like proteinase,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,C145A,99.67,0
8ue0,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 47,3C-like proteinase nsp5,1,A,306,Yes,"NA
CL",WDF,"2,4-dichloro-Nalpha-[(2R)-2-chloro-3-(2-cyanophenyl)propanoyl]-N-[(2S)-4-{[4-(dimethylamino)butyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7nij,SARS-CoV-2 main protease (Mpro) in a novel conformational state.,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
8ezv,SARS-CoV-2 Main Protease (Mpro) in Complex with ML2006a,3C-like proteinase nsp5,1,A,306,Yes,,X6O,"(1R,2S,5S)-N-{(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gma,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-7174c657-5 (Mpro-P2141),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R2X,"(2S,5R)-N-{(1R)-1-(3-chlorophenyl)-2-[(isoquinolin-4-yl)amino]-2-oxoethyl}-5-(pyrrolidine-1-carbonyl)oxolane-2-carboxamide (non-preferred name)",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7whc,Crystal structure of SARS-CoV-2 3CLpro catalytic domain,3C-like proteinase nsp5,4,"A,B,C,D",196,No,,,,,,,,6LU7_1|Chain,0,,64.05,110
7rfw,Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor,3C-like proteinase,1,A,307,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7gli,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-af1eef35-2 (Mpro-P1982),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R9I,"methyl N-[(4S)-6-chloro-4-[(isoquinolin-4-yl)carbamoyl]-3,4-dihydroisoquinoline-2(1H)-sulfonyl]-N-methylglycinate",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gex,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-66895286-1 (Mpro-x11532),3C-like proteinase,1,A,306,Yes,DMS,NX9,2-(3-chlorophenyl)-N-(1H-pyrazol-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-714a760b-16 (Mpro-x11044),3C-like proteinase,1,A,306,Yes,DMS,MQ3,(2R)-2-cyclohexyl-N-(4-methylpyridin-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gne,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIK-ENA-5d9157e9-6 (Mpro-P2605),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RWO,"(4R)-6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8xwt,Crystal structure of SARS-CoV-2 3CLpro-L50F mutant with its peptidyl substrate,3C-like proteinase nsp5,1,A,306,Yes,,CSGVTFQSAVKRTI,CYS-SER-GLY-VAL-THR-PHE-GLN-SER-ALA-VAL-LYS-ARG-THR-ILE,polypeptide(L),,No,,6LU7_1|Chain,2,"L50F, C145A",99.35,0
8udo,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 15,3C-like proteinase nsp5,1,A,306,Yes,,WBK,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-{[5-(dimethylamino)pentyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rey,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102911,3C-like proteinase,1,A,306,Yes,DMS,T4Y,"1-{4-[(2-methylphenyl)methyl]-1,4-diazepan-1-yl}ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rl5,PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-30 (Mpro-x3359),3C-like proteinase,1,A,306,Yes,DMS,VEY,N-(4-tert-butylphenyl)-N-[(1R)-2-(ethylamino)-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tdu,Joint X-ray/neutron structure of SARS-CoV-2 main protease (3CL Mpro) in complex with BBH-1,3C-like proteinase,1,A,306,Yes,,I1W,"(1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxo(1-~2~H)pyrrolidin-3-yl]propan-2-yl}-3-{N-[tert-butyl(~2~H)carbamoyl]-3-methyl-L-(N-~2~H)valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-(~2~H)carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7rvq,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI16,3C-like proteinase,1,A,306,Yes,,7VW,N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
6xr3,X-ray Structure of SARS-CoV-2 main protease bound to GRL-024-20 at 1.45 A,3C-like proteinase,1,A,306,Yes,,V7G,"N-[(2S)-1-({(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8cz7,Crystal structure of SARS-CoV-2 Mpro with compound C2,3C-like proteinase,4,"A,B,C,D",306,Yes,,P7L,N-[(4-chlorothiophen-2-yl)methyl]-2-(isoquinolin-4-yl)-N-(4-methoxyphenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7k3t,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) at 1.2 A Resolution and a Possible Capture of Zinc Binding Intermediate,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
6lu7,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,3C-like proteinase,1,A,306,Yes,,PRD_002214,"N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE",Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gcm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-THE-c331be7a-2 (Mpro-x10678),3C-like proteinase,1,A,306,Yes,DMS,LQU,"3-[(4R)-2-acetyl-1,2,3,4-tetrahydroisoquinolin-4-yl]benzonitrile",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gfg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with CHO-MSK-6e55470f-5 (Mpro-x11723),3C-like proteinase,1,A,306,Yes,DMS,OAO,"2-{3-chloro-5-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl}-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7giy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BRU-CON-c4e3408a-1 (Mpro-P0145),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OI4,"(4R)-6-chloro-N-(4-methylpyridin-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-3c65e9ce-2 (Mpro-x12719),3C-like proteinase,1,A,306,Yes,DMS,PVR,2-(4-acetylpiperazin-1-yl)-N-(4-cyclopropylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gil,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-6 (Mpro-P0108),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QH6,2-(3-chloro-4-fluorophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8r12,Structure of compound 8 bound to SARS-CoV-2 main protease,3C-like proteinase,2,"A,B",306,Yes,"CL
DMS
NA",XH9,"2-[[4-(5-chloranylpyridin-3-yl)carbonyl-1,4-diazepan-1-yl]methyl]benzenecarbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gi9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-26 (Mpro-P0061),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QDU,"2-(2,5-difluorophenyl)-N-(isoquinolin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dry,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp12-nsp13 (C12) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp12-nsp13 (C12) cut site,12,"A,B,C,D,E,F,G,H,I,J,K,L",306,No,PEG,,,,,,,6LU7_1|Chain,6,"C145A, S301P, G302H, V303T, T304V, F305L",98.04,0
7gdf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAG-UCB-a3ef7265-23 (Mpro-x10995),3C-like proteinase,1,A,306,Yes,DMS,M6U,N-(4-ethylpyridin-3-yl)-2-[6-(trifluoromethyl)pyridin-2-yl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gb5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-0da5ad92-2 (Mpro-x10201),3C-like proteinase,1,A,306,Yes,DMS,KOI,2-(3-chlorophenyl)-N-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8h5f,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) L167F Mutant in Complex with Inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,L167F,99.67,0
7gh2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-090737b9-1 (Mpro-x12735),3C-like proteinase,1,A,306,Yes,DMS,Q0I,"(4R)-6-chloro-N-(isoquinolin-4-yl)-N-propanoyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7t49,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 10c,3C-like proteinase,2,"A,B",309,Yes,,"FV5
FVE","(1R,2S)-1-hydroxy-2-{[N-({[7-(methanesulfonyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-1-hydroxy-2-{[N-({[7-(methanesulfonyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gb7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JOR-UNI-2fc98d0b-6 (Mpro-x10237),3C-like proteinase,1,A,306,Yes,DMS,KQ3,N-(3-chlorophenyl)-N-[2-(morpholin-4-yl)ethyl]-N'-(pyridin-3-yl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gek,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-8df914d1-4 (Mpro-x11473),3C-like proteinase,1,A,306,Yes,DMS,NOI,2-(3-chlorophenyl)-N-(1-methyl-1H-imidazol-5-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7giu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-05e671eb-10 (Mpro-P0130),3C-like proteinase,2,"A,B",306,Yes,DMS,QIZ,"(4R)-6-chloro-7-fluoro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gci,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-27 (Mpro-x10610),3C-like proteinase,1,A,306,Yes,DMS,LJO,(3R)-3-cyano-N-(4-methylpyridin-3-yl)oxolane-3-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mhg,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) at 240 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
8p87,"Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 5 mM X77, from an ""old"" crystal.",3C-like proteinase nsp5,2,"A,B",306,Yes,"ACT
EDO
CL
NA",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7bro,Crystal structure of the 2019-nCoV main protease,3C-like proteinase,1,A,307,No,,,,,,,,6LU7_1|Chain,0,,99.67,1
7gl6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-8695a11f-1 (Mpro-P1701),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R66,(3R)-3-(3-chlorophenyl)-3-hydroxy-1-(isoquinolin-4-yl)pyrrolidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gk5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-5d232de5-7 (Mpro-P0793),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QC3,(3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)pyrrolidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7bak,Crystal structure of SARS-CoV-2 main protease treated with ebselen,Main Protease,1,A,306,No,SE,,,,,,,6LU7_1|Chain,0,,100.00,0
7tq4,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 6c,3C-like proteinase,1,A,309,Yes,,IRZ,"N~2~-({[(1R,2R)-2-(3-chlorophenyl)cyclopropyl]methoxy}carbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
7gc5,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with DUN-NEW-f8ce3686-24 (Mpro-x10506),3C-like proteinase,1,A,306,Yes,DMS,L8F,N-(2-{7-[(4-acetylpiperazin-1-yl)methyl]-1H-indol-3-yl}ethyl)acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7get,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-0c2c77e1-1 (Mpro-x11507),3C-like proteinase,1,A,306,Yes,DMS,NV9,2-(3-chlorophenyl)-N-(4-phenylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gs1,Crystal structure of SARS-CoV-2 main protease in complex with cpd-24,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
CL
NA",GT7,2-cyano-~{N}-cyclohexyl-ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7glt,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-12 (Mpro-P2017),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RC9,"(4S)-6-chloro-2-[(1-cyanocyclobutyl)methanesulfonyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-2f867453-1 (Mpro-P0878),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QWU,"(3S)-5-chloro-N-(isoquinolin-4-yl)-3-methyl-2,3-dihydro-1H-indole-3-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gds,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with LOR-NOR-30067bb9-18 (Mpro-x11212),3C-like proteinase,1,A,306,Yes,DMS,MZF,"(3R)-5-bromo-3-hydroxy-1-[(1,2,4-oxadiazol-3-yl)methyl]-1,3-dihydro-2H-indol-2-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8u9u,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI98,3C-like proteinase nsp5,1,A,306,Yes,,W0W,"(1R,2S,5S)-3-[bis(4-chlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbh,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-49816e9b-2 (Mpro-x10334),3C-like proteinase,1,A,306,Yes,DMS,KVO,"2-(3-chlorophenyl)-N-(2,4-dimethylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ig8,Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with GC376,3C-like proteinase nsp5,2,"A,B",303,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S46F,98.69,3
7glk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-76744c27-4 (Mpro-P1986),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R9Z,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(1-methoxycyclopropyl)methanesulfonyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvv,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI22,3C-like proteinase,1,A,306,Yes,,7Y2,N-[(benzyloxy)carbonyl]-2-methyl-L-alanyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7lkw,1.65 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3d (deuterated analog of inhibitor 3c),3C-like proteinase,2,"A,B",309,Yes,"CL
PO4","Y8S
Y8V","(1R,2S)-2-((S)-2-(((((1R,3S,5S)-bicyclo[3.3.1]non-6-en-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-(((((1R,3S,5S)-bicyclo[3.3.1]non-6-en-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8u9k,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI94,3C-like proteinase nsp5,1,A,306,Yes,,W0B,"diphenylmethyl (1R,2S,5R)-2-({(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8u9n,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI64,3C-like proteinase nsp5,1,A,306,Yes,,W0L,"(1R,2S,5S)-3-[bis(4-chlorophenyl)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfm,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102539,3C-like proteinase,1,A,306,Yes,DMS,T7J,"N-[(3R)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-(4-methylphenyl)acetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rfi,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102353,3C-like proteinase,1,A,306,Yes,DMS,T71,"1-{4-[(2,5-dimethylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mgs,SARS-CoV-2 main protease in complex with N-terminal autoprocessing substrate,3C-like proteinase,1,A,306,Yes,CL,SAVLQSGFR,SER-ALA-VAL-LEU-GLN-SER-GLY-PHE,polypeptide(L),,No,,6LU7_1|Chain,1,C145A,99.67,0
9at4,Crystal structure of SARS-CoV-2 3CL protease in complex with a methylbicyclo[2.2.1]heptane 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,"A1AGN
A1AGM","(1S,2S)-2-{[N-({[(2S)-1-{[(1S,2S,4R)-bicyclo[2.2.1]heptan-2-yl]methyl}-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-{[N-({[(2S)-1-{[(1S,2S,4R)-bicyclo[2.2.1]heptan-2-yl]methyl}-5-oxopyrrolidin-2-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
9asy,Crystal structure of SARS-CoV-2 3CL protease in complex with a m-chlorobenzyl 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,"PG4
PO4","A1AGI
A1AGJ","(1R,2S)-2-({N-[({(2S)-1-[(3-chlorophenyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-({N-[({(2S)-1-[(3-chlorophenyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
7l0d,SARS-CoV-2 Main Protease (Mpro) in Complex with ML188,3C-like proteinase,1,A,306,Yes,,0EN,N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(4-tert-butylphenyl)furan-2-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ADA-UCB-6c2cb422-1 (Mpro-x10959),3C-like proteinase,1,A,306,Yes,DMS,860,2-(3-chlorophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gni,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-b1ef7fe3-1 (Mpro-P2660),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RZF,"2-[(3'S)-6-chloro-1'-(6-chloroisoquinolin-4-yl)-1,2'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gl9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UCB-50c39ae8-2 (Mpro-P1800),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QM3,"(1'P,3'S)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,3'-pyrrolidine]-2',5'-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with WAR-XCH-72a8c209-5 (Mpro-x10728),3C-like proteinase,1,A,306,Yes,DMS,LRN,"1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tq5,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 10d,3C-like proteinase,2,"A,B",309,Yes,"CL
PG4","IRW
ITX","(1S,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
6xb0,Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is highly reactive: Insights for enzyme mechanism and drug design,3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
7xb4,Crystal structure of SARS-Cov-2 main protease D48N mutant in complex with PF07321332,Replicase polyprotein 1a,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 145-(4WI, .)",6LU7_1|Chain,1,D48N,99.67,0
5ren,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102425,3C-like proteinase,1,A,306,Yes,DMS,T2V,"1-[(3R)-3-(1,3-benzothiazol-2-yl)piperidin-1-yl]ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8bgd,Structure of Mpro from SARS-CoV-2 in complex with FGA147,3C-like proteinase nsp5,1,A,306,Yes,,QH0,(phenylmethyl) N-[(2S)-4-methyl-1-[[(2S)-4-nitro-1-[(3R)-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-1-oxidanylidene-pentan-2-yl]carbamate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mav,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor dFFCit-yne,3C-like proteinase,2,"A,B",306,Yes,,YVY,N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-(carbamoylamino)-2-oxohexan-3-yl]-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8udw,Crystal structure of SARS-CoV-2 3CL protease with inhibitor 2,3C-like proteinase nsp5,1,A,306,Yes,,WDK,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-{[3-(dimethylamino)propyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gn3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-7fb4f80a-1 (Mpro-P2284),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RSL,4-[2-(3-chlorophenyl)acetamido]isoquinolin-7-yl methanesulfonate,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gls,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bfb445d4-2 (Mpro-P2011),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",OE6,N-(1H-benzotriazol-1-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gn1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-8bb691af-6 (Mpro-P2263),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RRU,"1-{[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-1H-spiro[isoquinoline-4,3'-pyrrolidine]-2(3H)-sulfonyl]methyl}cyclopropane-1-carbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6wtt,Crystals Structure of the SARS-CoV-2 (COVID-19) main protease with inhibitor GC-376,3C-like proteinase,3,"A,B,C",310,Yes,"PEG
GOL
CL
MG","K36
B1S","(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","peptide-like
peptide-like","
","Yes
Yes","CYS145 A
CYS145 C",6LU7_1|Chain,2,"F305H, Q306H",98.06,4
9bo4,Crystal Structure of T21I SARS-CoV-2 Main Protease in Complex with Nirmatrelvir,3C-like proteinase,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,T21I,99.67,0
5rgz,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1343543528 (Mpro-x2600),3C-like proteinase,1,A,306,Yes,DMS,UH1,2-(3-cyanophenyl)-N-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dfn,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H164N Mutant,3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,1,H164N,99.67,0
8dcz,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) M165Y Mutant in Complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,M165Y,99.67,0
5rhe,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PG-COV-42 (Mpro-x2052),3C-like proteinase,1,A,306,Yes,DMS,UPD,1-acetyl-N-(6-methoxypyridin-3-yl)piperidine-4-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8p5c,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 obtained in presence of 5 millimolar X77 enantiomer S.,3C-like proteinase nsp5,2,"A,B",306,Yes,"EDO
ACT
DMS
CL
NA",9M5,~{N}-(4-~{tert}-butylphenyl)-~{N}-[(1~{S})-2-(cyclohexylamino)-2-oxidanylidene-1-pyridin-3-yl-ethyl]-1~{H}-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gji,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-d08626de-3 (Mpro-P0243),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QO0,"(4S)-6,7-dichloro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jq0,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI3,3C-like proteinase,1,A,306,Yes,,VHV,N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7s75,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI42,3C-like proteinase,1,A,306,Yes,,8I7,"(1R,2S,5S)-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(3-methylbutanoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7wqa,SARS-CoV-2 main protease in complex with Z-VAD-FMK,3C-like proteinase,1,A,307,Yes,,PRD_002352,Z-VAD(OMe)-FMK,Peptide-like,Inhibitor,No,,6LU7_1|Chain,0,,99.67,1
7lke,X-ray crystal structure of the SARS-CoV-2 main protease in space group C2,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7m00,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 13c,3C-like proteinase,2,"A,B",309,Yes,,"YKA
YKD","(1R,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8gqt,Structure of Mpro complexed with Quercetin,3C-like proteinase nsp5,1,A,303,Yes,,QUE,"3,5,7,3',4'-PENTAHYDROXYFLAVONE",non-polymer,,No,,6LU7_1|Chain,0,,99.02,3
7xq7,The complex structure of WT-Mpro,3C-like proteinase nsp5,1,A,307,No,NA,,,,,,,6LU7_1|Chain,0,,99.67,1
7ak4,Structure of SARS-CoV-2 Main Protease bound to Tretazicar.,3C-like proteinase,1,A,306,Yes,"DMS
CL",CB1,"5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE",non-polymer,,Yes,MET165 A,6LU7_1|Chain,0,,100.00,0
7gfa,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-3b92565d-1 (Mpro-x11609),3C-like proteinase,1,A,306,Yes,DMS,Z26,2-(5-chloro-2-methoxyphenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-1901c25b-1 (Mpro-x11790),3C-like proteinase,1,A,306,Yes,DMS,OEO,N-[4-(dimethylamino)phenyl]-2-(isoquinolin-4-yl)-N-[(thiophen-3-yl)methyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-afb6844f-1 (Mpro-P1474),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R2L,"(4R)-6-chloro-N-[4-methyl-5-(methylamino)pyridin-3-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6wtj,Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication,3C-like proteinase,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ggg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ERI-UCB-d6de1f3c-2 (Mpro-x12582),3C-like proteinase,1,A,306,Yes,DMS,OVX,1-(3-chlorophenyl)-4-(isoquinoline-4-carbonyl)piperazin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7aqe,Structure of SARS-CoV-2 Main Protease bound to UNC-2327,3C-like proteinase,1,A,306,Yes,"CL
DMS",RV5,"N-1,2,3-Benzothiadiazol-6-yl-N'-[2-oxo-2-(1-piperidinyl)ethyl]urea also called unc-2327",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgv,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4444622066 (Mpro-x2563),3C-like proteinase,1,A,306,Yes,DMS,UGG,2-(isoquinolin-4-yl)-N-phenylacetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7tob,Crystal structure of the SARS-CoV-2 Omicron main protease (Mpro) in complex with inhibitor GC376,3C-like proteinase nsp5,1,A,306,Yes,PEG,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
9bo6,Crystal Structure of A173V/L50F SARS-CoV-2 Main Protease in Complex with Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,2,"L50F, A173V",99.35,0
7l11,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 5,3C-like proteinase,2,"A,B",306,Yes,,XF1,"2-[3-(3-chloro-5-propoxyphenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9bnz,Crystal Structure of E166V SARS-CoV-2 Main Protease,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,E166V,99.67,0
7aqj,Structure of SARS-CoV-2 Main Protease bound to Triglycidyl isocyanurate.,3C-like proteinase,1,A,306,Yes,,"S7H
RV8","1-[(2~{R})-2-oxidanylpropyl]-3-[[(2~{R})-oxiran-2-yl]methyl]-5-[[(2~{S})-oxiran-2-yl]methyl]-1,3,5-triazinane-2,4,6-trione
Triglycidyl isocyanurate","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7ar6,"Structure of apo SARS-CoV-2 Main Protease with large beta angle, space group C2.",3C-like proteinase,1,A,306,No,"CL
DMS",,,,,,,6LU7_1|Chain,0,,100.00,0
7gkx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-28 (Mpro-P1202),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R1I,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-(2-methoxyethyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ge4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with TRY-UNI-714a760b-19 (Mpro-x11318),3C-like proteinase,1,A,306,Yes,DMS,N6X,N-(5-amino-4-methylpyridin-3-yl)-2-(3-cyanophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ej9,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,E47N,99.67,0
7gdw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BRU-THA-a358fbdd-2 (Mpro-x11233),3C-like proteinase,1,A,306,Yes,DMS,N0X,"(4R)-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-4-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ty4,MI-30 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,SO0,"(1S,3aR,6aS)-2-[(2,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}octahydrocyclopenta[c]pyrrole-1-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gnu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-133e7cd9-2 (Mpro-P3074),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S7U,"1-{[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-1H-spiro[isoquinoline-4,3'-piperidine]-2(3H)-sulfonyl]methyl}cyclopropane-1-carbonitrile",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8j37,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,K90R,97.39,7
5rgw,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4444621910 (Mpro-x2569),3C-like proteinase,1,A,306,Yes,DMS,UGM,2-(5-cyanopyridin-3-yl)-N-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5r84,PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z31792168,3C-like proteinase,1,A,306,Yes,DMS,GWS,2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vth,The crystal structure of SARS-CoV-2 3CL protease in complex with compound 1,3C-like proteinase,2,"A,B",311,Yes,,7XB,"2-[4-[[4-[bis(fluoranyl)methoxy]-2-methyl-phenyl]amino]-2,6-bis(oxidanylidene)-3-[[3,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazin-1-yl]-N-methyl-ethanamide",non-polymer,,No,,6LU7_1|Chain,0,,98.39,5
7gk9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-477dc5b7-5 (Mpro-P0811),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QV0,"(3'R)-6-chloro-1'-(isoquinolin-4-yl)-2,3-dihydrospiro[[1]benzopyran-4,3'-piperidin]-2'-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ya5,Mpro from SARS-CoV-2,3C-like proteinase,1,A,301,No,,,,,,,,6LU7_1|Chain,0,,98.37,5
7gc1,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-590ac91e-25 (Mpro-x10478),3C-like proteinase,1,A,306,Yes,DMS,L7F,"2-[(1S,5R)-bicyclo[3.1.0]hexan-1-yl]-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8k6a,Crystal structure of SARS-CoV-2 3CLpro S301P mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,S301P,99.67,0
7lzw,Structure of SARS-CoV-2 3CL protease in complex with inhibitor 20b (deuterated analog of 19b),3C-like proteinase,2,"A,B",309,Yes,,"YLM
YLS","(1R,2S)-2-((S)-2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid
(1S,2S)-2-((S)-2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7baj,Crystal structure of ligand-free SARS-CoV-2 main protease,Main Protease,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7s3k,Room temperature X-ray structure of SARS-CoV-2 main protease in complex with compound Z1530718726,3C-like proteinase,1,A,306,Yes,,Z26,2-(5-chloro-2-methoxyphenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gm0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-bfd29aac-1 (Mpro-P2070),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RFF,"(4S)-6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-(1-methyl-1H-pyrazolo[4,3-c]pyridin-7-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hbk,The crystal structure of SARS-CoV-2 3CL protease in complex with Ensitrelvir,3C-like proteinase nsp5,1,A,306,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgk,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1310876699 (Mpro-x0426),3C-like proteinase,1,A,306,Yes,DMS,U0V,2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hvz,Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with PF07304814,3C-like proteinase nsp5,2,"A,B",299,Yes,,80I,"[(3~{S})-3-[[(2~{S})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonylamino]-4-methyl-pentanoyl]amino]-2-oxidanylidene-4-[(3~{R})-2-oxidanylidene-3,4-dihydropyrrol-3-yl]butyl] dihydrogen phosphate",non-polymer,,Yes,"CYS, 143-(80I, .)",6LU7_1|Chain,1,V186F,97.39,7
7gg2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-8a69d52e-7 (Mpro-x12073),3C-like proteinase,1,A,306,Yes,DMS,OO6,"(3S,4R)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ifq,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 2,3C-like proteinase nsp5,1,A,306,Yes,,I1Z,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 145-(I1Z, .)",6LU7_1|Chain,0,,100.00,0
8h4y,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) F140L Mutant in Complex with Inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,F140L,99.67,0
7p2g,Identification of low micromolar SARS-CoV-2 Mpro inhibitors from hits identified by in silico screens,3C-like proteinase,1,A,306,Yes,,4N0,"(4~{R})-~{N}-(4-iodophenyl)-2-oxidanylidene-3,4-dihydro-1~{H}-quinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gio,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fce787c2-3 (Mpro-P0121),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QI4,"(2S)-2-(3,4-dichlorophenyl)-N-(isoquinolin-4-yl)propanamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hzr,Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with PF07321332,3C-like proteinase nsp5,2,"A,B",296,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 143-(4WI, .)",6LU7_1|Chain,1,S46F,96.41,10
7wo3,SARS-CoV-2 3CLpro,3C-like proteinase,1,A,306,Yes,,59S,(2S)-2-[[(2S)-2-[[(E)-3-(4-methoxyphenyl)prop-2-enoyl]amino]-3-methyl-butanoyl]amino]-4-methyl-N-[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepiperidin-3-yl]propan-2-yl]pentanamide,peptide-like,,No,,6LU7_1|Chain,0,,100.00,0
7jfq,The crystal structure of 3CL MainPro of SARS-CoV-2 with de-oxidized C145,3C-like proteinase,1,A,306,No,"EDO
FMT",,,,,,,6LU7_1|Chain,0,,100.00,0
7glx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-2e8b2191-11 (Mpro-P2039),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RDQ,"(4S)-6-chloro-N-{6-[(methanesulfonyl)amino]isoquinolin-4-yl}-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9asw,Crystal structure of SARS-CoV-2 3CL protease in complex with a m-fluorobenzyl 2-pyrrolidone inhibitor,3C-like proteinase nsp5,2,"A,B",308,Yes,PG4,"A1AGB
A1AGA","(1R,2S)-2-({N-[({(2S)-1-[(3-fluorophenyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1S,2S)-2-({N-[({(2S)-1-[(3-fluorophenyl)methyl]-5-oxopyrrolidin-2-yl}methoxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.06,6
7gn0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-43f8f7d6-6 (Mpro-P2256),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RRD,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-{2-[(oxetan-3-yl)amino]-2-oxoethyl}-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5sml,PanDDA analysis group deposition of SARS-CoV-2 main protease ligands identified from single sequence-guideddeep generative framework -- Crystal structure of SARS-CoV-2 main protease in complex with Z68337194 (Mpro-IBM0045),3C-like proteinase,1,A,306,Yes,DMS,O3R,"6-{[(3,4-dichlorophenyl)methyl](methyl)amino}pyridine-3-sulfonamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgp,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102628 (Mpro-x0771),3C-like proteinase,1,A,306,Yes,DMS,U1M,"1-{4-[(2,4-dimethylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-fe871b40-11 (Mpro-P0626),3C-like proteinase,2,"A,B",306,Yes,DMS,QPQ,"(4S)-6-chloro-7-fluoro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hux,Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with S217622,3C-like proteinase nsp5,2,"A,B",299,Yes,,7YY,"6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione",non-polymer,,No,,7TOB_1|Chain,0,,97.71,7
5re4,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1129283193,3C-like proteinase,1,A,306,Yes,DMS,SZY,N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8jcj,The crystal structure of SARS-CoV-2 main protease in complex with Compound 18,3C-like proteinase nsp5,1,A,306,Yes,"H2S
DMS
GOL",PBP,p-Bromophenacyl bromide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rhf,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PG-COV-34 (Mpro-x2754),3C-like proteinase,1,A,306,Yes,DMS,UPJ,1-acetyl-N-methyl-N-phenylpiperidine-4-carboxamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7tq6,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 13d,3C-like proteinase,2,"A,B",309,Yes,PG4,"IT3
ITG","(1S,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2R)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid
(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2R)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7gka,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-5d232de5-8 (Mpro-P0816),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QV9,(3R)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)pyrrolidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e119ab4f-2 (Mpro-P2182),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RJO,"(4S)-6-chloro-N-(6-fluoroisoquinolin-4-yl)-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7bb2,Crystal structure of the main protease (3CLpro/Mpro) of SARS-CoV-2 at 1.6A resolution (spacegroup P2(1)2(1)2(1)),3C-like proteinase,2,"A,B",306,No,"EDO
CL
NA",,,,,,,6LU7_1|Chain,0,,100.00,0
8ykm,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with X77,3C-like proteinase nsp5,2,"A,B",298,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,1,G15S,97.06,8
9bo1,Crystal Structure of T190I SARS-CoV-2 Main Protease in Complex with Compound Mpro61,3C-like proteinase nsp5,2,"A,B",306,Yes,,XEK,"(5P)-5-[(1P,3M,3'P)-3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl]-1-methylpyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,1,T190I,99.67,0
7k6e,SARS-CoV-2 Main Protease Co-Crystal Structure with Telaprevir Determined from Crystals Grown with 40 nL Acoustically Ejected Mpro Droplets at 1.63 A Resolution (Direct Vitrification),3C-like proteinase,1,A,306,Yes,DMS,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8ift,SARS-CoV-2 3CL protease (3CLpro) in complex with compound 10,3C-like proteinase nsp5,1,A,306,Yes,,OZB,"(8S)-N-[(1S)-1-cyano-2-[(3S)-2-oxidanylidenepyrrolidin-3-yl]ethyl]-7-[(2S)-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxamide",non-polymer,,Yes,"CYS, 145-(OZB, .)",6LU7_1|Chain,0,,100.00,0
7cb7,1.7A resolution structure of SARS-CoV-2 main protease (Mpro) in complex with broad-spectrum coronavirus protease inhibitor GC376,3C-like proteinase,2,"A,B",311,Yes,NA,"K36
B1S","(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","peptide-like
peptide-like","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
7rvt,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI20,3C-like proteinase,2,"A,B",306,Yes,,7XK,N~2~-[(2S)-2-{[(benzyloxy)carbonyl]amino}-2-cyclopropylacetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7ggl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-ce760d3f-8 (Mpro-x12674),3C-like proteinase,1,A,306,Yes,DMS,OZC,(3S)-3-(4-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7dpu,SARS-CoV-2 3CL protease (3CLpro) in complex with 7-O-methyl-myricetin,3C-like proteinase,2,"A,B",306,Yes,GOL,HER,"7-methoxy-3,5-bis(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7o46,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 17,3C-like proteinase nsp5,1,A,306,Yes,,V18,"2-cyclobutyl-7-isoquinolin-4-yl-5,7-diazaspiro[3.4]octane-6,8-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvu,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI21,3C-like proteinase,1,A,306,Yes,,7XT,N-[(benzyloxy)carbonyl]-3-methyl-L-isovalyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
7tiu,Crystal structure of SARS-CoV-2 3CL in complex with inhibitor EB46,3C-like proteinase nsp5,1,A,306,Yes,"PO4
MG",V46,"(1S,2S)-2-[(N-{[(3-chlorophenyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8y7u,Crystal structure of SARS-CoV-2 main protease in complex with C5,3C-like proteinase nsp5,1,A,306,Yes,,A1LX2,"2-(3-fluoro-4-(trifluoromethyl)phenyl)-6-(iminomethyl)-4-(2-oxo-2-(pyridin-2-yl)ethyl)-1,2,4-triazine-3,5(2H,4H)-dione",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,100.00,0
7vfb,the complex of SARS-CoV2 3cl and NB2B4,"nb2b4
3C-like proteinase",2,"A,B","134, 306",No,,,,,,,,6LU7_1|Chain,"71
0","R4Q, K5V, M6Q, A7L, F8Q, P9E, C16G, M17S, C22A, V68S, Q69C, I78S, D92Y, A94Y, N95S, P96S, P99C, K100L, Y101G, K102W, I106Q, Q107A, Q110K, T111E, F112R, S113E, V114G, L115I, C117I, N119T, S121G, P122G, G124T, V125Y, Q127V, C128D, A129S, M130V, R131K, P132G, N133R, F140Q, L141D, G149A, F150K, E178Q, G179M, F181S, Y182L, G183K, T196E, W207M, L208Y, V212A, N214A, D216I, W218L, F219C, N221P, R222G, F223H, N238T, E240G, P241Q, L242G, S301H, G302H, V303H, T304H, F305H, Q306H
","18.65
100.00","182
0"
7gfs,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAR-UCB-f313ec4d-6 (Mpro-x11812),3C-like proteinase,1,A,306,Yes,DMS,OIK,(isoquinolin-4-yl)(4-phenylpiperazin-1-yl)methanone,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rfd,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z126932614,3C-like proteinase,1,A,306,Yes,DMS,T6J,2-[(methylsulfonyl)methyl]-1H-benzimidazole,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gg9,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ANT-DIA-62e4526e-1 (Mpro-x12204),3C-like proteinase,1,A,306,Yes,DMS,SQ2,"2-(1H-1,2,3-benzotriazol-1-yl)-1-(4-methylpiperidin-1-yl)ethan-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-9c80c481-1 (Mpro-P0845),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QVJ,"(4R)-6-chloro-N-(isoquinolin-4-yl)-4-{[2-(methylamino)-2-oxoethoxy]methyl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7woh,SARS-CoV-2 3CLpro,3C-like proteinase,2,"A,B",303,Yes,,5IW,(2S)-4-methyl-N-[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-2-[[(2S)-3-phenyl-2-[[(E)-3-phenylprop-2-enoyl]amino]propanoyl]amino]pentanamide,peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,99.02,3
7t2v,SARS CoV2 Mpro C145S mutant,3C-Like Protease,4,"A,B,C,D",319,No,,,,,,,,6LU7_1|Chain,1,C145S,95.61,13
7gl0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-a13804f0-4 (Mpro-P1477),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R2X,"(2S,5R)-N-{(1R)-1-(3-chlorophenyl)-2-[(isoquinolin-4-yl)amino]-2-oxoethyl}-5-(pyrrolidine-1-carbonyl)oxolane-2-carboxamide (non-preferred name)",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gm7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-a577c8a2-1 (Mpro-P2099),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RI1,"(4S)-6-chloro-N-(isoquinolin-4-yl)-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgq,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1849009686 (Mpro-x1086),3C-like proteinase,1,A,306,Yes,DMS,U1V,1-(4-fluoro-2-methylphenyl)methanesulfonamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-25 (Mpro-x10787),3C-like proteinase,1,A,306,Yes,DMS,LT9,1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)-3-oxocyclobutane-1-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ge7,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ADA-UCB-6c2cb422-3 (Mpro-x11354),3C-like proteinase,1,A,306,Yes,DMS,N9I,"2-(4-methylpyridin-3-yl)-N-(1,2,3,4-tetrahydroisoquinolin-8-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7awu,Structure of SARS-CoV-2 Main Protease bound to LSN2463359.,3C-like proteinase,1,A,306,Yes,CL,S8B,~{N}-propan-2-yl-5-(2-pyridin-4-ylethynyl)pyridine-2-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7wqb,SARS-CoV-2 main protease mutant (P168A) in complex with MG-132,3C-like proteinase nsp5,1,A,307,Yes,MG,ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,P168A,99.35,1
8h7w,Crystal structure of SARS-CoV-2 main protease (Mpro) Mutant (S144A) in complex with protease inhibitor Nirmatrelvir,3C-like proteinase nsp5,1,A,305,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,S144A,99.35,1
5rff,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102704,3C-like proteinase,1,A,306,Yes,DMS,T6M,1-{4-[(4-chlorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gj8,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-fce787c2-6 (Mpro-P0185),3C-like proteinase,2,"A,B",306,Yes,DMS,QKR,"2-(3,4-dichlorophenyl)-2,2-difluoro-N-(isoquinolin-4-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gg6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-477dc5b7-2 (Mpro-x12171),3C-like proteinase,1,A,306,Yes,DMS,OQL,"(4R)-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7sh7,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI87,3C-like proteinase nsp5,1,A,306,Yes,,9GI,"benzyl [(2S,3R)-3-tert-butoxy-1-{[(2S)-3-cyclohexyl-1-oxo-1-(2-{[(3S)-2-oxopyrrolidin-3-yl]methyl}-2-propanoylhydrazinyl)propan-2-yl]amino}-1-oxobutan-2-yl]carbamate (non-preferred name)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uud,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI33,3C-like proteinase nsp5,1,A,306,Yes,,I71,"(1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-(ethylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7l8j,SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21212),3C-like proteinase,1,A,306,Yes,,AG7,4-{2-(4-FLUORO-BENZYL)-6-METHYL-5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-4-OXO-HEPTANOYLAMINO}-5-(2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gcs,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-18 (Mpro-x10733),3C-like proteinase,1,A,306,Yes,DMS,LS0,2-(6-fluoro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7c7p,Crystal structure of the SARS-CoV-2 main protease in complex with Telaprevir,3C-like proteinase,2,"A,B",306,Yes,CL,SV6,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjv,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-932d1078-3 (Mpro-P0661),3C-like proteinase,2,"A,B",306,Yes,DMS,QP6,"(4S)-6,8-difluoro-N-(isoquinolin-4-yl)-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gdu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-SGC-a8a902d9-1 (Mpro-x11225),3C-like proteinase,1,A,306,Yes,DMS,N0F,(3R)-3-(4-hydroxypiperidin-1-yl)-N-(4-methylpyridin-3-yl)-3-(thiophen-3-yl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7q5e,Crystal structure of F2F-2020209-00X bound to the main protease (3CLpro/Mpro) of SARS-CoV-2.,3C-like proteinase,2,"A,B",306,Yes,"CL
NA",90I,"benzyl (S)-2-(((S)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-4-(phenethylamino)butan-2-yl)carbamoyl)pyrrolidine-1-carboxylate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mbi,Structure of SARS-CoV2 3CL protease covalently bound to peptidomimetic inhibitor,3C-like proteinase,4,"A,B,C,D",306,Yes,,"YWJ
FN7","4-methoxy-N-[(2S)-4-methyl-1-oxo-1-({(2S)-3-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}amino)pentan-2-yl]-1H-indole-2-carboxamide
2,4,6-trimethylpyridine-3-carboxylic acid","non-polymer
non-polymer","
","Yes
No","CYS145 A
",6LU7_1|Chain,0,,100.00,0
7phz,Crystal structure of X77 bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 in spacegroup P2(1)2(1)2(1).,Replicase polyprotein 1ab,2,"A,B",306,Yes,"EDO
CL
DMS
NA",X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7rvw,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI23,3C-like proteinase,1,A,306,Yes,,7YB,benzyl (1-{[(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamoyl}cyclopropyl)carbamate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
8tqh,MPI68 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,JX6,N~2~-[(benzyloxy)carbonyl]-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gnl,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NIR-WEI-dcc3321b-1 (Mpro-P2757),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",S1U,"(4S)-6-chloro-2-{2-[4-(4-ethylpiperazin-1-yl)anilino]-2-oxoethyl}-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gea,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-2 (Mpro-x11372),3C-like proteinase,1,A,306,Yes,DMS,N6F,(2S)-N-(4-acetamidopyridin-3-yl)-2-(3-chlorophenyl)propanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vic,The crystal structure of SARS-CoV-2 3C-like protease in complex with a traditional Chinese Medicine Inhibitors,3C-like proteinase,1,A,306,Yes,,ODN,"(1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gfp,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-6b94ceba-5 (Mpro-x11801),3C-like proteinase,1,A,306,Yes,DMS,OHC,2-[3-(acetamidomethyl)-5-chlorophenyl]-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7si9,Room temperature X-ray structure of SARS-CoV-2 main protease (Mpro) in complex with PF-07321332,3C-like proteinase,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gs5,Crystal structure of SARS-CoV-2 main protease in complex with cpd-28,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
SO4
MG",0TI,"(3R)-5-fluoro-3-hydroxy-1,3-dihydro-2H-indol-2-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ggf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-6d04362c-2 (Mpro-x12423),3C-like proteinase,1,A,306,Yes,DMS,OVF,2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-[4-(dimethylamino)phenyl]acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8czx,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 17d,3C-like proteinase,2,"A,B",309,Yes,PG4,"PJR
P8C","[(1~{S},2~{R})-2-[4,4-bis(fluoranyl)cyclohexyl]cyclopropyl]methyl ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate
[(1~{S},2~{R})-2-[4,4-bis(fluoranyl)cyclohexyl]cyclopropyl]methyl ~{N}-[(2~{S})-1-[[(1~{R},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
5rh8,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4444621965 (Mpro-x2764),3C-like proteinase,1,A,306,Yes,DMS,UHM,"2-(cyanomethoxy)-N-[(1,2-thiazol-4-yl)methyl]benzamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8d4p,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor Jun10-90-3-C1,3C-like proteinase,1,A,306,Yes,,QAO,2-chloro-N-[(1R)-2-{[2-(3-fluorophenyl)ethyl]amino}-2-oxo-1-(pyridin-3-yl)ethyl]-N-[4-(pentafluoro-lambda~6~-sulfanyl)phenyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8di3,Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates,3C-like proteinase nsp5,1,A,306,No,,,,,,,,7TOB_1|Chain,0,,100.00,0
7mlf,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) Covalently Bound to Compound C7,3C-like proteinase,1,A,304,Yes,,C7A,N-(4-tert-butylphenyl)-2-chloro-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]acetamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.35,2
5rek,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102327,3C-like proteinase,1,A,306,Yes,DMS,T1Y,1-{4-[(3-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gbq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-23 (Mpro-x10396),3C-like proteinase,1,A,306,Yes,DMS,KYU,"2-(3-chlorophenyl)-2,2-difluoro-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7c2y,The crystal structure of COVID-2019 main protease in the apo state,3C-like proteinase,2,"A,B",298,No,,,,,,,,6LU7_1|Chain,0,,97.39,8
6m2n,SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor,3C-like proteinase,4,"A,B,C,D",306,Yes,,3WL,"5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ggc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-044491d2-3 (Mpro-x12321),3C-like proteinase,1,A,306,Yes,DMS,OTV,"2-(3-chloro-5-{[(1S,2R)-2-(trifluoromethyl)cyclopropyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8j38,Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with PF00835231,3C-like proteinase nsp5,2,"A,B",299,Yes,,V2M,"N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,CYS145 A,7TOB_1|Chain,0,,97.71,7
7ng3,Crystal structure of MG-132 covalently bound to the main protease (3CLpro/Mpro) of SARS-CoV-2 in spacegroup P1.,3C-like proteinase,2,"A,B",306,Yes,CL,ALD,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gaw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e194df51-1 (SARS2_MproA-x0862),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",KG9,"(4S)-6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8bs1,Room-temperature structure of SARS-CoV-2 Main protease at atmospheric pressure,3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
7ggm,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-afd4d4fd-2 (Mpro-x12677),3C-like proteinase,1,A,306,Yes,DMS,OZX,2-(6-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ntv,Crystal structure of SARS CoV2 main protease in complex with DN_EG_002 (modelled using PanDDA event map),3C-like proteinase,2,"A,B",306,Yes,DMS,US8,2-acetamido-N-cyclopropyl-5-phenyl-thiophene-3-carboxamide,non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
8igy,SARS-CoV-2 3CL protease (3CLpro) in complex with nirmatrelvir,3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,"CYS, 145-(4WI, .)",6LU7_1|Chain,0,,100.00,0
7gbu,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ADA-UNI-f8e79267-5 (Mpro-x10421),3C-like proteinase,1,A,306,Yes,DMS,L2I,(2S)-4-(methylamino)-2-phenyl-N-(pyridin-3-yl)butanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rl3,PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-39 (Mpro-x3117),3C-like proteinase,1,A,306,Yes,DMS,VEP,N-(4-tert-butylphenyl)-N-[(1R)-2-[(oxan-4-yl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gki,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RUB-POS-1325a9ea-4 (Mpro-P0887),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QX9,2-(3-chlorophenyl)-N-(6-methylisoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ig7,Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with GC376,3C-like proteinase nsp5,2,"A,B",299,Yes,,UED,N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,G15S,97.39,7
7m8m,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 11,3C-like proteinase,2,"A,B",306,Yes,,YSG,"5-[3-(3-chloro-5-propoxyphenyl)-2-oxo-2H-[1,3'-bipyridin]-5-yl]pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7maw,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM129,3C-like proteinase,2,"A,B",306,Yes,,YVA,ethyl (4R)-4-({3-cyclopropyl-N-[(2E)-3-(4-ethynylphenyl)prop-2-enoyl]-L-alanyl}amino)-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7set,SARS-CoV-2 Main Protease (Mpro) in Complex with ML1000,3C-like proteinase,1,A,306,Yes,CL,I70,"(1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rgg,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z2856434890 (Mpro-x0165),3C-like proteinase,1,A,306,Yes,DMS,NZD,4-methyl-N-phenylpiperazine-1-carboxamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gf2,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MIC-UNK-08cd9c58-1 (Mpro-x11548),3C-like proteinase,1,A,306,Yes,DMS,O0X,"2-(3-chlorophenyl)-N-(1,7-naphthyridin-5-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8k6d,Crystal structure of SARS-CoV-2 3CLpro M49K/S301P mutant in complex with WU-04,3C-like proteinase nsp5,1,A,306,Yes,,J7R,"~{N}-[(1~{S},2~{R})-2-[[4-bromanyl-2-(methylcarbamoyl)-6-nitro-phenyl]amino]cyclohexyl]isoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,2,"M49K, S301P",99.35,0
7gku,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-40 (Mpro-P1079),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R08,"(4S)-6-chloro-N-(isoquinolin-4-yl)-2-(1-methyl-1H-pyrazole-5-carbonyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ap6,Structure of SARS-CoV-2 Main Protease bound to MUT056399.,3C-like proteinase,1,A,306,Yes,,RQN,4-(4-ethyl-5-fluoranyl-2-oxidanyl-phenoxy)-3-fluoranyl-benzamide,non-polymer,,Yes,"MET, 165-(RQN, .); MET, 49-(RQN, .)",6LU7_1|Chain,0,,100.00,0
7ghf,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-4e090d3a-47 (Mpro-x3305),3C-like proteinase,1,A,306,Yes,DMS,Q60,"N'-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]-N-(2-phenylethyl)-N-[(pyridin-3-yl)methyl]urea",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9ars,Crystal structure of SARS-CoV-2 main protease E166V mutant in complex with an inhibitor TKB-245,3C-like proteinase nsp5,2,"A,B",306,Yes,,T2L,"(1R,2S,5S)-N-{(1S,2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E166V,99.67,0
7tel,SARS-CoV-2 3CLPro in complex with N-(4-(1H-imidazol-4-yl)phenyl)-N-(3-chloro-5-fluorobenzyl)-2-(isoquinolin-4-yl)acetamide,3C-like proteinase,1,A,306,Yes,,I2N,N-[(3-chloro-5-fluorophenyl)methyl]-N-[4-(1H-imidazol-4-yl)phenyl]-2-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8d4k,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H172Y Mutant in Complex with Inhibitor GC376,3C-like proteinase nsp5,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,H172Y,99.67,0
7m8z,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 29,3C-like proteinase,1,A,306,Yes,,YTV,"5-{3-[3-chloro-5-(3-hydroxy-3-methylbutoxy)phenyl]-2-oxo-2H-[1,3'-bipyridin]-5-yl}pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mhq,Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 310 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7gmq,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-90fd5f68-13 (Mpro-P2210),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RMI,2-(3-chlorophenyl)-N-{7-[2-(dimethylamino)ethoxy]isoquinolin-4-yl}acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8dz2,Crystal Structure of SARS-CoV-2 Main protease in complex with Nirmatrelvir,3C-like proteinase nsp5,2,"A,B",306,Yes,DMS,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9aul,"Structure of SARS-CoV-2 Mpro mutant (A173V,T304I)) in complex with Nirmatrelvir (PF-07321332)",3C-like proteinase nsp5,1,A,306,Yes,,4WI,"(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,2,"A173V, T304I",99.35,0
7gbg,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-83b26c96-1 (Mpro-x10329),3C-like proteinase,1,A,306,Yes,DMS,KVF,(2S)-2-(3-chlorophenyl)-N-(5-methylpyridazin-4-yl)butanamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8stz,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI37,3C-like proteinase nsp5,1,A,306,Yes,,WGI,benzyl (3S)-3-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-2-azaspiro[4.5]decane-2-carboxylate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8udf,Crystal structure of SARS-CoV-2 3CL protease with inhibitor DEL_7,3C-like proteinase nsp5,1,A,306,Yes,"CL
NA",WB0,"2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-1-(4-fluorophenyl)-4-(methylamino)-4-oxobutan-2-yl]-D-phenylalaninamide",non-polymer,,Yes,"CSO, 145-(WB0, .)",6LU7_1|Chain,0,,100.00,0
6xoa,The crystal structure of 3CL MainPro of SARS-CoV-2 with C145S mutation,3C-like proteinase,4,"A,B,C,D",306,No,EDO,,,,,,,6LU7_1|Chain,1,C145S,99.67,0
8tqu,MPI51 bound to Mpro of SARS-CoV-2,3C-like proteinase nsp5,1,A,306,Yes,,PRD_002393,UAW247,Peptide-like,Inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7nbt,Crystal Structure of SARS-CoV-2 main protease (Nsp5) in complex with compound 21,3C-like proteinase nsp5,1,A,306,Yes,DMS,U7W,"2-(benzotriazol-1-yl)-1-[(4~{S})-4-methyl-6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-yl]ethanone",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8hqg,Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with inhibitor YH-53,3C-like proteinase nsp5,2,"A,B",299,Yes,,HUR,"N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",non-polymer,,Yes,"CYS, 143-(HUR, .)",6LU7_1|Chain,1,K90R,97.39,7
7qt7,Room temperature In-situ SARS-CoV-2 MPRO with bound Z4439011520,3C-like proteinase nsp5,1,A,305,Yes,DMS,UHV,"N-(5-tert-butyl-1,2-oxazol-3-yl)-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
8dif,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,2,"A,B",306,Yes,,U1R,5-bromo-3-[(naphthalen-2-yl)methoxy]pyridine-2-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7ax6,Structure of SARS-CoV-2 Main Protease bound to Glutathione isopropyl ester,3C-like proteinase,1,A,306,Yes,"DMS
IMD",S8H,(2~{S})-2-azanyl-5-oxidanylidene-5-[[(2~{S})-1-oxidanylidene-1-[(2-oxidanylidene-2-propan-2-yloxy-ethyl)amino]-3-sulfanyl-propan-2-yl]amino]pentanoic acid,non-polymer,,Yes,CYS156 A,6LU7_1|Chain,0,,100.00,0
8gvy,SARS CoV-2 Mpro in complex with D-3-149,3C-like proteinase nsp5,1,A,306,Yes,,(ACY)AI(0A9),"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE",polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gkr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-4223bc15-2 (Mpro-P1015),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QZC,"(4S)-6-chloro-2-(dimethylsulfamoyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8jcn,The crystal structure of SARS-CoV-2 main protease in complex with Compound 58,3C-like proteinase nsp5,1,A,306,Yes,"GOL
DMS",AO0,1-[3-(diphenoxyphosphorylamino)phenyl]ethanone,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7djr,Crystal structure of SARS-CoV-2 main protease (no ligand),3C-like proteinase,1,A,306,No,DMS,,,,,,,6LU7_1|Chain,0,,100.00,0
9bnt,Crystal Structure of T21I SARS-CoV-2 Main Protease,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,1,T21I,99.67,0
7kfi,SARS-CoV-2 Main protease immature form - apo structure,3C-like proteinase,2,"A,B",309,No,"DMS
PEG",,,,,,,6LU7_1|Chain,0,,99.03,3
8wzp,Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with CCF0058981,3C-like proteinase nsp5,2,"A,B",302,Yes,,XIU,2-(benzotriazol-1-yl)-~{N}-[(3-chlorophenyl)methyl]-~{N}-[4-(1~{H}-imidazol-5-yl)phenyl]ethanamide,non-polymer,,No,,6LU7_1|Chain,4,"M49I, R222A, F223R, Q306V",97.39,4
7mhp,Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 298 K at high humidity,3C-like proteinase,1,A,306,No,ZN,,,,,,,6LU7_1|Chain,0,,100.00,0
5rfg,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102372,3C-like proteinase,1,A,306,Yes,DMS,T6V,"N-[(3S)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-phenylacetamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5r81,PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z1367324110,3C-like proteinase,1,A,306,Yes,DMS,RZJ,"1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8igo,Crystal structure of apo SARS-CoV-2 main protease,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7tfr,Room temperature X-ray structure of SARS-CoV-2 main protease (3CL Mpro) in complex with NBH-2,3C-like proteinase,1,A,306,Yes,,NB2,"(1R,2S,5S)-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-({1-[(2-methylpropane-2-sulfonyl)methyl]cyclohexyl}carbamoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gjx,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-3ccb8ef6-1 (Mpro-P0744),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QNU,"(4S)-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ehk,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) T135I Mutant,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,1,T135I,99.67,0
8did,Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors,3C-like proteinase nsp5,2,"A,B",306,Yes,,U0R,5-bromo-3-[(5-bromo-2-chlorophenyl)methoxy]pyridine-2-carbaldehyde,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
5rgx,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1344037997 (Mpro-x2572),3C-like proteinase,1,A,306,Yes,DMS,UGP,2-(3-cyanophenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8e69,Crystal structure of SARS-CoV-2 3CL protease in complex with a m-fluorodimethyl oxybenzene inhibitor,3C-like proteinase,2,"A,B",309,Yes,,WIO,"(1R,2S)-2-[(N-{[2-(3-fluorophenoxy)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,98.39,5
7gmy,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-e69ed63d-13 (Mpro-P2242),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RQF,"(4S)-6-chloro-N-(7-fluoroisoquinolin-4-yl)-1-oxo-2-[2-oxo-2-(propylamino)ethyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcn,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with BAR-COM-0f94fc3d-41 (Mpro-x10679),3C-like proteinase,1,A,306,Yes,DMS,LQ0,2-(6-chloro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6xb2,Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is highly reactive: Insights for enzyme mechanism and drug design,3C-like proteinase,1,A,306,Yes,DMS,NEN,"1-ETHYL-PYRROLIDINE-2,5-DIONE",non-polymer,,Yes,CYS156 A,6LU7_1|Chain,0,,100.00,0
7gb0,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-c0143b99-1 (Mpro-x10082),3C-like proteinase,1,A,306,Yes,DMS,KLR,(2S)-N-tert-butyl-2-[4-(2-cyanoethyl)anilino]-2-(pyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ju7,The crystal structure of SARS-CoV-2 Main Protease in complex with masitinib,3C-like proteinase,1,A,306,Yes,"DMS
GOL",G65,Masitinib,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7m90,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 50,3C-like proteinase,1,A,306,Yes,,YTS,"5-(3-{3-chloro-5-[2-(3-oxopiperazin-1-yl)ethoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7vah,The crystal structure of COVID-19 main protease in H41A mutation,3C-like proteinase,1,A,306,No,,,,,,,,6LU7_1|Chain,1,H41A,99.67,0
7ein,SARS-CoV-2 main proteinase complex with microbial metabolite leupeptin,3C-like proteinase,2,"A,B",306,Yes,,(ACY)LL(OAR),leupeptin,polypeptide(L),,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gir,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-971238d3-1 (Mpro-P0125),3C-like proteinase,2,"A,B",306,Yes,DMS,QIB,"(4S)-6-chloro-4-hydroxy-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
6y2g,"Crystal structure (orthorhombic form) of the complex resulting from the reaction between SARS-CoV-2 (2019-nCoV) main protease and tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate (alpha-ketoamide 13b)",3C-like proteinase nsp5,2,"A,B",303,Yes,,O6K,"~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.02,3
7gky,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RUB-POS-1325a9ea-14 (Mpro-P1470),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R1U,"2-(3-chlorophenyl)-N-(1-methyl-1H-pyrazolo[4,3-c]pyridin-7-yl)acetamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gkd,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-UNI-8d415491-3 (Mpro-P0850),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QVU,"(4R)-6,7-dichloro-N-(2,7-naphthyridin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7m8n,CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV) MAIN PROTEASE IN COMPLEX WITH COMPOUND 16,3C-like proteinase,2,"A,B",306,Yes,,YSP,"5-(3-{3-chloro-5-[(2-methylphenyl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rf7,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z316425948_minor,3C-like proteinase,1,A,306,Yes,DMS,T67,"1-(4-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7ghe,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-916a2c5a-4 (Mpro-x3303),3C-like proteinase,1,A,306,Yes,DMS,Q5R,4-(4-phenylpiperazine-1-carbonyl)quinolin-2(1H)-one,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcc,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with ALP-POS-95b75b4d-4 (Mpro-x10566),3C-like proteinase,1,A,306,Yes,DMS,LBO,2-(3-cyclopropylphenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8ykq,Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with X77,3C-like proteinase nsp5,1,A,299,Yes,,X77,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,non-polymer,,No,,6LU7_1|Chain,1,V186F,97.39,7
7ldx,SARS-CoV-2 Main protease immature form - F2X Entry Library E06 fragment,3C-like proteinase,2,"A,B",309,Yes,"PEG
DMS",R9V,(3-endo)-8-benzyl-8-azabicyclo[3.2.1]octan-3-ol,non-polymer,,No,,6LU7_1|Chain,0,,99.03,3
7rnw,SARS-CoV-2 Main Protease in complex with a cyclic peptide inhibitor,3C-like proteinase,4,"A,B,C,D",306,Yes,,(ACE)(DTY)LQYAVLRHKRRE(9OW),ACE-DTY-LEU-GLN-TYR-ALA-VAL-LEU-ARG-HIS-LYS-ARG-ARG-GLU-SEC,polypeptide(L),,No,,6LU7_1|Chain,0,,100.00,0
7gs6,Crystal structure of SARS-CoV-2 main protease in complex with cpd-29,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
SO4
MG",XXN,"(3S)-4,7-dichloro-3-hydroxy-1,3-dihydro-2H-indol-2-one",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uu7,Crystal structure of the SARS-CoV-2 main protease in its apo-form,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7gdz,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-c9973a83-1 (Mpro-x11271),3C-like proteinase,1,A,306,Yes,DMS,N3I,2-(3-chloro-5-methoxyphenyl)-N-(4-methylpyridin-3-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gib,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-2d450e86-10 (Mpro-P0064),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",QER,2-(3-fluorophenyl)-N-(isoquinolin-4-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7grg,Crystal structure of SARS-CoV-2 main protease in complex with cpd-3,3C-like proteinase nsp5,2,"A,B",306,Yes,"DMS
NA
CL",Y2C,"3,5-dichloropyridin-4-amine",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
8gfn,"Room temperature X-ray structure of truncated SARS-CoV-2 main protease C145A mutant, residues 1-304, in complex with BBH1",3C-like proteinase nsp5,2,"A,B",304,Yes,,ZGI,"(1R,2S,5S)-N-{(2S)-1-(1,3-benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,No,,6LU7_1|Chain,1,C145A,99.02,2
8dru,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp7-nsp8 (C7) cut site sequence,Fusion protein of 3C-like proteinase nsp5 and nsp7-nsp8 (C7) cut site,7,"A,B,C,D,E,F,G",306,No,"PO4
PEG
1PE",,,,,,,6LU7_1|Chain,5,"C145A, S301N, G302R, V303A, F305L",98.37,0
5r83,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z44592329,3C-like proteinase,1,A,306,Yes,DMS,K0G,N-phenyl-N'-pyridin-3-ylurea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gcw,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with NAU-LAT-445f63e5-6 (Mpro-x10800),3C-like proteinase,1,A,306,Yes,DMS,LV9,N-(4-benzyloxan-4-yl)-N'-(pyridin-3-yl)urea,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
9arq,Crystal structure of SARS-CoV-2 main protease (authentic protein) in complex with an inhibitor TKB-245,3C-like proteinase nsp5,1,A,306,Yes,,T2L,"(1R,2S,5S)-N-{(1S,2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gm6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-7889e8da-5 (Mpro-P2090),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RHI,"(4S)-6-chloro-N-[7-(methanesulfonyl)isoquinolin-4-yl]-2-[2-(methylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7wyp,Structure of the SARS-COV-2 main protease with EN102 inhibitor,3C-like proteinase,2,"A,B",306,Yes,,G7O,"N-(1,3-benzothiazol-2-ylmethyl)-N-cyclopropyl-prop-2-enamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7s73,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI37,3C-like proteinase,1,A,306,Yes,,I69,"(6S)-5-{(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-5-azaspiro[2.4]heptane-6-carboxamide (non-preferred name)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,1,E178A,99.67,0
8d4m,Crystal Structure of SARS-CoV-2 Main Protease (Mpro) S144A Mutant in Complex with Inhibitor GC376,3C-like proteinase nsp5,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,1,S144A,99.67,0
5rg0,PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102535,3C-like proteinase,1,A,306,Yes,DMS,T8Y,"1,1'-(piperazine-1,4-diyl)di(ethan-1-one)",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7mrr,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor Leupeptin,3C-like proteinase,1,A,306,Yes,DMS,PRD_000216,LEUPEPTIN,Oligopeptide,Enzyme inhibitor,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7gj4,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDG-MED-5d232de5-1 (Mpro-P0160),3C-like proteinase,2,"A,B",306,Yes,DMS,QKB,"(4R)-6-chloro-N-(6-fluoroisoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gmr,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with PET-UNK-7fb4f80a-2 (Mpro-P2214),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RN0,4-[2-(3-chlorophenyl)acetamido]isoquinolin-6-yl methanesulfonate,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7c8u,The crystal structure of COVID-19 main protease in complex with GC376,3C-like proteinase,1,A,306,Yes,,K36,"(1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",peptide-like,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7jp0,Crystal structure of Mpro with inhibitor r1,3C-like proteinase,1,A,306,Yes,DMS,VJA,N-[(benzyloxy)carbonyl]-L-valyl-N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8e63,Crystal structure of SARS-CoV-2 3CL protease in complex with a phenyl sulfane inhibitor,3C-like proteinase,2,"A,B",309,Yes,PG4,"UV2
UUR","(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-[(N-{[2-(phenylsulfanyl)ethoxy]carbonyl}-L-leucyl)amino]propane-1-sulfonic acid
2-phenylsulfanylethyl ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[bis(oxidanyl)-oxidanylidene-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate","non-polymer
non-polymer","
","Yes
Yes","CYS145 A
CYS145 A",6LU7_1|Chain,0,,98.39,5
8u9v,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI101,3C-like proteinase nsp5,1,A,306,Yes,DMS,W1C,N-{(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-N~2~-{[(pyridin-3-yl)methoxy]carbonyl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7aeh,"SARS-CoV-2 main protease in a covalent complex with a pyridine derivative of ABT-957, compound 1",3C-like proteinase nsp5,1,A,305,Yes,DMS,R8H,"(2~{R})-5-oxidanylidene-~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl]-1-(phenylmethyl)pyrrolidine-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,99.67,1
7lcr,Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability,3C-like proteinase,2,"A,B",306,Yes,,XTM,N~2~-{[(3-fluorophenyl)methoxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
9auo,"Structure of SARS-CoV-2 Mpro mutant (L50F,T304I)",3C-like proteinase nsp5,2,"A,B",306,No,,,,,,,,6LU7_1|Chain,2,"L50F, T304I",99.35,0
5rgs,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1259086950 (Mpro-x1163),3C-like proteinase,1,A,306,Yes,DMS,S7V,[(2~{R})-4-(phenylmethyl)morpholin-2-yl]methanol,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
5rgu,PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z4444622180 (Mpro-x2562),3C-like proteinase,1,A,306,Yes,DMS,UGD,N-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7jpz,Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI1,3C-like proteinase,1,A,306,Yes,,GHX,(phenylmethyl) N-[(2S)-1-oxidanylidene-1-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-3-phenyl-propan-2-yl]carbamate,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7uu9,Crystal structure of the SARS-CoV-2 main protease in its apo-form,3C-like proteinase nsp5,1,A,306,No,,,,,,,,6LU7_1|Chain,0,,100.00,0
7nt1,Crystal structure of SARS CoV2 main protease in complex with FSP007,3C-like proteinase,2,"A,B",306,Yes,DMS,UQW,[(2R)-1-[2-(1H-indol-3-yl)ethylamino]-1-oxidanylidene-butan-2-yl] prop-2-enoate,non-polymer,,Yes,CYS145 B,6LU7_1|Chain,0,,100.00,0
8fy6,SARS-CoV-2 main protease in complex with covalent inhibitor,3C-like proteinase nsp5,1,A,306,Yes,,YVZ,"(1R,2S,5S)-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-N-{(2R)-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-azabicyclo[3.1.0]hexane-2-carboxamide",non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
7glo,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with JAN-GHE-5a013bed-2 (Mpro-P2001),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",L6D,N-(1H-benzimidazol-1-yl)-2-(3-chlorophenyl)acetamide,non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gl3,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with EDJ-MED-1981ceba-2 (Mpro-P1624),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",R4X,"(4S)-2-(azetidine-1-sulfonyl)-6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gjk,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with RAL-THA-4aa06b95-7 (Mpro-P0578),3C-like proteinase,2,"A,B",306,Yes,DMS,QOU,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-(2-methoxyethyl)-1,2,3,4-tetrahydroquinoline-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7gn6,Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-e119ab4f-5 (Mpro-P2358),3C-like proteinase,2,"A,B",306,Yes,"DMS
CL",RTS,"(4S)-6-chloro-N-(isoquinolin-4-yl)-4-methyl-2-[2-(methylamino)-2-oxoethyl]-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide",non-polymer,,No,,6LU7_1|Chain,0,,100.00,0
7mb3,SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM145,3C-like proteinase,6,"A,B,C,D,E,F",306,Yes,,YVV,N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide,non-polymer,,Yes,CYS145 A,6LU7_1|Chain,0,,100.00,0
8c2r,SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody,"Spike glycoprotein
CAB-A17 antibody (LC)
CAB-A17 antibody (HC)",7,"A,B,C,D,F,E,G","1122, 214, 213",Yes,NAG,"2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,",2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,"oligosaccharide,",,No,,6LU7_1|Chain,"125
100
120","G2F, F3T, K5G, M6V, A7Y, F8Y, G11D, E14F, G15R, C16S, M17S, C22N, G29D, L30P, W31F, V36Y, C38E, P39F, I43N, S46F, D48Y, M49V, L50S, N51Q, N53F, Y54L, E55M, R60F, N63K, G71P, N72L, Q74D, V77P, M82L, N84P, C85R, V86T, L87F, K88L, T93C, N95D, P99L, Y101S, K102F, F103T, I106V, G109N, Q110A, N119G, G120V, Y126R, C128I, M130A, R131D, H132Y, F140N, G143K, S144P, S147V, V148A, D153C, D155R, C156S, V157Y, C160T, M162G, H164S, M165F, V171P, H172K, A173K, G174S, D176N, E178N, G179F, Y182N, R188P, A191C, Q192S, A193F, A194G, D197P, T198G, I200N, V202S, V204Q, L205V, W207V, A210Q, A211G, N214H, G215A, W218T, F219G, L220S, R222V, T224Q, N228G, D229A, F230E, L232S, M235Y, K236S, Y237N, Y239T, P241I, Q244K, D245T, H246S, L250C, P252L, Q256L, L262Q, M264V, C265F, Q273F, M276F, N277K, R279L, I281V, G283T, E288A, D289G, E290T, F291I
G15I, C16V, M17L, V18T, T21S, C22P, N51S, Y54G, K61A, T93R, I106S, P108S, G109L, Q110S, V114Y, C117W, N119Q, G120Q, S121K, N133R, F134L, T135L, K137F, C145R, G146A, Y154P, C156R, V157F, V171G, H172G, A173S, G179E, N180D, Q189T, T190F, A191G, D197K, T198V, T199E, T201K, V202R, N203T, L205A, W207P, L208S, Y209V, A210F, A211I, V212F, I213P, N214P, G215S, W218E, F219Q, N221K, R222S, F223G, T225C, T226L, D229N, N238P, Y239R, P241A, L242K, T243V, D245W, H246K, I249A, G251Q, P252S, L253G, S254N, A255S, G258E, I259Q, A260D, V261S, L262K, M264S, C265T, A266Y, K269S, E270S, L271T, G283S, S284K, L286D, L287Y, D289H, E290K, F291V, T292Y, P293A, F294C, D295E, V297T, R298H, C300S, G302P, Q306C
R4D, K5V, M6H, A7L, F8V, P9E, C16G, M17L, V18I, N28P, L30G, W31S, H41L, V42S, I43C, C44A, T45A, D48F, M49I, L50V, N51S, P52A, K61M, L67W, I78P, H80E, S81G, M82L, K90W, F103S, Q107Y, Q110S, N119A, G120E, P122V, S123K, F140R, L141D, F150R, I152T, D153L, D155Q, C156M, V157N, H163L, H164R, M165A, P168D, H172Y, A173Y, G174C, T175A, D176R, L177D, E178Y, N180D, A193Y, A194W, T196Q, D197G, T199L, I200V, Y209S, A210S, V212S, I213T, N214K, D216P, R217S, W218V, L220P, N221L, R222A, F223P, T224S, T225S, L227A, N228A, D229L, F230G, N231C, N238F, Y239P, L242V, D248W, I249N, L250S, P252A, A255V, Q256H, G258F, I259P, C265Q, A266S, K269Y, E270S, L272S, Q273S, N274V, G275V, M276T, N277V, G278P, R279S, T280S, I281S, S284N, A285V, L286N, L287H, E288K, D289P, E290S, F291N, P293K, F294V, V296R, R298E, Q299P, C300K","15.51
23.17
24.30","828
162
123"
7mhl,Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 100 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7mhn,Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 277 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
7mho,Ensemble refinement structure of SARS-CoV-2 main protease (Mpro) at 298 K,3C-like proteinase,1,A,306,No,"DMS
ZN",,,,,,,6LU7_1|Chain,0,,100.00,0
